CARBOXAMIDE APYRASE INHIBITORS
20250275537 ยท 2025-09-04
Inventors
- John Clough (Marlow, GB)
- Matthew Duncton (San Bruno, CA, US)
- Simon Hiebert (Austin, TX, US)
- Jeffrey D. Fowler (Wilkesboro, NC, US)
- Tanya Sabharwal (Austin, TX, US)
Cpc classification
A01N37/20
HUMAN NECESSITIES
A01N43/30
HUMAN NECESSITIES
A01N43/82
HUMAN NECESSITIES
A01N37/24
HUMAN NECESSITIES
A01N37/22
HUMAN NECESSITIES
A01N43/72
HUMAN NECESSITIES
A01N43/84
HUMAN NECESSITIES
International classification
A01N37/22
HUMAN NECESSITIES
A01N37/24
HUMAN NECESSITIES
A01N43/30
HUMAN NECESSITIES
A01N37/20
HUMAN NECESSITIES
A01N43/84
HUMAN NECESSITIES
A01N43/90
HUMAN NECESSITIES
A01N43/82
HUMAN NECESSITIES
A01N43/72
HUMAN NECESSITIES
Abstract
Disclosed herein are apyrase inhibitors of Formula (I):
##STR00001##
Also disclosed herein are methods for using the disclosed inhibitors, including in methods for protecting crops from pests. In one aspect the apyrase inhibitors are useful for enhancing the activity of pesticides for the protection of crops from pathogens and to support crop yield.
Claims
1. A method for inhibiting apyrase, comprising contacting the apyrase with a compound of the formula ##STR00100## wherein R.sup.1 and R.sup.2 are independently selected from C.sub.1-6 alkyl optionally substituted with one or more R.sup.5; C.sub.6-10 aryl, optionally substituted with one or more R.sup.5, aralkyl optionally substituted with one or more R.sup.5; cycloalkyl optionally substituted with one or more R.sup.5; C.sub.5-10 heteroaryl optionally substituted with one or more R.sup.5; and heterocyclylalkyl optionally substituted with one or more R.sup.5; R.sup.3 and R.sup.4 are independently selected from hydrogen, C.sub.1-6 alkyl, C.sub.6-10 aryl, C.sub.5-10 heteroaryl, each optionally substituted with one or more R.sup.a and R.sup.b; or R.sup.3 and R.sup.4, together with the atoms to which they are attached form a dihydrophthalazine-1,4-dione; or each R.sup.5 is independently selected from R.sup.a, R.sup.b, R.sup.a substituted with one or more R.sup.a, R.sup.b, or both and OR.sup.a substituted with one or more of the same or different R.sup.a or R.sup.b, or (CH.sub.2).sub.mR.sup.b, (CHR.sup.a).sub.mR.sup.b, O(CH.sub.2).sub.mR.sup.b, S(CH.sub.2).sub.mR.sup.b, OCHR.sup.aR.sup.b, OCR.sup.a(R).sub.2, O(CHR.sup.a).sub.mR.sup.b, O(CH.sub.2).sub.mCH[(CH.sub.2).sub.mR.sup.b]R.sup.b, S(CHR.sup.a).sub.mR.sup.b, C(O)NH(CH.sub.2).sub.mR.sup.b, C(O)NH(CHR.sup.a).sub.mR.sup.b, O(CH.sub.2).sub.mC(O)NH(CH.sub.2).sub.mR.sup.b; each R.sup.a is independently selected from the group consisting of hydrogen, C.sub.1-6 alkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, C.sub.1-6 haloalkyl, C.sub.3-8 cycloalkyl, C.sub.6-10 aryl, C.sub.5-10 heteroaryl, C.sub.6-16 arylalkyl, 2-6 membered heteroalkyl and 3-8 membered heterocyclylalkyl, or R.sup.a together with the nitrogen and the R.sup.1 or R.sup.2 attached thereto forms a heterocyclylalkyl optionally substituted with one or more R.sup.d; Z is selected from halogen, C.sub.1-6 alkyl optionally substituted with one or more R.sup.b, OR.sup.a, C.sub.1-6 haloalkyl, or Z, together with R.sup.4 and the atoms to which Z and R are attached, forms a 5- or 6-membered ring optionally substituted with one or more of R.sup.a, R.sup.b, and R.sup.a substituted with one or more R.sup.b, R.sup.d, or both; R.sup.b is independently selected from the group consisting of O, OR.sup.d, halogen, C.sub.1-3 haloalkyloxy, OCF.sub.3, S, SR.sup.d, =NR.sup.d, =NOR.sup.d, NR.sup.cR.sup.c, SF.sub.5, halogen, CF.sub.3, CN, NO.sub.2, S(O)R.sup.d, S(O).sub.2R.sup.d, S(O).sub.2OR.sup.d, S(O)NR.sup.cR.sup.c, S(O).sub.2NR.sup.cR.sup.c, OS(O)R.sup.d, OS(O).sub.2R.sup.d, OS(O).sub.2OR.sup.d, OS(O).sub.2NR.sup.cR.sup.c, C(O)R.sup.d, C(O)OR.sup.d, C(O)NR.sup.cR.sup.c, C(NH)NR.sup.cR.sup.c, C(NR.sup.a)NR.sup.cR.sup.c, C(NOH)R.sup.d, C(NOH)NR.sup.cR.sup.c, OC(O)R.sup.d, OC(O)OR.sup.d, OC(O)NR.sup.cR.sup.c, OC(NH)NR.sup.cR.sup.c, OC(NR.sup.a)NR.sup.cR.sup.c, [NHC(O)].sub.nR.sup.d, [NR.sup.aC(O)].sub.nR.sup.d, [NHC(O)].sub.nOR.sup.d, [NR.sup.aC(O)].sub.nOR.sup.d, [NHC(O)].sub.nNR.sup.cR.sup.c, [NR.sup.aC(O)].sub.nNR.sup.cR.sup.c, [NHC(NH)].sub.nNR.sup.cR.sup.c and [NR.sup.aC(NR.sup.a)].sub.nNR.sup.cR.sup.c; each R.sup.c is independently R.sup.a, or, alternatively, two R.sup.c are taken together with the nitrogen atom to which they are bonded to form a 5 to 10-membered heterocyclylalkyl or heteroaryl which may optionally include one or more of the same or different additional heteroatoms and which may optionally be substituted with one or more of the same or different R.sup.e groups; each R.sup.d is independently hydrogen or C.sub.1-6 alkyl; each R.sup.e is independently halogen, C.sub.1-6 alkyl or C(O)R.sup.d; each m is independently an integer from 1 to 3; and each n is independently an integer from 0 to 3.
2. The method of claim 1, wherein the compound has the formula ##STR00101##
3. The method of claim 1, wherein the compound has the formula ##STR00102##
4. The method of claim 1, wherein the compound has the formula ##STR00103##
5. The method of claim 1, wherein at least one of R.sup.1 and R.sup.2 is C.sub.6-10 aryl, optionally substituted with one or more R.sup.5.
6. The method of claim 1, wherein R.sup.1 and R.sup.2 are both C.sub.6-10 aryl, optionally substituted with one or more R.sup.3.
7. The method of claim 1, wherein R.sup.1 and R.sup.2 are the same.
8. The method of claim 1, wherein at least one of R.sup.1 and R.sup.2 is C.sub.1-6 alkyl.
9. The method of claim 1, wherein one of R.sup.1 and R.sup.2 is aralkyl optionally substituted with one or more R.sup.5.
10. The method of claim 1, wherein one of R.sup.1 and R.sup.2 is cycloalkyl optionally substituted with one or more R.sup.5.
11. The method of claim 1, wherein one of R.sup.1 and R.sup.2 is heteroaryl optionally substituted with one or more R.sup.5.
12. The method of claim 1, wherein one of R.sup.1 and R.sup.2 is heterocyclylalkyl optionally substituted with one or more R.sup.5.
13. The method of claim 1, wherein at least one of R.sup.3 and R.sup.4 is hydrogen.
14. The method of claim 1, wherein at least one of R.sup.3 and R.sup.4 is C.sub.1-6 alkyl.
15. The method of claim 1, wherein the compound has the formula ##STR00104##
16. The method of claim 1, wherein the compound has the formula ##STR00105##
17. The method of claim 1, wherein the compound has the formula ##STR00106##
18. The method of claim 1, wherein the compound has the formula ##STR00107##
19. The method of claim 1, wherein R.sup.3 is R.sup.a that together with R.sup.1 and the nitrogen they are both attached to thereto forms a heterocyclylalkyl optionally substituted with one or more R.sup.d.
20. The method of claim 1, wherein R.sup.4 is R.sup.a that together with R.sup.2 and the nitrogen they are both attached to thereto forms a heterocyclylalkyl optionally substituted with one or more R.sup.d.
21. The method of claim 1, wherein R.sup.1 and R.sup.2 independently are selected from ##STR00108## ##STR00109## ##STR00110## ##STR00111##
22. The method of claim 1, wherein contacting the apyrase comprises treating a crop with the compound.
23. The method of claim 22, further comprising treating the crop with a pesticide.
24. The method of claim 22, wherein the pesticide is selected from acaricides, fungicides, herbicides, insecticides, molluscicides, nematocides, or a combination thereof.
25. The method of claim 23, wherein the pesticide comprises a fungicide.
26. The method of claim 22, further comprising treating the crop with a fungicide selected from selected from benzimidazoles, dicarboximides, phenylpyrroles, anilinopyrimidines, hydroxyanilides, carboxamides, phenyl amides, phosphonates, cinnamic acids, oxysterol binding protein inhibitors (OSBPI), triazole carboxamides, cymoxanil, carbamates, benzamides, demethylation inhibiting piperazines, demethylation inhibiting pyrimidines, demethylation inhibiting azoles, including imidazoles and triazoles, such as cyproconazole, difenoconazole, fenbuconazole, flutriafol, mefentrifluconazole, metconazole, ipconazole, prothioconazole, tebuconazole, tetraconazole, triadimefon, triadimenol, triticonazole, morpholines, cyflufenamid, metrafenone, pyriofenone, strobilurins, copper ammonium complex, copper hydroxide, copper oxide, copper oxychloride, copper sulfate, sulfur, lime sulfur, ethylenebisdithiocarbamates, aromatic hydrocarbons, phthalimides, guanidines, polyoxins, fluazinam, thiazolidines and combinations thereof.
27. A composition, comprising a pesticide; compound of the formula ##STR00112## wherein wherein R.sup.1 and R.sup.2 are independently selected from C.sub.1-6 alkyl optionally substituted with one or more R.sup.a optionally substituted with one or more R.sup.a, R.sup.b, or both; C.sub.6-10 aryl, optionally substituted with one or more R.sup.5, aralkyl optionally substituted with one or more R.sup.5, cycloalkyl optionally substituted with one or more R.sup.5, C.sub.5-10 heteroaryl optionally substituted with one or more R.sup.5 and heterocyclylalkyl optionally substituted with one or more R.sup.5; R.sup.3 and R.sup.4 are independently selected from hydrogen, C.sub.1-6 alkyl, C.sub.6-10 aryl, C.sub.5-10 heteroaryl, each optionally substituted with one or more R.sup.a and R.sup.b; or R.sup.3 and R.sup.4, together with the atoms to which they are attached form a dihydrophthalazine-1,4-dione; or each R.sup.5 is independently selected from R.sup.a, R.sup.b, R.sup.a substituted with one or more R.sup.a, R.sup.b, or both and OR.sup.a substituted with one or more of the same or different R.sup.a or R.sup.b, or (CH.sub.2).sub.mR.sup.b, (CHR.sup.a).sub.mR.sup.b, O(CH.sub.2).sub.mR.sup.b, S(CH.sub.2).sub.mR.sup.b, OCHR.sup.cR.sup.c, OCR.sup.a(R.sup.b).sub.2, O(CHR.sup.a).sub.mR.sup.b, O(CH.sub.2).sub.mCH[(CH.sub.2).sub.mR.sup.b]R.sup.b, S(CHR.sup.a).sub.mR.sup.b, C(O)NH(CH.sub.2).sub.mR.sup.b, C(O)NH(CHR.sup.a).sub.mR.sup.b, O(CH.sub.2).sub.mC(O)NH(CH.sub.2).sub.mR.sup.b; each R.sup.a is independently selected from the group consisting of hydrogen, C.sub.1-6 alkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, C.sub.1-6 haloalkyl, C.sub.3-8 cycloalkyl, C.sub.6-10 aryl, C.sub.5-10 heteroaryl, C.sub.6-16 arylalkyl, 2-6 membered heteroalkyl and 3-8 membered heterocyclylalkyl, or R.sup.a together with the nitrogen and the R.sup.1 or R.sup.2 attached thereto forms a heterocyclylalkyl optionally substituted with one or more R.sup.d; Z is selected from halogen, C.sub.1-6 alkyl optionally substituted with one or more R.sup.b, OR.sup.a, C.sub.1-6 haloalkyl, or Z, together with R.sup.4 and the atoms to which Z and R are attached, forms a 5- or 6-membered ring optionally substituted with one or more of R.sup.a, R.sup.b, and R.sup.a substituted with one or more R.sup.b, R.sup.d, or both; R.sup.b is independently selected from the group consisting of =O, OR.sup.d, halogen, C.sub.1-3 haloalkyloxy, OCF.sub.3, S, SR.sup.d, =NR.sup.d, =NOR.sup.d, NR.sup.cR.sup.c, SF.sub.5, halogen, CF.sub.3, CN, NO.sub.2, S(O)R.sup.d, S(O).sub.2R.sup.d, S(O).sub.2OR, S(O)NR.sup.cR.sup.c, S(O).sub.2NR.sup.cR.sup.c, OS(O)R.sup.d, OS(O).sub.2R.sup.d, OS(O).sub.2OR.sup.d, OS(O).sub.2NR.sup.cR.sup.c, C(O)R.sup.d, C(O)OR.sup.d, C(O)NR.sup.cR.sup.c, C(NH)NR.sup.cR.sup.c, C(NR.sup.a)NR.sup.cR.sup.c, C(NOH)R.sup.a, C(NOH)NR.sup.cR.sup.c, OC(O)R.sup.d, OC(O)OR.sup.d, OC(O)NR.sup.cR.sup.c, OC(NH)NR.sup.cR.sup.c, OC(NR.sup.a)NR.sup.cR.sup.c, [NHC(O)].sub.nR.sup.d, [NR.sup.aC(O)].sub.nR.sup.d, [NHC(O)].sub.nOR.sup.d, [NR.sup.aC(O)].sub.nOR.sup.d, [NHC(O)].sub.n NR.sup.cR.sup.c, [NR.sup.aC(O)].sub.n NR.sup.cR.sup.c, [NHC(NH)].sub.n NR.sup.cR.sup.c and [NR.sup.aC(NR)].sub.nN.sup.cR.sup.c; each R.sup.c is independently R.sup.a, or, alternatively, two R.sup.c are taken together with the nitrogen atom to which they are bonded to form a 5 to 10-membered heterocyclylalkyl or heteroaryl which may optionally include one or more of the same or different additional heteroatoms and which may optionally be substituted with one or more of the same or different R.sup.c groups; each R.sup.d is independently hydrogen or C.sub.1-6 alkyl; each R.sup.e is independently halogen, C.sub.1-6 alkyl or C(O)R.sup.d; each m is independently an integer from 1 to 3; and each n is independently an integer from 0 to 3; and a phytologically acceptable carrier.
28. The composition of claim 27, wherein the composition comprises from about 1 to about 80 weight percent of the compound.
29. A pesticidal composition, comprising a pesticide; compound of the formula ##STR00113## herein wherein R.sup.1 and R.sup.2 are independently selected from C.sub.1-6 alkyl optionally substituted with one or more R.sup.a optionally substituted with one or more R.sup.a, R.sup.b, or both; C.sub.6-10 aryl, optionally substituted with one or more R.sup.5, aralkyl optionally substituted with one or more R.sup.5, cycloalkyl optionally substituted with one or more R.sup.5, C.sub.5-10 heteroaryl optionally substituted with one or more R.sup.5 and heterocyclylalkyl optionally substituted with one or more R.sup.5; R.sup.3 and R.sup.4 are independently selected from hydrogen, C.sub.1-6 alkyl, C.sub.6-10 aryl, C.sub.5-10 heteroaryl, each optionally substituted with one or more R.sup.a and R.sup.b; or R.sup.3 and R.sup.4, together with the atoms to which they are attached form a dihydrophthalazine-1,4-dione; or each R.sup.5 is independently selected from R.sup.a, R.sup.b, R.sup.a substituted with one or more R.sup.a, R.sup.b, or both and OR.sup.a substituted with one or more of the same or different R.sup.a or R.sup.b, or (CH.sub.2).sub.mR.sup.b, (CHR.sup.8).sub.mR.sup.b, O(CH.sub.2).sub.mR.sup.b, S(CH.sub.2).sub.mR.sup.b, OCHR.sup.aR.sup.b, OCR.sup.a(R.sup.b).sub.2, O(CHR.sup.a).sub.mR.sup.b, O(CH.sub.2).sub.mCH[(CH.sub.2).sub.mR.sup.b]R.sup.b, S(CHR.sup.a).sub.mR.sup.b, C(O)NH(CH.sub.2).sub.mR.sup.b, C(O)NH(CHR.sup.a).sub.mR.sup.b, O(CH.sub.2), C(O)NH(CH.sub.2).sub.mR.sup.b; each R.sup.a is independently selected from the group consisting of hydrogen, C.sub.1-6 alkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, C.sub.1-6 haloalkyl, C.sub.3-8 cycloalkyl, C.sub.6-10 aryl, C.sub.5-10 heteroaryl, C.sub.6-16 arylalkyl, 2-6 membered heteroalkyl and 3-8 membered heterocyclylalkyl, or R.sup.a together with the nitrogen and the R.sup.1 or R.sup.2 attached thereto forms a heterocyclylalkyl optionally substituted with one or more R.sup.d; Z is selected from halogen, C.sub.1-6 alkyl optionally substituted with one or more R.sup.b, OR.sup.a, C.sub.1-6 haloalkyl, or Z, together with R.sup.4 and the atoms to which Z and R are attached, forms a 5- or 6-membered ring optionally substituted with one or more of R.sup.a, R.sup.b, and R.sup.a substituted with one or more R.sup.b, R.sup.d, or both; R.sup.b is independently selected from the group consisting of O, OR.sup.d, halogen, C.sub.1-3 haloalkyloxy, OCF.sub.3, S, SR.sup.d, =NR.sup.d, =NOR.sup.d, NR.sup.cR.sup.c, SF.sub.5, halogen, CF.sub.3, CN, NO.sub.2, S(O)R.sup.d, S(O).sub.2R.sup.d, S(O).sub.2OR.sup.d, S(O)NR.sup.cR.sup.c, S(O).sub.2NR.sup.cR.sup.c, OS(O)R.sup.d, OS(O).sub.2R.sup.d, OS(O).sub.2OR.sup.d, OS(O).sub.2NR.sup.cR.sup.c, C(O)R.sup.d, C(O)OR.sup.d, C(O)NR.sup.cR.sup.c, C(NH)NR.sup.cR.sup.c, C(NR.sup.a)NR.sup.cR.sup.c, C(NOH)R.sup.a, C(NOH)NR.sup.cR.sup.c, OC(O)R.sup.d, OC(O)OR.sup.d, OC(O)NR.sup.cR.sup.d, OC(NH)NR.sup.cR.sup.c, OC(NR.sup.a)NR.sup.cR.sup.c, [NHC(O)].sub.nR.sup.d, [NR.sup.aC(O)].sub.nR.sup.d, [NHC(O)].sub.nOR.sup.d, [NR.sup.aC(O)].sub.nOR.sup.d, [NHC(O)].sub.nNR.sup.cR.sup.c, [NR.sup.aC(O)].sub.nNR.sup.cR.sup.c, [NHC(NH)].sub.nNR.sup.cR.sup.c and [NR.sup.aC(NR.sup.a)].sub.n NR.sup.cR.sup.c, each R.sup.c is independently R.sup.a, or, alternatively, two R.sup.c are taken together with the nitrogen atom to which they are bonded to form a 5 to 10-membered heterocyclylalkyl or heteroaryl which may optionally include one or more of the same or different additional heteroatoms and which may optionally be substituted with one or more of the same or different R.sup.e groups; each R.sup.d is independently hydrogen or C.sub.1-6 alkyl; each R.sup.e is independently halogen, C.sub.1-6 alkyl or C(O)R.sup.d; each m is independently an integer from 1 to 3; and each n is independently an integer from 0 to 3; and a phytologically acceptable carrier.
30. The pesticidal composition of claim 29, wherein the pesticide comprises an acaricide, fungicide, herbicide, insecticide, molluscicide, nematocide, or a combination thereof.
Description
DETAILED DESCRIPTION
I. Terms
[0008] The following explanations of terms and methods are provided to better describe the present disclosure and to guide those of ordinary skill in the art in the practice of the present disclosure. The singular forms a. an, and the refer to one or more than one, unless the context clearly dictates otherwise. The term or refers to a single element of stated alternative elements or a combination of two or more elements, unless the context clearly indicates otherwise. As used herein, comprises means includes. Thus, comprising A or B, means including A, B. or A and B, without excluding additional elements. All references, including patents and patent applications cited herein, are incorporated by reference in their entirety, unless otherwise specified.
[0009] Unless otherwise indicated, all numbers expressing quantities of components, molecular weights, percentages, temperatures, times, and so forth, as used in the specification or claims, are to be understood as being modified by the term about. Accordingly, unless otherwise indicated, implicitly or explicitly, the numerical parameters set forth are approximations that may depend on the desired properties sought and/or limits of detection under standard test conditions/methods. When directly and explicitly distinguishing embodiments from discussed prior art, the embodiment numbers are not approximates unless the word about is expressly recited.
[0010] Unless explained otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this disclosure pertains. Although methods and materials similar or equivalent to those described herein can be used in the practice or testing of the present disclosure, suitable methods and materials are described below. The materials, methods, and examples are illustrative only and not intended to be limiting.
[0011] Administering refers to any suitable mode of administration, to control a fungal pathogen, including, treatment of an extant crop, seeds, soil or combination thereof.
[0012] Control with reference to a fungal pathogen, means block, inhibit and/or eradicate a fungal pathogen and/or prevent the fungal pathogen from damaging a crop. In one embodiment, control refers to the reduction of one or more fungi to undetectable levels, or to the reduction or suppression of a fungus to acceptable levels as determined by one of ordinary skill in the art (for example, a crop grower). Determinations of acceptable levels of fungus reduction are based on a number of factors, including to the crop, pathogen, severity of the pathogen, use restrictions, economic thresholds and other factors known to those of ordinary skill in the art.
[0013] As used herein, the terms enhancer and potentiator, refer to a compound or compounds disclosed herein that enhance the effects of a pesticide. Without limitation to theory the present enhancer compounds disclosed herein may function by blocking one or more pathways by which a pathogen, such as a fungal pathogen, evades toxicity, such as by detoxifying, sequestering or transporting a pesticide. In certain embodiment, the present compounds inhibit enzymatic apyrase activity which leads to the enhancement, accentuation or potentiation of a pesticide, such as an acaricide, antimicrobial, fungicide, herbicide, insecticide, molluscicide and/or nematocide. For example, when the enhancer or potentiator is used in conjunction with a fungicide, the combination of the potentiator and the fungicide enhances the fungicidal effect of the fungicide and/or renders a fungus that has become resistant to the fungicide susceptible to the fungicide as a result of the activity of the potentiator. Most often, these enhancers or potentiators do not themselves inhibit the growth of a fungus itself, nor do they have a detrimental effect on a living organism that is (or could be) infected with a fungus.
[0014] As used herein, the term inoculation refers to a method used to administer or apply an effective amount of a disclosed compound or formulation thereof to a target area of a field and/or plant. The inoculation method can be, but is not limited to, aerosol spray, pressure spray, direct watering, and dipping. Target areas of a plant could include, but are not limited to, the leaves, roots, stems, buds, flowers, fruit, seed of the plant, and bulbs of the plant including bulb, corm, rhizoma, stem tuber, root tuber and rhizophore. Inoculation can include a method wherein a plant is treated in one area (for example, the root zone or foliage) and another area of the plant becomes protected (for example, foliage is inoculated when a disclosed compound is applied in the root zone or new growth when applied to foliage).
[0015] As used herein, the terms wettable granule, water dispersible granule, and dispersible granule refer to a solid granular formulation prepared by a granulation process, optionally containing fine particles of polymer-associated active ingredient, or aggregates of the same, a wetting agent and/or a dispersant, and optionally an inert filler. Wettable granules can be stored as a formulation, and can be provided to the market and/or end user without further processing. In some embodiments, they can be placed in a water-soluble bag for ease of use by the end user. In practical application, wettable granules are prepared for application by the end user. The wettable granules are mixed with water in the end user's spray tank to the proper dilution for the particular application. Dilution can vary by crop, target pathogen, time of year, geography, local regulations, and intensity of infection or pathogen load among other factors. Once properly diluted, the solution can be applied by spraying.
[0016] As used herein, the terms wettable powder, water dispersible powder, and dispersible powder, refer to a solid powdered formulation that contains active ingredient, optionally associated with a polymer, or aggregates of the same, and optionally one or more of a dispersant, a wetting agent, and an inert filler. Wettable powders can be stored as a formulation, and can be provided to the market and/or end user without further processing. In some embodiments, they can be placed in a water-soluble bag for ease of use by the end user. In practical application, a wettable powder is prepared for application by the end user. The wettable powder is mixed with water in the end user's spray tank to the proper dilution for the particular application. Dilution can vary by crop, fungal pathogen, time of year, geography, local regulations, and intensity of fungal load, among other factors. Once properly diluted, the solution can be applied by spraying.
[0017] As used herein, the term high solids liquid suspension refers to a liquid formulation that contains fine particles of active ingredient, or fine polymer particles associated with active ingredient, or aggregates of the same, a wetting agent and/or a dispersant, an anti-freezing agent, optionally an anti-settling agent or thickener, optionally a preservative, and water or oil as a carrier. High solids liquid suspensions can be stored as a formulation, and can be provided to the market and/or end user without further processing. In practical application, high solids liquid suspensions are prepared for application by the end user. The high solids liquid suspensions are mixed with water or oil in the end user's spray tank to the proper dilution for the particular application. Dilution can vary by crop, fungal pathogen, time of year, geography, local regulations, and intensity of infection among other factors. Once properly diluted, the solution can be applied by spraying.
[0018] As used herein, the term phytologically acceptable refers to compositions, diluents, excipients, and/or carriers that are generally applicable for use with any part of a plant during any part of its life cycle, including but not limited to seeds, seedlings, plant cells, plants, or flowers. The compositions can be prepared according to procedures, methods and formulas that are known to those of skill in the agricultural arts. Following the teachings of the present disclosure the artist skilled in the agricultural and/or chemical arts can readily prepare a desired composition. Most commonly, the compounds disclosed herein can be formulated to be stored, and/or applied, as aqueous or non-aqueous suspensions or emulsions prepared neat or from concentrated formulations of the compositions. Alternatively the compounds disclosed herein can be formulated for use in aerosol-generating equipment for application to agricultural produce stored in sealed chambersan application method known as fogging. Water-soluble, water-suspendable or emulsifiable formulations comprising the presently disclosed compounds can also be converted into or formulated as solids (for example, wettable powders), which can then be diluted into a final formulation. In certain formulations, the compositions of the present disclosure can also be provided in growth media, such as in vitro media for growth of plant or other types of cells, in laboratory plant growth media, in soil, or for spraying on seeds, seedlings, roots, stems, stalks, leaves, flowers or the entire plant.
[0019] Compounds herein can include all stereoisomers, including E and Z isomers, enantiomers, diastereomers, mixtures, racemates, atropisomers, and tautomers thereof.
[0020] Non-limiting examples of optional substituents include hydroxyl groups, sulfhydryl groups, halogens, amino groups, nitro groups, nitroso groups, cyano groups, azido groups, sulfoxide groups, sulfone groups, sulfonamide groups, carboxyl groups, carboxaldehyde groups, imine groups, alkyl groups, halo-alkyl groups, alkenyl groups, haloalkenyl groups, alkynyl groups, halo-alkynyl groups, alkoxy groups, aryl groups, aryloxy groups, aralkyl groups, arylalkoxy groups, heterocyclylalkyl groups, heteroaryl groups, cycloalkyl groups, acyl groups, acyloxy groups, carbamate groups, amide groups, ureido groups, epoxy groups, and ester groups.
[0021] Alkyl refers to an optionally substituted straight-chain, or optionally substituted branched-chain saturated hydrocarbon. Non-limiting examples of alkyl groups include straight, branched, and cyclic alkyl and alkylene groups. An alkyl group can be, for example, a C.sub.1, C.sub.2, C.sub.3, C.sub.4, C.sub.5, C.sub.6, C.sub.7, C.sub.8, C.sub.9, C.sub.10, C.sub.11, C.sub.12, C.sub.13, C.sub.14, C.sub.15, C.sub.16, C.sub.17, C.sub.18, C.sub.19, C.sub.20, C.sub.21, C.sub.22, C.sub.23, C.sub.24, C.sub.25, C.sub.26, C.sub.27, C.sub.28, C.sub.29, C.sub.30, C.sub.31, C.sub.32, C.sub.33, C.sub.34, C.sub.35, C.sub.36, C.sub.37, C.sub.38, C.sub.39, C.sub.40, C.sub.41, C.sub.42, C.sub.43, C.sub.44, C.sub.45. C.sub.46, C.sub.47, C.sub.48, C.sub.49, or C.sub.50 group that is substituted or unsubstituted. In some cases alkyl refers to a group having from one to about ten carbon atoms, or from one to six carbon atoms, wherein an sp.sup.3-hybridized carbon of the alkyl residue is attached to the rest of the molecule by a single bond. Whenever it appears herein, a numerical range such as C.sub.1-6 alkyl means that the alkyl group consists of 1 carbon atom, 2 carbon atoms, 3 carbon atoms, 4 carbon atoms, 5 carbon atoms or 6 carbon atoms, although the present definition also covers the occurrence of the term alkyl where no numerical range is designated. In some embodiments, the alkyl is a C.sub.1-10 alkyl, a C.sub.1-9 alkyl, a C.sub.1-8 alkyl, a C.sub.1-7 alkyl, a C.sub.1-6 alkyl, a C.sub.1-5 alkyl, a C.sub.1-4 alkyl, a C.sub.1-3 alkyl, a C.sub.1-2 alkyl, or a C.sub.1 alkyl.
[0022] Examples of alkyl groups include, but are not limited to, methyl, ethyl, n-propyl, isopropyl, 2-methyl-1-propyl, 2-methyl-2-propyl, 2-methyl-1-butyl, 3-methyl-1-butyl, 2-methyl-3-butyl, 2,2-dimethyl-1-propyl, 2-methyl-1-pentyl, 3-methyl-1-pentyl, 4-methyl-1-pentyl, 2-methyl-2-pentyl, 3-methyl-2-pentyl, 4-methyl-2-pentyl, 2,2-dimethyl-1-butyl, 3,3-dimethyl-1-butyl, 2-ethyl-1-butyl, n-butyl, isobutyl, sec-butyl, t-butyl, n-pentyl, isopentyl, neopentyl, tert-amyl, and hexyl, and longer alkyl groups, such as heptyl, octyl, and the like.
[0023] Non-limiting examples of straight alkyl groups include methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl, and decyl.
[0024] Branched alkyl groups include any straight alkyl group substituted with any number of alkyl groups. Non-limiting examples of branched alkyl groups include isopropyl, isobutyl, sec-butyl, and t-butvl.
[0025] Unless stated otherwise specifically in the specification, an alkyl group is optionally substituted, for example, with oxo, halogen, amino, nitrile, nitro, hydroxyl, haloalkyl, alkoxy, aryl, cycloalkyl, heterocyclylalkyl, heteroaryl, and the like. In some embodiments, the alkyl is optionally substituted with oxo, halogen, CN, CF.sub.3, OH, OMe, NH.sub.2, or NO.sub.2. In some embodiments, the alkyl is optionally substituted with oxo, halogen, CN, CF.sub.3, OH, or OMe. In some embodiments, the alkyl is optionally substituted with halogen. Non-limiting examples of substituted alkyl groups includes hydroxymethyl, chloromethyl, trifluoromethyl, aminomethyl, 1-chloroethyl, 2-hydroxyethyl, 1,2-difluoroethyl, and 3-carboxypropyl.
[0026] Alkenyl refers to an optionally substituted straight-chain, or optionally substituted branched-chain hydrocarbon having one or more carbon-carbon double-bonds. The olefin or olefins of an alkenyl group can be, for example, E, Z, cis, trans, terminal, or exo-methylene. An alkenyl group can be, for example, a C.sub.2, C.sub.3, C.sub.4, C.sub.5, C.sub.6, C.sub.7, C.sub.8, C.sub.9, C.sub.10, C.sub.11, C.sub.12, C.sub.13, C.sub.14, C.sub.15, C.sub.16, C.sub.17, C.sub.18, C.sub.19, C.sub.20, C.sub.21, C.sub.22, C.sub.23, C.sub.24, C.sub.25, C.sub.26, C.sub.27, C.sub.28, C.sub.29, C.sub.30, C.sub.31, C.sub.32, C.sub.33, C.sub.34, C.sub.35, C.sub.36, C.sub.37, C.sub.38, C.sub.39, C.sub.40, C.sub.41, C.sub.42, C.sub.43, C.sub.44, C.sub.45, C.sub.46, C.sub.47, C.sub.48, C.sub.49, or C.sub.50 group that is substituted or unsubstituted. Non-limiting examples of alkenyl and alkenylene groups include ethenyl, prop-1-en-1-yl, isopropenyl, but-1-en-4-yl; 2-chloroethenyl, 4-hydroxybuten-1-yl, 7-hydroxy-7-methyloct-4-en-2-yl, and 7-hydroxy-7-methyloct-3,5-dien-2-yl.
[0027] Whenever it appears herein, a numerical range such as C.sub.2-C.sub.6 alkenyl means that the alkenyl group may consist of 2 carbon atoms, 3 carbon atoms, 4 carbon atoms, 5 carbon atoms, or 6 carbon atoms, although the present definition also covers the occurrence of the term alkenyl where no numerical range is designated. In some embodiments, the alkenyl is a C.sub.2-C.sub.10 alkenyl, a C.sub.2-C.sub.9 alkenyl, a C.sub.2-C.sub.8 alkenyl, a C.sub.2-C.sub.7 alkenyl, a C.sub.2-C.sub.6 alkenyl, a C.sub.2-C.sub.5 alkenyl, a C.sub.2-C.sub.4 alkenyl, a C.sub.2-C.sub.3 alkenyl, or a C.sub.2 alkenyl. Unless stated otherwise specifically in the specification, an alkenyl group is optionally substituted, for example, with oxo, halogen, amino, nitrile, nitro, hydroxyl, haloalkyl, alkoxy, aryl, cycloalkyl, heterocyclylalkyl, heteroaryl, and the like. In some embodiments, an alkenyl is optionally substituted with oxo, halogen, CN, CF.sub.3, OH, OMe, NH.sub.2, or NO.sub.2. In some embodiments, an alkenyl is optionally substituted with oxo, halogen. CN, CF.sub.3, OH, or OMe. In some embodiments, the alkenyl is optionally substituted with halogen.
[0028] Alkynyl refers to an optionally substituted straight-chain or optionally substituted branched-chain hydrocarbon. The triple bond of an alkynyl group can be internal or terminal. An alkynyl or alkynylene group can be, for example, a C.sub.2, C.sub.3, C.sub.4. C.sub.5, C.sub.6, C.sub.7, C.sub.8, C.sub.9, C.sub.10, C.sub.11, C.sub.12, C.sub.13, C.sub.14, C.sub.15, C.sub.16, C.sub.17, C.sub.18, C.sub.19, C.sub.20, C.sub.21, C.sub.22, C.sub.23, C.sub.24, C.sub.25, C.sub.26, C.sub.27, C.sub.28, C.sub.29, C.sub.30, C.sub.31, C.sub.32, C.sub.33, C.sub.34, C.sub.35, C.sub.36, C.sub.37, C.sub.38, C.sub.39, C.sub.40, C.sub.41, C.sub.42, C.sub.43, C.sub.44, C.sub.45, C.sub.46, C.sub.47, C.sub.48, C.sub.49, or C.sub.50 group that is substituted or unsubstituted. Non-limiting examples of alkynyl groups include ethynyl, prop-2-yn-1-yl, prop-1-yn-1-yl, and 2-methyl-hex-4-yn-1-yl; 5-hydroxy-5-methylhex-3-yn-1-yl, 6-hydroxy-6-methylhept-3-yn-2-yl, and 5-hydroxy-5-ethylhept-3-yn-1-yl.
[0029] Whenever it appears herein, a numerical range such as C.sub.2-C.sub.6 alkynyl means that the alkynyl group may consist of 2 carbon atoms, 3 carbon atoms, 4 carbon atoms, 5 carbon atoms, or 6 carbon atoms, although the present definition also covers the occurrence of the term alkynyl where no numerical range is designated. In some embodiments, the alkynyl is a C.sub.2-C.sub.10 alkynyl, a C.sub.2-C.sub.9 alkynyl, a C.sub.2-C.sub.8 alkynyl, a C.sub.2-C.sub.7 alkynyl, a C.sub.2-C.sub.6 alkynyl, a C.sub.2-C.sub.5 alkynyl, a C.sub.2-C.sub.4 alkynyl, a C.sub.2-C.sub.3 alkynyl, or a C.sub.2 alkynyl. Unless stated otherwise specifically in the specification, an alkynyl group is optionally substituted, for example, with oxo, halogen, amino, nitrile, nitro, hydroxyl, haloalkyl, alkoxy, aryl, cycloalkyl, heterocyclylalkyl, heteroaryl, and the like. In some embodiments, an alkynyl is optionally substituted with oxo, halogen, CN, CF.sub.3, OH, OMe, NH.sub.2, or NO.sub.2. In some embodiments, an alkynyl is optionally substituted with oxo, halogen. CN, CF.sub.3, OH, or OMe. In some embodiments, the alkynyl is optionally substituted with halogen.
[0030] A haloalkyl group can be any alkyl group substituted with any number of halogen atoms, for example, fluorine, chlorine, bromine, and iodine atoms. A halo-alkenyl group can be any alkenyl group substituted with any number of halogen atoms. A haloalkynyl group can be any alkynyl group substituted with any number of halogen atoms.
[0031] An alkoxy group can be, for example, an oxygen atom substituted with any alkyl, alkenyl, or alkynyl group. An ether or an ether group comprises an alkoxy group. Non-limiting examples of alkoxy groups include methoxy, ethoxy, propoxy, isopropoxy, and isobutoxy.
[0032] The term acyl refers to the groups HC(O), alkyl-C(O), cycloalkyl-C(O), cycloalkenyl-C(O), aryl-C(O), heteroaryl-C(O) and heterocyclyl-C(O) where alkyl, cycloalkyl, cycloalkenyl, aryl, heteroaryl, and heterocyclyl are as described herein. By way of example acyl groups include acetyl and benzoyl groups.
[0033] Alkoxy refers to a radical of the formula OR where R is an alkyl radical as defined. Unless stated otherwise specifically in the specification, an alkoxy group may be optionally substituted, for example, with oxo, halogen, amino, nitrile, nitro, hydroxyl, haloalkyl, alkoxy, aryl, cycloalkyl, heterocyclylalkyl, heteroaryl, and the like. In some embodiments, an alkoxy is optionally substituted with oxo, halogen. CN, CF.sub.3, OH, OMe, NH.sub.2, or NO.sub.2. In some embodiments, an alkoxy is optionally substituted with oxo, halogen, CN, CF.sub.3, OH, or OMe. In some embodiments, the alkoxy is optionally substituted with halogen.
[0034] Aminoalkyl refers to an alkyl radical, as defined above, that is substituted by one or more amines. In some embodiments, the alkyl is substituted with one amine. In some embodiments, the alkyl is substituted with one, two, or three amines. Hydroxyalkyl includes, for example, aminomethyl, aminoethyl, aminopropyl, aminobutyl, or aminopentyl. In some embodiments, the hydroxyalkyl is aminomethyl.
[0035] Aryl refers to a radical derived from a hydrocarbon ring system comprising hydrogen, 6 to 30 carbon atoms, and at least one aromatic ring. The aryl radical may be a monocyclic, bicyclic, tricyclic, or tetracyclic ring system, which may include fused (when fused with a cycloalkyl or heterocyclylalkyl ring, the aryl is bonded through an aromatic ring atom) or bridged ring systems. In some embodiments, the aryl is a 6- to 10-membered aryl. In some embodiments, the aryl is a 6-membered aryl. Aryl radicals include, but are not limited to, aryl radicals derived from the hydrocarbon ring systems of anthrylene, naphthvlene, phenanthrvlene, anthracene, azulene, benzene, chrysene, fluoranthene, fluorene, as-indacene, s-indacene, indane, indene, naphthalene, phenalene, phenanthrene, pleiadene, pyrene, and triphenylene. In some embodiments, the arvl is phenyl. Unless stated otherwise specifically in the specification, an aryl may be optionally substituted, for example, with halogen, amino, nitrile, nitro, hydroxyl, alkyl, alkenyl, alkynyl, haloalkyl, alkoxy, aryl, cycloalkyl, heterocyclylalkyl, heteroaryl, and the like. In some embodiments, an aryl is optionally substituted with halogen, methyl, ethyl, CN, CF.sub.3, OH, OMe, NH.sub.2, or NO.sub.2. In some embodiments, an aryl is optionally substituted with halogen, methyl, ethyl, CN, CF.sub.3, OH, or OMe. In some embodiments, the aryl is optionally substituted with halogen.
[0036] Cycloalkyl refers to a stable, partially or fully saturated, monocyclic or polycyclic carbocyclic ring, which may include fused (when fused with an aryl or a heteroaryl ring, the cycloalkyl is bonded through a non-aromatic ring atom), bridged, or spiro ring systems. Representative cycloalkyls include, but are not limited to, cycloalkyls having from three to fifteen carbon atoms (C.sub.3-C.sub.15 cycloalkyl), from three to ten carbon atoms (C.sub.3-C.sub.10 cycloalkyl), from three to eight carbon atoms (C.sub.3-C.sub.8 cycloalkyl), from three to six carbon atoms (C.sub.3-C.sub.6 cycloalkyl), from three to five carbon atoms (C.sub.3-C.sub.5 cycloalkyl), or three to four carbon atoms (C.sub.3-C.sub.4 cycloalkyl). In some embodiments, the cycloalkyl is a 3- to 6-membered cycloalkyl. In some embodiments, the cycloalkyl is a 5- to 6-membered cycloalkyl. Non-limiting examples of cycloalkyl groups include cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, and cyclooctyl groups. Cycloalkyl groups also include fused-, bridged-, and spiro-bicycles and higher fused-, bridged-, and spiro-systems. A cycloalkyl group can be substituted with any number of straight, branched, or cyclic alkyl groups. Non-limiting examples of cyclic alkyl groups include cyclopropyl, 2-methyl-cycloprop-1-yl, cycloprop-2-en-1-yl, cyclobutyl, 2,3-dihydroxycyclobut-1-yl, cyclobut-2-en-1-yl, cyclopentyl, cyclopent-2-en-1-yl, cyclopenta-2,4-dien-1-yl, cyclohexyl, cyclohex-2-en-1-yl, cycloheptyl, cyclooctanyl, 2,5-dimethylcyclopent-1-yl, 3,5-dichlorocyclohex-1-yl, 4-hydroxycyclohex-1-yl, 3,3,5-trimethylcyclohex-1-yl, octahydropentalenyl, octahydro-1H-indenyl, 3a,4,5,6,7,7a-hexahydro-3H-inden-4-yl, decahydroazulenyl, bicyclo-[2.1.1]hexanyl, bicyclo[2.2.1]heptanyl, bicyclo[3.1.1]heptanyl, 1,3-dimethyl[2.2.1]heptan-2-yl, bicyclo[2.2.2]octanyl, and bicyclo[3.3.3]undecanyl.
Monocyclic cycloalkyls include, for example, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, and cyclooctyl.
[0037] Polycyclic cycloalkyls or carbocycles include, for example, adamantyl, norbomyl, decalinyl, bicyclo[3.3.0]octane, bicyclo[4.3.0]nonane, cis-decalin, trans-decalin, bicyclo[2.1.1]hexane, bicyclo[2.2.1]heptane, bicyclo[2.2.2]octane, bicyclo[3.2.2]nonane, and bicyclo[3.3.2]decane, and 7,7-dimethyl-bicyclo[2.2.1]heptanyl.
[0038] Partially saturated cycloalkyls include, for example, cyclopentenyl, cyclohexenyl, cycloheptenyl, and cyclooctenyl. Unless stated otherwise specifically in the specification, a cycloalkyl is optionally substituted, for example, with oxo, halogen, amino, nitrile, nitro, hydroxyl, alkyl, alkenyl, alkynyl, haloalkyl, alkoxy, aryl, cycloalkyl, heterocyclylalkyl, heteroaryl, and the like. In some embodiments, a cycloalkyl is optionally substituted with oxo, halogen, methyl, ethyl, CN, CF.sub.3, OH, OMe, NH.sub.2, or NO.sub.2. In some embodiments, a cycloalkyl is optionally substituted with oxo, halogen, methyl, ethyl, CN, CF.sub.3, OH, or OMe. In some embodiments, the cycloalkyl is optionally substituted with halogen.
[0039] Deuteroalkyl refers to an alkyl radical, as defined above, that is substituted by one or more deuteriums. In some embodiments, the alkyl is substituted with one deuterium. In some embodiments, the alkyl is substituted with one, two, or three deuteriums. In some embodiments, the alkyl is substituted with one, two, three, four, five, or six deuteriums. Deuteroalkyl include, for example, CD.sub.3, CH.sub.2D, CHD.sub.2, CH.sub.2CD.sub.3, CD.sub.2CD.sub.3, CHDCD.sub.3, CH.sub.2CH.sub.2D, or CH.sub.2CHD.sub.2. In some embodiments, the deuteroalkyl is CD.sub.3.
[0040] Haloalkyl refers to an alkyl radical, as defined above, that is substituted by one or more halogens. In some embodiments, the alkyl is substituted with one, two, or three halogens. In some embodiments, the alkyl is substituted with one, two, three, four, five, or six halogens. Haloalkyl include, for example, trifluoromethyl, difluoromethyl, fluoromethyl, trichloromethyl, 2,2,2-trifluoroethyl, 1,2-difluoroethyl, 3-bromo-2-fluoropropyl, 1,2-dibromoethyl, and the like. In some embodiments, the haloalkyl is trifluoromethyl.
[0041] Halo or halogen refers to bromo, chloro, fluoro, or iodo. In some embodiments, halogen is fluoro or chloro. In some embodiments, halogen is fluoro.
[0042] Heteroalkyl refers to an alkyl group in which one or more skeletal atoms of the alkyl are selected from an atom other than carbon, e.g., oxygen, nitrogen (e.g., NH, N(alkyl)-), sulfur, or combinations thereof. A heteroalkyl is attached to the rest of the molecule at a carbon atom of the heteroalkyl. In one aspect, a heteroalkyl is a C.sub.1-6 heteroalkyl wherein the heteroalkyl is comprised of 1 to 6 carbon atoms and one or more atoms other than carbon, e.g., oxygen, nitrogen (e.g. NH, N(alkyl)-), sulfur, or combinations thereof wherein the heteroalkyl is attached to the rest of the molecule at a carbon atom of the heteroalkyl. Examples of such heteroalkyl are, for example, CH.sub.2OCH.sub.3, CH.sub.2CH.sub.2OCH.sub.3, CH.sub.2CH.sub.2OCH.sub.2CH.sub.2OCH.sub.3, or CH(CH.sub.3)OCH.sub.3. Unless stated otherwise specifically in the specification, a heteroalkyl is optionally substituted for example, with oxo, halogen, amino, nitrile, nitro, hydroxyl, alkyl, alkenyl, alkynyl, haloalkyl, alkoxy, aryl, cycloalkyl, heterocyclylalkyl, heteroaryl, and the like. In some embodiments, a heteroalkyl is optionally substituted with oxo, halogen, methyl, ethyl, CN, CF.sub.3, OH, OMe, NH.sub.2, or NO.sub.2. In some embodiments, a heteroalkyl is optionally substituted with oxo, halogen, methyl, ethyl, CN, CF.sub.3, OH, or OMe. In some embodiments, the heteroalkyl is optionally substituted with halogen.
[0043] Hydroxyalkyl refers to an alkyl radical, as defined above, that is substituted by one or more hydroxyls. In some embodiments, the alkyl is substituted with one hydroxyl. In some embodiments, the alkyl is substituted with one, two, or three hydroxyls. Hydroxyalkyl include, for example, hydroxymethyl, hydroxyethyl, hydroxypropyl, hydroxybutyl, or hydroxypentyl. In some embodiments, the hydroxyalkyl is hydroxymethyl.
[0044] A heterocycle can be any ring containing a ring atom that is not carbon, for example, N, O, S, P, Si, B, or any other heteroatom. A heterocycle can be substituted with any number of substituents, for example, alkyl groups and halogen atoms. A heterocycle can be aromatic (heteroaryl) or non-aromatic. Non-limiting examples of heterocycles include pyrrole, pyrrolidine, pyridine, pyrimidine, pyrazine, pyridazine, piperidine, succinimide, maleimide, morpholine, imidazole, thiophene, furan, tetrahydrofuran, pyran, and tetrahydropyran.
[0045] Heterocyclyl refers to a stable 3- to 24-membered heterocycle. Non-limiting examples of heterocycles include: heterocyclic units having a single ring containing one or more heteroatoms, non-limiting examples of which include, diazirinyl, aziridinyl, azetidinyl, pyrazolidinyl, imidazolidinyl, oxazolidinyl, isoxazolinyl, thiazolidinyl, isothiazolinyl, oxathiazolidinonyl, oxazolidinonyl, hydantoinyl, tetrahydrofuranyl, pyrrolidinyl, morpholinyl, piperazinyl, piperidinyl, dihydropyranyl, tetrahydropyranyl, piperidin-2-onyl, 2,3,4,5-tetrahydro-1H-azepinyl, 2,3-dihydro-1H-indole, and 1,2,3,4-tetrahydroquinoline; and ii) heterocyclic units having 2 or more rings one of which is a heterocyclic ring, non-limiting examples of which include hexahydro-1H-pyrrolizinyl, 3a,4,5,6,7,7a-hexahydro-1H-benzo[d]imidazolyl, 3a,4,5,6,7,7a-hexahydro-1H-indolyl, 1,2,3,4-tetrahydroquinolinyl, and decahydro-1H-cycloocta[b]pyrrolyl.
[0046] Heterocyclylalkyl refers to a stable 3- to 24-membered partially or fully saturated ring radical comprising 2 to 23 carbon atoms and from one to 8 heteroatoms selected from the group consisting of nitrogen, oxygen, phosphorous, and sulfur. Unless stated otherwise specifically in the specification, the heterocyclylalkyl radical may be a monocyclic, bicyclic, tricyclic, or tetracyclic ring system, which may include fused (when fused with an aryl or a heteroaryl ring, the heterocyclylalkyl is bonded through a non-aromatic ring atom) or bridged ring systems; and the nitrogen, carbon, or sulfur atoms in the heterocyclylalkyl radical may be optionally oxidized; the nitrogen atom may be optionally quaternized.
[0047] Representative heterocyclylalkyls include, but are not limited to, heterocyclylalkyls having from two to fifteen carbon atoms (C.sub.2-C.sub.15 heterocyclylalkyl), from two to ten carbon atoms (C.sub.2-C.sub.10 heterocyclylalkyl), from two to eight carbon atoms (C.sub.2-C.sub.8 heterocyclylalkyl), from two to six carbon atoms (C.sub.2-C.sub.6 heterocyclylalkyl), from two to five carbon atoms (C.sub.2-C.sub.5 heterocyclylalkyl), or two to four carbon atoms (C.sub.2-C.sub.4 heterocyclylalkvl). In some embodiments, the heterocyclylalkyl is a 3- to 6-membered heterocyclylalkyl. In some embodiments, the cycloalkyl is a 5- to 6-membered heterocyclylalkyl. Examples of such heterocyclylalkyl radicals include, but are not limited to, aziridinyl, azetidinyl, dioxolanyl, thienyl[1,3]dithianyl, decahydroisoquinolyl, imidazolinyl, imidazolidinyl, isothiazolidinyl, isoxazolidinyl, morpholinyl, octahydroindolyl, octahydroisoindolyl, 2-oxopiperazinyl, 2-oxopiperidinyl, 2-oxopyrrolidinyl, oxazolidinyl, piperidinyl, piperazinyl, 4-piperidonyl, pyrrolidinyl, pyrazolidinyl, quinuclidinyl, thiazolidinyl, tetrahydrofuryl, trithianyl, tetrahydropyranyl, thiomorpholinyl, thiamorpholinyl, 1-oxo-thiomorpholinyl, 1,1-dioxo-thiomorpholinyl, 1,3-dihydroisobenzofuran-1-yl, 3-oxo-1,3-dihydroisobenzofuran-1-yl, methyl-2-oxo-1,3-dioxol-4-yl, and 2-oxo-1,3-dioxol-4-yl. The term heterocyclylalkyl also includes all ring forms of the carbohydrates, including but not limited to, the monosaccharides, the disaccharides, and the oligosaccharides. It is understood that when referring to the number of carbon atoms in a heterocyclylalkyl, the number of carbon atoms in the heterocyclylalkyl is not the same as the total number of atoms (including the heteroatoms) that make up the heterocyclylalkyl (i.e. skeletal atoms of the heterocyclylalkyl ring). Unless stated otherwise specifically in the specification, a heterocyclylalkyl is optionally substituted, for example, with oxo, halogen, amino, nitrile, nitro, hydroxyl, alkyl, alkenyl, alkynyl, haloalkyl, alkoxy, aryl, cycloalkyl, heterocyclylalkyl, heteroaryl, and the like. In some embodiments, a heterocyclylalkyl is optionally substituted with oxo, halogen, methyl, ethyl, CN, CF.sub.3, OH, OMe, NH.sub.2, or NO.sub.2. In some embodiments, a heterocyclylalkyl is optionally substituted with oxo, halogen, methyl, ethyl, CN, CF.sub.3, OH, or OMe. In some embodiments, the heterocyclylalkyl is optionally substituted with halogen.
[0048] Heteroaryl refers to a 5- to 14-membered ring system radical comprising hydrogen atoms, one to thirteen carbon atoms, one to six heteroatoms selected from the group consisting of nitrogen, oxygen, phosphorous, and sulfur, and at least one aromatic ring, he heteroaryl radical may be a monocyclic, bicyclic, tricyclic, or tetracyclic ring system, which may include fused (when fused with a cycloalkyl or heterocyclylalkyl ring, the heteroaryl is bonded through an aromatic ring atom) or bridged ring systems; and the nitrogen, carbon, or sulfur atoms in the heteroaryl radical may be optionally oxidized; the nitrogen atom may be optionally quaternized. In some embodiments, the heteroaryl is a 5- to 10-membered heteroaryl. In some embodiments, the heteroaryl is a 5- to 6-membered heteroaryl. Examples include, but are not limited to, azepinyl, acridinyl, benzimidazolyl, benzothiazolyl, benzindolyl, benzodioxolyl, benzofuranyl, benzooxazolyl, benzothiazolyl, benzothiadiazolyl, benzo[b][1,4]dioxepinyl, 1,4-benzodioxanyl, benzonaphthofuranyl, benzoxazolyl, benzodioxolyl, benzodioxinyl, benzopyranyl, benzopyranonyl, benzofuranyl, benzofuranonyl, benzothienyl (benzothiophenyl), benzotriazolyl, benzo[4,6]imidazo[1,2-a]pyridinyl, carbazolyl, cinnolinyl, dibenzofuranyl, dibenzothiophenyl, furanyl, furanonyl, isothiazolyl, imidazolyl, indazolyl, indolyl, indazolyl, isoindolyl, indolinyl, isoindolinyl, isoquinolyl, indolizinyl, isoxazolyl, naphthyridinyl, oxadiazolyl, 2-oxoazepinyl, oxazolyl, oxiranyl, 1-oxidopyridinyl, 1-oxidopyrimidinyl, 1-oxidopyrazinyl, 1-oxidopyridazinyl, 1-phenyl-1H-pyrrolyl, phenazinyl, phenothiazinyl, phenoxazinyl, phthalazinyl, pteridinyl, purinyl, pyrrolyl, pyrazolyl, pyridinyl, pyrazinyl, pyrimidinyl, pyridazinyl, quinazolinyl, quinoxalinyl, quinolinyl, quinuclidinyl, isoquinolinyl, tetrahydroquinolinyl, thiazolyl, thiadiazolyl, triazolyl, tetrazolyl, triazinyl, and thiophenyl (i.e., thienyl). Unless stated otherwise specifically in the specification, a heteroaryl is optionally substituted, for example, with halogen, amino, nitrile, nitro, hydroxyl, alkyl, alkenyl, alkynyl, haloalkyl, alkoxy, aryl, cycloalkyl, heterocyclylalkyl, heteroaryl, and the like. In some embodiments, a heteroaryl is optionally substituted with halogen, methyl, ethyl, CN, CF.sub.3, OH, OMe, NH.sub.2, or NO.sub.2. In some embodiments, a heteroaryl is optionally substituted with halogen, methyl, ethyl, CN, CF.sub.3, OH, or OMe. In some embodiments, the heteroaryl is optionally substituted with halogen.
II. Compounds
[0049] In one embodiment enhancers of pesticidal activity disclosed herein include those having the Formulas set forth below. In one embodiment, the present disclosure provides a method for inhibiting apyrase, comprising contacting the apyrase with a compound of Formula (I)
##STR00003##
wherein [0050] R.sup.1 and R.sup.2 are independently selected from C.sub.1-6 alkyl optionally substituted with one or more R.sup.5, C.sub.6-10 aryl, optionally substituted with one or more R.sup.5, aralkyl optionally substituted with one or more R.sup.5, cycloalkyl optionally substituted with one or more R.sup.5, C.sub.5-10 heteroaryl optionally substituted with one or more R.sup.5 and heterocyclylalkyl optionally substituted with one or more R.sup.5; [0051] R.sup.3 and R.sup.4 are independently selected from hydrogen, C.sub.1-6 alkyl, C.sub.6-10 aryl, C.sub.5-10 heteroaryl, each optionally substituted with one or more R.sup.a and R.sup.b; or R.sup.3 and R.sup.4, together with the atoms to which they are attached form a dihydrophthalazine-1,4-dione; or [0052] each R.sup.5 is independently selected from R.sup.a, R.sup.b, R.sup.a substituted with one or more R.sup.a, R.sup.b, or both and OR.sup.a substituted with one or more of the same or different R.sup.a or R.sup.b, or (CH.sub.2).sub.mR.sup.b, (CHR.sup.a).sub.mR.sup.b, O(CH.sub.2).sub.mR.sup.b, S(CH.sub.2).sub.mR.sup.b, OCHR.sup.aR.sup.b, OCR.sup.a(R.sup.b).sub.2, O(CHR.sup.a).sub.mR.sup.b, O (CH.sub.2).sub.mCH[(CH.sub.2).sub.mR.sup.b]R.sup.b, S(CHR.sup.a).sub.mR.sup.b, C(O)NH(CH.sub.2).sub.mR.sup.b, C(O)NH(CHR.sup.a).sub.mR.sup.b, O(CH.sub.2).sub.mC(O)NH(CH.sub.2).sub.mR.sup.b; [0053] each R.sup.a is independently selected from the group consisting of hydrogen, C.sub.1-6 alkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, C.sub.1-6 haloalkyl, C.sub.3-8 cycloalkyl, C.sub.6-10 aryl, C.sub.5-10 heteroaryl, C.sub.6-16 arylalkyl, 2-6 membered heteroalkyl and 3-8 membered heterocyclylalkyl, or R.sup.a together with the nitrogen and the R.sup.1 or R.sup.2 attached thereto forms a heterocyclylalkyl optionally substituted with one or more R.sup.d; [0054] Z is selected from halogen. C.sub.1-6 alkyl optionally substituted with one or more R.sup.b, OR.sup.a, C.sub.1-6 haloalkyl, or Z, together with R.sup.4 and the atoms to which Z and R are attached, forms a 5- or 6-membered ring optionally substituted with one or more of R.sup.a, R.sup.b, and R.sup.a substituted with one or more R.sup.b, R.sup.d, or both; [0055] R.sup.b is independently selected from the group consisting of =O, OR.sup.d, halogen, C.sub.1-3 haloalkyloxy, OCF.sub.3, S, SR.sup.d, =NR.sup.d, =NOR.sup.d, NR.sup.cR.sup.c, SF.sub.5, halogen, CF.sub.3, CN, NO.sub.2, S(O)R.sup.d, S(O).sub.2R.sup.d, S(O).sub.2OR.sup.d, S(O)NR.sup.cR.sup.c, S(O).sub.2NR.sup.cR.sup.c, OS(O)R.sup.d, OS(O).sub.2R.sup.d, OS(O).sub.2OR.sup.d, OS(O).sub.2NR.sup.cR.sup.c, C(O)R.sup.d, C(O)OR.sup.d, C(O)NR.sup.cR.sup.c, C(NH)NR.sup.cR.sup.c, C(NR.sup.a)NR.sup.cR.sup.c, C(NOH)R.sup.a, C(NOH)NR.sup.cR.sup.c, OC(O)R.sup.d, OC(O)OR.sup.d. OC(O)NR.sup.cR.sup.c, OC(NH)NR.sup.cR.sup.c, OC(NR.sup.a)NR.sup.cR.sup.c, [NHC(O)].sub.nR.sup.d, [NR.sup.aC(O)].sub.nR.sup.d, [NHC(O)].sub.nOR.sup.d, [NR.sup.aC(O)].sub.n OR.sup.d, [NHC(O)].sub.nNR.sup.cR.sup.c, [NR.sup.aC(O)].sub.nNR.sup.cR.sup.c, [NHC(NH)].sub.nNR.sup.cR.sup.c and [NR.sup.aC(NR.sup.a)].sub.nNR.sup.cR.sup.c; [0056] each R.sup.c is independently R.sup.a, or, alternatively, two R.sup.c are taken together with the nitrogen atom to which they are bonded to form a 5 to 10-membered heterocyclylalkyl or heteroaryl which may optionally include one or more of the same or different additional heteroatoms and which may optionally be substituted with one or more of the same or different R.sup.c groups; [0057] each R.sup.d is independently hydrogen or C.sub.1-6 alkyl; [0058] each R.sup.c is independently halogen, C.sub.1-6 alkyl or C(O)R.sup.d; [0059] each m is independently an integer from 1 to 3; and [0060] each n is independently an integer from 0 to 3.
[0061] In one embodiment, enhancer compounds of Formula (I) have Formula (Ia)
##STR00004##
R.sup.1 and R.sup.2 are independently selected from C.sub.1-6 alkyl optionally substituted with one or more R.sup.a optionally substituted with one or more R.sup.a, R.sup.b, or both; C.sub.6-10 aryl, optionally substituted with one or more R.sup.5, aralkyl optionally substituted with one or more R.sup.5, cycloalkyl optionally substituted with one or more R.sup.5, C.sub.5-10 heteroaryl optionally substituted with one or more R.sup.5 and heterocyclylalkyl optionally substituted with one or more R.sup.5; [0062] R.sup.3 and R.sup.4 are independently selected from hydrogen, C.sub.1-6 alkyl, C.sub.6-10 aryl, C.sub.5-10 heteroaryl, each optionally substituted with one or more R.sup.a and R.sup.b; or R.sup.3 and R.sup.4, together with the atoms to which they are attached form a dihydrophthalazine-1,4-dione; or [0063] each R.sup.5 is independently selected from R.sup.a, R.sup.b, R.sup.a substituted with one or more R.sup.a, R.sup.b, or both and OR.sup.a substituted with one or more of the same or different R.sup.a or R.sup.b, or (CH.sub.2).sub.mR.sup.b, (CHR.sup.a).sub.mR.sup.b, O(CH.sub.2).sub.mR.sup.b, S(CH.sub.2).sub.mR.sup.b, OCHR.sup.aR.sup.b, OCR.sup.a(R.sup.b).sub.2, O(CHR.sup.a).sub.mR.sup.b, O (CH.sub.2).sub.mCH[(CH.sub.2).sub.mR.sup.b]R.sup.b, S(CHR.sup.a).sub.mR.sup.b, C(O)NH(CH.sub.2).sub.mR.sup.b, C(O)NH(CHR.sup.a).sub.mR.sup.b, O(CH.sub.2).sub.mC(O)NH(CH.sub.2).sub.mR.sup.b; [0064] each R.sup.a is independently selected from the group consisting of hydrogen, C.sub.1-6 alkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, C.sub.1-6 haloalkyl, C.sub.3-8 cycloalkyl, C.sub.6-10 aryl, C.sub.5-10 heteroaryl, C.sub.6-16 arylalkyl, 2-6 membered heteroalkyl and 3-8 membered heterocvclylalkvl, or R.sup.a together with the nitrogen and the R.sup.1 or R.sup.2 attached thereto forms a heterocyclylalkyl optionally substituted with one or more R.sup.d; [0065] Z is selected from halogen, C.sub.1-6 alkyl optionally substituted with one or more R.sup.b, OR.sup.a, C.sub.1-6 haloalkyl, or Z, together with R.sup.4 and the atoms to which Z and R are attached, forms a 5- or 6-membered ring optionally substituted with one or more of R.sup.a, R.sup.b, and R.sup.a substituted with one or more R.sup.b, R.sup.d, or both; [0066] R.sup.b is independently selected from the group consisting of O, OR.sup.d, halogen, C.sub.1-3 haloalkyloxy, OCF.sub.3, S, SR.sup.d, =NR.sup.d, =NOR.sup.d, NR.sup.cR.sup.c, SF.sub.5, halogen, CF.sub.3, CN, NO.sub.2, S(O)R.sup.d, S(O).sub.2R.sup.d, S(O).sub.2OR.sup.d, S(O)NR.sup.cR.sup.c, S(O).sub.2NR.sup.cR.sup.c, OS(O)R.sup.d, OS(O).sub.2R.sup.d. OS(O).sub.2OR.sup.d, OS(O).sub.2NR.sup.cR.sup.c, C(O)R.sup.d, C(O)OR.sup.d, C(O)NR.sup.cR.sup.c, C(NH)NR.sup.cR.sup.c, C(NR.sup.a)NR.sup.cR.sup.c, C(NOH)R.sup.a, C(NOH)NR.sup.cR.sup.c, OC(O)R.sup.d, OC(O)OR.sup.d, OC(O)NR.sup.cR.sup.c, OC(NH)NR.sup.cR.sup.c, OC(NR.sup.a)NR.sup.cR.sup.c, [NHC(O)].sub.nR.sup.d, [NR.sup.aC(O)].sub.nR.sup.d, [NHC(O)].sub.nOR.sup.d, [NR.sup.aC(O)].sub.n OR.sup.d, [NHC(O)].sub.nNR.sup.cR.sup.c, [NR.sup.aC(O)].sub.n NR.sup.cR.sup.c, [NHC(NH)].sub.nNR.sup.cR.sup.c and [NR.sup.aC(NR.sup.a)].sub.nNR.sup.cR.sup.c: [0067] each R.sup.c is independently R.sup.a, or, alternatively, two R.sup.c are taken together with the nitrogen atom to which they are bonded to form a 5 to 10-membered heterocyclylalkyl or heteroaryl which may optionally include one or more of the same or different additional heteroatoms and which may optionally be substituted with one or more of the same or different R.sup.e groups; [0068] each R.sup.d is independently hydrogen or C.sub.1-6 alkyl; [0069] each R.sup.c is independently halogen, C.sub.1-6 alkyl or C(O)R.sup.d; [0070] each m is independently an integer from 1 to 3; and [0071] each n is independently an integer from 0 to 3.
[0072] In one embodiment of compounds having Formula (I), disclosed enhancers have Formula (Ib)
##STR00005##
wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4 and Z are as described with respect to Formula (I).
[0073] In one embodiment of compounds having Formula (I), disclosed enhancers have Formula (Ic)
##STR00006##
wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4 and Z are as described with respect to Formula (I).
[0074] In certain embodiments of compounds according to Formulas (I), (Ia), (Ib) and (Ic) at least one of R.sup.1 and R.sup.2 is aryl, such as wherein R.sup.1 is aryl, R.sup.2 is aryl, or both R.sup.1 and R.sup.2 are aryl. In embodiments of compounds according to Formulas (I), (Ia), (Ib) and (Ic), R.sup.1 is aryl, wherein R.sup.2 is selected from C.sub.1-6 alkyl, aryl and heteroaryl. In embodiments of compounds according to Formulas (I), (Ia), (Ib) and (Ic), R.sup.2 is aryl, wherein R.sup.1 is selected from C.sub.1-6 alkyl optionally substituted with one or more R.sup.a and R.sup.b, aryl optionally substituted with one or more R.sup.3, aralkyl optionally substituted with one or more R.sup.3, heterocyclyl optionally substituted with one or more R.sup.d and heteroaryl optionally substituted with one or more R.sup.3. In certain embodiments of compounds according to Formulas (I), (Ia), (Ib) and (Ic), wherein R.sup.1, R.sup.2, or both are aryl, the arvi is substituted or unsubstituted. In certain embodiments of compounds according to Formulas (I), (Ia), (Ib) and (Ic), wherein R.sup.1, R.sup.2, or both are aryl, at least one aryl is substituted or unsubstituted phenyl.
[0075] In one embodiment of compounds according to Formulas (I), (Ia), (Ib) and (Ic) at least one of R.sup.1 and R.sup.2 is aryl or heteroaryl. In one embodiment of compounds according to Formulas (I), (Ia), (Ib) and (Ic) at one of R.sup.1 and R.sup.2 is aryl and the other of R.sup.1 and R.sup.2 is heteroaryl. In one embodiment wherein Ar.sup.1 and Ar.sup.2 are independently selected from aryl and heteroaryl each is optionally substituted with one or more R.sup.3.
[0076] In one embodiment of compounds according to Formulas (I), (Ia), (Ib) and (Ic) at least one of R.sup.1 and R.sup.2 is heteroaryl, such as wherein R.sup.1 is heteroaryl, R.sup.2 is heteroaryl, or both R.sup.1 and R.sup.2 are heteroaryl. In certain embodiments of compounds according to Formulas (I), (Ia), (Ib) and (Ic), wherein R.sup.1, R.sup.2, or both are heteroaryl, the heteroaryl is substituted or unsubstituted with one or more R.sup.3.
[0077] In one embodiment of compounds according to Formulas (I), (Ia), (Ib) and (Ic) at least one of R.sup.1 and R.sup.2 is substituted with one or more R.sup.3. In one such embodiment, of compounds according to Formulas (I), (Ia), (Ib) and (Ic) at least one of R.sup.1 and R.sup.2 is substituted with one or more R.sup.3.
[0078] In one embodiment of compounds disclosed herein, including compounds according to Formulas (I), (Ia), (Ib) and (Ic), at least one of R.sup.1 and R.sup.2 is substituted with one or more R.sup.5 and each R.sup.5 is independently selected from is independently selected from R.sup.a, R.sup.b, R.sup.a substituted with one or more R.sup.a, R.sup.b, or both and OR.sup.a substituted with one or more of the same or different R.sup.a or R.sup.b, or (CH.sub.2).sub.mR.sup.b, (CHR.sup.a).sub.mR.sup.b, O(CH.sub.2).sub.mR.sup.b, S(CH.sub.2).sub.mR.sup.b, OCHR.sup.aR.sup.b, OCR.sup.a(R.sup.b).sub.2, O(CHR.sup.a).sub.mR.sup.b, O(CH.sub.2).sub.mCH[(CH.sub.2).sub.mR.sup.b]R.sup.b, S(CHR.sup.b).sub.mR.sup.b, C(O)NH(CH.sub.2).sub.mR.sup.b, C(O)NH(CHR.sup.a).sub.mR.sup.b, O(CH.sub.2).sub.mC(O)NH(CH.sub.2).sub.mR.sup.b.
[0079] In one embodiment of compounds disclosed herein, including compounds according to Formulas (I), (Ia), (Ib) and (Ic), at least one of R.sup.1 and R.sup.2 is substituted with one or more R.sup.5 wherein at least one R.sup.5 is halogen.
[0080] In one embodiment of compounds disclosed herein, including compounds according to Formulas (I), (Ia), (Ib) and (Ic), at least one of R.sup.1 and R.sup.2 is substituted with one or more R.sup.5 wherein at least one R.sup.5 is OR.sup.a substituted with one or more of the same or different R.sup.a or R.sup.b.
[0081] In one embodiment of compounds disclosed herein, including compounds according to Formulas (I), (Ia), (Ib) and (Ic), R.sup.1 and R.sup.2 are the same. In one embodiment of compounds disclosed herein, including compounds according to Formulas (I), (Ia), (Ib) and (Ic), at least one of R.sup.1 and R.sup.2 is C.sub.1-6 alkyl.
[0082] In one embodiment of compounds disclosed herein, including compounds according to Formulas (I), (Ia), (Ib) and (Ic), one of R.sup.1 and R.sup.2 is aralkyl optionally substituted with one or more R.sup.5. In one embodiment of compounds disclosed herein, including compounds according to Formulas (I), (Ia), (Ib) and (Ic), one of R.sup.1 and R.sup.2 is cycloalkyl optionally substituted with one or more R.sup.5. In one embodiment of compounds disclosed herein, including compounds according to Formulas (I), (Ia), (Ib) and (Ic), one of R.sup.1 and R.sup.2 is heteroaryl optionally substituted with one or more R.sup.5. In one embodiment of compounds disclosed herein, including compounds according to Formulas (I), (Ia), (Ib) and (Ic), one of R.sup.1 and R.sup.2 is heterocyclylalkyl optionally substituted with one or more R.sup.5.
[0083] In one embodiment of compounds disclosed herein, including compounds according to Formulas (I), (Ia), (Ib) and (Ic), at least one of R.sup.3 and R.sup.4 is hydrogen. In one embodiment of compounds disclosed herein, including compounds according to Formulas (I), (Ia), (Ib) and (Ic), at least one of R.sup.1 and R.sup.4 is C.sub.1-6 alkyl.
[0084] In one embodiment of compounds disclosed herein according to Formula (I), the compound has Formula (II)
##STR00007##
[0085] In one embodiment of compounds disclosed herein according to Formula (I), R.sup.3 is R.sup.a that together with R.sup.1 and the nitrogen they are both attached to thereto forms a heterocyclylalkyl optionally substituted with one or more R.sup.d. In one embodiment of compounds disclosed herein according to Formula (I), R.sup.4 is R.sup.a that together with R.sup.2 and the nitrogen they are both attached to thereto forms a heterocyclylallyl optionally substituted with one or more R.sup.d.
[0086] In one embodiment of compounds disclosed herein, including compounds according to Formulas (I), (Ia), (Ib) and (Ic), R.sup.1 and R.sup.2 independently are selected from
##STR00008## ##STR00009## ##STR00010##
[0087] In one embodiment of enhancer compounds disclosed herein, including compounds according to Formulas (I), (Ia), (Ib) and (Ic), the compound is selected from: [0088] N.sup.1,N.sup.4-di-p-tolylterephthalamide; [0089] N.sup.1,N.sup.4-bis(3-(methylthio)phenyl)terephthalamide; [0090] N.sup.1,N.sup.4-diphenylterephthalamide; [0091] N.sup.1-(6-chlorobenzo[d][1,3]dioxol-5-yl)-N.sup.3-phenylisophthalamide; [0092] N.sup.1,N.sup.4-bis(benzo[d][1,3]dioxol-5-yl)terephthalamide; [0093] N.sup.1,N.sup.4-bis(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)terephthalamide; [0094] diethyl 4,4-(isophthaloylbis(azanediyl))dibenzoate; [0095] N.sup.1-cyclohexyl-N.sup.2-(2-methoxy-5-methylphenyl)-N.sup.1-methylphthalimide; [0096] N.sup.1-(3-(1H-1,2,3-triazol-1-yl)phenyl)-N.sup.4-(3-methylbenzyl)terephthalamide; [0097] 1,3-dioxo-N-(3-(pyrrolidin-1-yl)phenyl)isoindoline-5-carboxamide; [0098] N.sup.1-(3-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)phenyl)-N.sup.3-phenylisophthalamide; [0099] N.sup.1-(3,4-dihydro-2H-benzo[b][1,4]dioxepin-7-yl)-N.sup.2,N.sup.2-dimethylphthalamide; [0100] N.sup.1-(4-(ethylcarbamoyl)quinolin-2-yl)-N.sup.4-phenylterephthalamide; [0101] N.sup.1,N.sup.2-bis(2-chlorophenyl)phthalimide; [0102] 2-isobutyl-3-methyl-2,3-dihydrophthalazine-1,4-dione; [0103] N.sup.1-(4-(benzo[d][1,3]dioxol-5-y)-1H-pyrazol-5-yl)-N.sup.3-phenylisophthalamide; [0104] N.sup.1,N.sup.3-bis(4-(1H-imidazol-4-yl)phenyl)isophthalamide; [0105] N.sup.1-(benzo[d][1,3]dioxol-5-yl)-N.sup.2-cyclohexyl-N.sup.2-methylphthalamide; [0106] N.sup.1,N.sup.3-bis(3-methyl-1H-indazol-6-yl)isophthalamide; [0107] N.sup.1,N.sup.4-bis(3,5-dimethoxyphenyl)terephthalamide; [0108] 2-((3-ethyl-5-methylisoxazol-4-yl)methyl)-3-methyl-2,3-dihydrophthalazine-1,4-dione; [0109] N.sup.1-(2-ethyl-2H-indazol-6-yl)-N.sup.3-methylisophthalamide; [0110] N.sup.1-phenyl-N.sup.4-(3-phenylprop-2-yn-1-yl)terephthalamide; [0111] N-(2-isopropyl-2H-indazol-6-yl)-1,3-dioxoisoindoline-5-carboxamide; [0112] 2-(4-amino-2-chlorophenyl)isoindoline-1,3-dione; [0113] 2-((5-chloro-1-methyl-1H-pyrazol-3-yl)methyl)-3-methyl-2,3-dihydrophthalazine-1,4-dione; [0114] N.sup.1-(3-(1H-imidazol-1-yl)benzyl)-N.sup.4-phenylterephthalamide; [0115] N.sup.1-(2-methoxy-2-methylpropyl)-N.sup.4-phenylterephthalamide; [0116] N.sup.1-(3-(1H-tetrazol-5-yl)phenyl)-N.sup.3-phenylisophthalamide; [0117] N.sup.1,N.sup.2-dibenzylphthalamide; [0118] 2-(4-methoxybut-2-yn-1-yl)-3-methyl-2,3-dihydrophthalazine-1,4-dione; [0119] N.sup.1-(1-(1,1-dioxidothiomorpholino)-1-oxopropan-2-yl)-N.sup.3-phenylisophthalamide; [0120] N-(3-nitrophenyl)-2-(pyrrolidine-1-carbonyl)benzamide; [0121] N.sup.1-(5,6-dihydro-4H-pvrrolo[1,2-b]pyrazol-2-yl)-N.sup.4-phenylterephthalamide; [0122] N.sup.1-(4-cyano-3-(trifluoromethyl)phenyl)-N.sup.3-methylisophthalamide; [0123] N.sup.1,N.sup.3-bis(2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-7-yl)isophthalamide; [0124] N.sup.1-benzyl-N.sup.2-(2,6-dimethylphenyl)-N.sup.1-methylphthalamide; [0125] N.sup.1-(5-methyl-1H-imidazol-2-yl)-N.sup.4-phenylterephthalamide; [0126] N.sup.1-(5-methyl-1H-1,2,4-triazol-3-yl)-N.sup.4-phenylterephthalamide; [0127] N.sup.1-benzyl-N.sup.2-(2-methoxyphenyl)-N.sup.1-methylphthalamide; [0128] N.sup.1-(benzo[d]thiazol-5-yl)-N.sup.4-cyclopropylterephthalamide; [0129] N.sup.1-phenyl-N.sup.4-((1R,2S)-2-phenylcyclopropyl)terephthalamide: [0130] N.sup.1-cyclohexyl-N.sup.1-methyl-N.sup.2-(3-(trifluoromethyl)phenyl)phthalimide; [0131] N.sup.1-(3-(cyclopentylamino)phenyl)-N.sup.3-methylisophthalamide; [0132] N.sup.1,N.sup.4-bis(2,4-dimethoxyphenyl)terephthalamide; [0133] N.sup.1,N.sup.4-bis(4-(2-oxopyrrolidin-1-yl)phenyl)terephthalamide; [0134] N.sup.1-(2-(1H-imidazol-2-yl)phenyl)-N.sup.4-cyclopropylterephthalamide; [0135] N.sup.1-((1H-imidazol-2-yl)methyl)-N.sup.4-phenylterephthalamide; [0136] N.sup.1-(2-(3-methyl-4H-1,2,4-triazol-4-yl)ethyl)-N.sup.4-phenylterephthalamide; [0137] N.sup.1-methyl-N.sup.3-(2-oxo-2,3-dihydrobenzo[d]thiazol-6-yl)isophthalamide; [0138] N.sup.1,N.sup.4-dimesitylterephthalamide; [0139] N.sup.1-(2H-indazol-6-yl)-N.sup.3-propvlisophthalamide; [0140] N-(4-fluorophenyl)-2-(4-methylpiperazine-1-carbonyl)benzamide; [0141] N.sup.1,N.sup.3-bis(1-oxoisoindolin-4-yl)isophthalamide; [0142] N.sup.1-((4-aminopyrimidin-2-yl)methyl)-N.sup.4-phenylterephthalamide; [0143] N.sup.1-methyl-N.sup.3-(4-((trifluoromethyl)sulfonamido)phenyl)isophthalamide; [0144] N-(1H-indazol-7-yl)-N.sup.3-propylisophthalamide; [0145] N-(3-ethynylphenyl)-2-(4-methylpiperazine-1)-carbonyl)benzamide; [0146] 2-((5-cyclopropyl-1,3,4-oxadiazol-2-yl)methyl)-3-methyl-2,3-dihydrophthalazine-1,4-dione; [0147] 5-oxo-N-(2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-8-yl)-2,3,4,5-tetrahydrobenzo[f][1,4]oxazepine-7-carboxamide; and [0148] N.sup.1-phenyl-N.sup.4-(1-((tetrahydrofuran-2-yl)methyl)-1H-pyrazol-4-yl)terephthalamide.
[0149] Specific examples of apyrase inhibitors according to the present disclosure, including compounds of Formulas (I), (Ia), (Ib), (Ic) and/or (II), for use to enhance the activity of an agricultural or horticultural pesticide as described herein, are illustrated below in Table 1:
TABLE-US-00001 TABLE 1 ID Structure Name I-1
III. Target Crops and their Pathogens
[0150] The present disclosure provides formulations and methods for their use in treating crops for pathogens. In one embodiment, a disclosed compound, such as a compound of Formulas (I). (Ia), (Ib), (Ic) and/or (II), is administered in combination with an agricultural or horticultural pesticide, such as an acaricide, antimicrobial, fungicide, herbicide, insecticide, molluscicide and/or nematocide. Crops that can be treated, include those plagued by various pathogens, including without limitation, bacteria, viruses, fungal pathogens, mites, nematodes, molluscs, weeds or other pests, as is known to those of ordinary skill in the agricultural arts. By way of example, such agricultural and horticultural crops that can be treated according to the present disclosure include plants, whether genetically modified or not, including their harvested products, such as: cereals; vegetables; root crops; potatoes; trees such as fruit trees, for example banana trees, tea, coffee trees, or cocoa trees; grasses; lawn grass; or cotton.
[0151] Roux and coworkers describe the compound:
##STR00078##
referred to herein as Roux compound 13, as enhancing the ability of certain fungicides to inhibit the growth of different plant-pathogenic fungi (Molecular Plant Pathology, 2017, 18(7), 1012-1023; and WO 2016/123191). The present compounds surprisingly enhance the ability of a variety of pesticides against a broad variety of pathogens, including fungal pathogens. In addition, examples of the presently disclosed compound exhibit superior enhancer activity than Roux compound 13.
[0152] The agricultural or horticultural enhancer disclosed herein may be applied to each part of plants, such as leaves, stems, patterns, flowers, buds, fruits, seeds, sprouts, roots, tubers, tuberous roots, shoots, or cuttings. The agricultural or horticultural enhancer according to the present disclosure may also be applied to improved varieties/varieties, cultivars, as well as mutants, hybrids and genetically modified embodiments of these plants.
[0153] The agricultural or horticultural treatment described herein may be used to conduct seed treatment, foliage application, soil application, or water application, so as to control various diseases occurring in agricultural or horticultural crops, including flowers, lawns, and pastures.
[0154] The present compounds are useful for potentiating the effects of antimicrobial agents. For example, the present compounds can be used in combination with an antimicrobial agent to combat bacterial and viral infection.
[0155] The present compounds are useful for potentiating the effects of herbicides. For example, the present compounds can be used in combination with one or more herbicide to control weeds or other unwanted vegetation.
[0156] The present compounds are useful for potentiating the effects of insecticides. For example, the present compounds can be used in combination with one or more insecticide to control insect infestation. The present compounds are useful for potentiating the effects of acaricides or miticides. For example, the present compounds can be used in combination with one or more acaricidal agent to control mites. The present compounds are useful for potentiating the effects of molluscicides. For example, the present compounds can be used in combination with one or more molluscicide to prevent interference of slugs or snails with a crop.
[0157] The present compounds are useful for potentiating the effects of nematocides. For example, the present compounds can be used in combination with one or more nematocide to prevent interference of nematodes with a crop.
[0158] The present compounds are particularly useful for potentiating the effects of fungicides against plant fungal pathogens. Examples of pathogens treated according to the present disclosure include, without limitation, Botrytis cinerea. Colletotrichum graminicola, Fusarium oxysporum, Sclerotiana sclerotiorum, Verticillium dahlia, Mycospharella gramincola and Sphacelotheca reliana.
[0159] Botrytis cinerea is an airborne plant pathogen with a necrotrophic lifestyle attacking over 2(x) crop hosts worldwide. It mainly attacks dicotyledonous plant species, including important protein, oil, fiber and horticultural crops, grapes and strawberries and also Botrytis also causes secondary soft rot of fruits and vegetables during storage, transit and at the market. Many classes of fungicides have failed to control Botrytis cinerea due to its genetic plasticity.
[0160] The genus Colletotrichum comprises 600 species attacking over 3,200 species of monocot and dicot plants. Colletotrichum graminicola primarily infects maize (Zea mays), causing annual losses of approximately 1 billion dollars in the United States alone (Connell et al., 2012).
[0161] Fusarium wilt of banana, caused by the soil-borne fungus Fusarium oxysporum f. sp. cubense, is a major threat to banana production worldwide. No fungicides are currently available to effectively control the disease once plants are infected (Peng J et al., 2014).
[0162] The w % bite mold fungus Sclerotinia sclerotiorum is known to attack more than 400 host species and is considered one of the most prolific plant pathogens. The majority of the affected crop species are dicotyledonous, along with a number of agriculturally significant monocotyledonous plants. Some important crops affected by S. sclerotiorum include legumes (soybean), most vegetables, stone fruits and tobacco.
[0163] The ascomycete Verticillium dahliae is a soil-borne fungal plant pathogen that causes vascular wilt diseases in a broad range of dicotyledonous host species. V. dahliae can cause severe yield and quality losses in cotton and other important crops such as vegetables, fibers, fruit, nut trees, forest trees and ornamental plants.
[0164] The ascomycete fungus Mycospharella gramincola (anamorph: Septoria tritici) is one of the most important foliar diseases of wheat leaves, occurring wherever wheat is grown. Yield losses attributed to this disease range from 25%-50%, and are especially high in Europe, the Mediterranean region and East Africa. Infection by M. gramincola is initiated by air borne ascopores produced on residues of last season's crop. Primary infection usually occurs after seedlings emerge in spring or fall. The mature disease is characterized by necrotic lesions on the leaves and stems of infected plants.
[0165] The basidiomycete fungus Sphacelotheca reliana infects corn (Zea mays) systemically, causing Head Smut. Yield loss attributed to the disease is variable, and is directly dependent on the incidence of the disease. The fungus overwinters as diploid teliospores in crop debris or soil. Floral structures are converted to sori containing masses of powdery teliospores that resemble mature galls of common smut.
[0166] Examples of crops to be treated and plant diseases (pathogens) to be controlled using the presently disclosed compounds and compositions include, without limitation:
[0167] Sugar beet: brown spot disease (Cercospora beticola), black root disease (Aphanomyces cochlioides), root rot disease (Thanatephorus cucumeris), leaf rot disease (Thanatephorus cucumeris), and the like.
[0168] Peanut: brown spot disease (Mycosphaerella arachidis), leaf mold (Ascochyta sp.), rust disease (Puccinia arachidis), damping-off disease (Pythium debaryanum), rust spot disease (Alternaria alternata), stem rot disease (Sclerotium rolfsii), black rust disease (Mycosphaerella berkeleyi), and the like.
[0169] Cucumber: powdery mildew (Sphaerotheca fuliginea), downy mildew (Pseudoperonospora cubensis), gummy stem blight (Mycosphaerella melonis), wilt disease (Fusarium oxysporum), sclerotinia rot (Scerotinia sclerotiorum), gray mold (Botrytis cinerea), anthracnose (Colletotrichum orbiculare), scab (Cladosporium cucumerinum), brown spot disease (Corynespora cassiicola), damping-off disease (Pythiun debaryanum, Rhizoctonia solani Kuhn), Phomopsis root rot disease (Phomopsis sp.), Bacterial spot (Pseudomonas syringae pv. Lechrymans), and the like.
[0170] Tomato: gray mold disease (Botrytis cinerea), leaf mold disease (Cladosporium fulvum), late blight disease (Phytophthora infestans), Verticillium wilt disease (Verticillium albo-atrum, Verticillium dahliae), powdery mildew disease (Oidium neolycopersici), early blight disease (Alternaria solani), leaf mold disease (Pseudocercospora fuligena), and the like.
[0171] Eggplant: gray mold disease (Botrytis cinerea), black rot disease (Corynespora melongenae), powdery mildew disease (Erysiphe cichoracearum), leaf mold disease (Myovellosiella nattrassii), sclerotinia rot disease (Sclerotinia sclerotiorum), Verticillium wilt disease (Verticillium dahlia), Mycosphaerella blight (Phomopsis vexans), and the like.
[0172] Strawberry: gray mold disease (Botrytis cinerea), powdery mildew disease (Sphaerotheca humuli), anthracnose disease (Colletotrichum acutatum, Colletotrichum fragariae), phytophthora rot disease (Phytophthora cactorum), soft rot disease (Rhizopus stolonifer), fusarium wilt disease (Fusarium oxysporum), verticillium wilt disease (Verticillium dahlia), and the like.
[0173] Onion: neck rot disease (Botrytis allii), gray mold disease (Botyrytis cinerea), leaf blight disease (Botrytis squamosa), downy mildew disease (Peronospora destructor), Phytophthora pom disease (Phytophthora porn), and the like.
[0174] Cabbage: clubroot disease (Plasmodiophora brassicae), soft rot disease (Erwinia carotovora), black rot disease (Xanthomonas campesrtis pv. campestris), bacterial black spot disease (Pseudomonas syringae pv. Maculicola, P.s. pv alisalensis), downy mildew disease (Peronospora parasitica), sclerotinia rot disease (Sclerotinia sclerotiorum), black spot disease (Alternaria brassicicola), gray mold disease (Botrytis cinerea), and the like.
[0175] Common bean: sclerotinia rot disease (Sclerotinia sclerotiorum), gray mold disease (Botrytis cinerea), anthracnose (Colletotrichum lindemuthianum), angular spot disease (Phaeoisariopsis griseola), and the like.
[0176] Apple: powdery mildew disease (Podosphaera leucotricha), scab disease (Venturia inaequalis), Monilinia disease (Monilinia mali), black spot disease (Mycosphaerella pomi), valla canker disease (Valsa mali), alternaria blotch disease (Alternaria mali), rust disease (Gymnosporangium yamadae), ring rot disease (Botryosphaeria berengeriana), anthracnose disease (Glomerella cingulata, Colletotrichum acutatum), leaf rot disease (Diplocarpon mali), fly speck disease (Zygophiala jamaicensis), Sooty blotch (Gloeodes pomigena), violet root rot disease (Helicobasidium mompa), gray mold disease (Botrytis cinerea), and the like.
[0177] Japanese apricot: scab disease (Cladosporium carpophilum), gray mold disease (Botrytis cinerca), brown rot disease (Monilinia munecola), and the like.
[0178] Persimmon: powdery mildew disease (Phyllactinia kakicola), anthracnose disease (Gloeosporium kaki), angular leaf spot (Cercospora kaki), and the like.
[0179] Peach: brown rot disease (Monilinia fructicola), scab disease (Cladosporium carpophilum), phomopsis rot disease (Phomopsis sp.), bacterial shot hole disease (Xanthomonas campestris pv. pruni), and the like.
[0180] Almond: brown rot disease (Monilinia taxa), spot blotch disease (Stigmina carpophila), scab disease (Cladosporium carpophilum), red leaf spot disease (Polystigma rubrum), alternaria blotch disease (Alternaria alternata), anthracnose (Colletotrichum gloeospoides), and the like.
[0181] Yellow peach: brown rot disease (Monilinia fructicola), anthracnose disease (Colletotrichum acutalum), black spot disease (Alternaria sp.), Monilinia kusanoi disease (Monilinia kusanoi), and the like.
[0182] Grape: gray mold disease (Botrytis cinerea), powdery mildew disease (Uncinula necator), ripe rot disease (Glomerella cingulata, Colletotrichum acutatum), downy mildew disease (Plasmopara viticola), anthracnose disease (Elsinoe ampelina), brown spot disease (Pseudocercospora vs), black rot disease (Guignardia bidwellii), white rot disease (Coniella castaneicola), rust disease (Phakopsora ampelopsidis), and the like.
[0183] Pear; scab disease (Venturia nashicola), rust disease (Gymnosporangium asiaticum), black spot disease (Alternaria kikuchiana), ring rot disease (Botryosphaeria berengeriana), powdery mildew disease (Phyllactinia mali), Cytospora canker disease (Phomopsis fukushii), brown spot blotch disease (Stemphylium vesicarium), anthracnose disease (Glomerella cingulata), and the like.
[0184] Tea: ring spot disease (Pestalotiopsis longiseta, P. theae), anthracnose disease (Colletotrichum theae-sinensis), Net blister blight (Exobasidium reticulatum), and the like.
[0185] Citrus fruits: scab disease (Elsinoe fawcettii), blue mold disease (Penicillium italicum), common green mold disease (Penicillium digitatum), gray mold disease (Botrytis cinerea), melanose disease (Diaporthe citri), canker disease (Xanthomonas campestris pv. Citri), powdery mildew disease (Oidium sp.), and the like.
[0186] Wheat: powdery mildew (Blumeria graminis f. sp. tritici), red mold disease (Gibberella zeae), brown rust disease (Puccinia recondita), brown snow mold disease (Pythium iwaymai), pink snow mold disease (Monographella nivalis), eye spot disease (Pseudocercosporella herpotrichoides), leaf scorch disease (Seploria tritici), glume blotch disease (Leptosphaeria nodorum), typhula snow blight disease (Typhula incarnata), sclerotinia snow blight disease (Myriosclerotinia borealis), damping-off disease (Gaeumannomyces graminis), ergot disease (Claviceps purpurea), stinking smut disease (Tilletia caries), loose smut disease (Ustilago nuda), and the like.
[0187] Barley: leaf spot disease (Pyrenophora graminea), net blotch disease (Pyrenophora teres), leaf blotch disease (Rhynchosporium secalis), loose smut disease (Ustilago tritici, U. nuda), and the like.
[0188] Rice: blast disease (Pyricularia oryzae), sheath blight disease (Rhizoctonia solani), bakanae disease (Gibberella fujikuroi), brown spot disease (Cochliobolus miyabeanus), damping-off disease (Pythium graminicola), bacterial leaf blight (Xanthomonas oryzae), bacterial seedling blight disease (Burkholderia plantarii), brown stripe disease (Acidovorax avenae), bacterial grain rot disease (Burkholderia glumae), Cercospora leaf spot disease (Cercospora oryzae), false smut disease (Ustilaginoidea virens), rice brown spot disease (Alternaria alternata, Curvularia intermedia), kernel discoloration of rice (Alternaria padwickii), pink coloring of rice grains (Epicoccum purpurascens), and the like.
[0189] Tobacco: sclerotinia rot disease (Sclerotinia sclerotiorum), powdery mildew disease (Erysiphe cichoracearum), phytophthora rot disease (Phytophthora nicotianae), and the like.
[0190] Tulip: gray mold disease (Botrytis cinerea), and the like.
[0191] Sunflower: downy mildew disease (Plasmopara halstedii), sclerotinia rot disease (Sclerotinia sclerotiorum), and the like.
[0192] Bent grass: Sclerotinia snow blight (Sclerotinia borealis), Large patch (Rhizoctonia solani), Brown patch (Rhizoctonia solani), Dollar spot (Sclerotinia homoeocarpa), blast disease (Pyricularia sp.), Pythium red blight disease (Pythium aphanidermatum), anthracnose disease (Colletotrichum graminicola), and the like.
[0193] Orchard grass: powdery mildew disease (Erysiphe graminis), and the like.
[0194] Soybean: purple stain disease (Cercospora kikuchii), downy mildew disease (Peronospora manshurica), phytophthora rot disease (Phytophthora sojae), rust disease (Phakopsora pachyrhizi), sclerotinia rot disease (Sclerotinia sclerotiorum), anthracnose disease (Colletotrichum truncatum), gray mold disease (Botrytis cinerea), Sphaceloma scab (Elsinoe glycines), melanoses (Diaporthe phaseolorum var. sojae), and the like.
[0195] Potato: hytophthora rot disease (Phytophthora infestans), early blight disease (Alternaria solani), scurf disease (Thanatephorus cucumeris), verticillium wilt disease (Verticillium albo-atrum, V. dahlia, V. nigrescens, and the like.
[0196] Banana: Panama disease (Fusarium oxysporum), Sigatoka disease (Mycosphaerella fijiensis, M. musicola), and the like.
[0197] Rapeseed: sclerotinia rot disease (Sclerotinia sclerotiorum), root rot disease (Phoma lingam), black leaf spot disease (Alternaria brassicae), and the like.
[0198] Coffee: rust disease (Hemileia vastatrix), anthracnose (Colletotrichum coffeanum), leaf spot disease (Cercospora coffeicola), and the like.
[0199] Sugarcane: brown rust disease (Puccinia melanocephala), and the like.
[0200] Com: zonate spot disease (Gloeocercospora sorghi), rust disease (Puccinia sorghi), southern rust disease (Puccinia polysora), smut disease (Ustilago maydis), brown spot disease (Cochliobolus heterostrophus), northern leaf blight (Setosphaeria turcica), and the like.
[0201] Cotton: seedling blight disease (Pythium sp.), rust disease (Phakopsora gossypii), sour rot disease (Mycosphaerella areola), anthracnose (Glomerella gossypii), and the like.
IV. Pesticides
[0202] The presently disclosed compounds, including compounds according to Formulas (I), (Ia), (Ib), (Ic) and/or (II), are useful for enhancing the effect of a variety of agrochemicals, including fungicides, antiviral agents, bactericides, herbicides, insecticidallacaricidal agents, molluscicides, nematicides, soil pesticides, plant control agents, synergistic agents, fertilizers and soil conditioners.
[0203] In one embodiment, the presently disclosed compounds are useful for enhancing the fungicidal effect of a variety of fungicides. Fungicides for use with the presently disclosed compounds, such as a compound of Formulas (I), (Ia), (Ib), (Ic) and/or (II), are well known to those of skill in the art and include, without limitation those set forth by class in Table 2:
TABLE-US-00002 TABLE 2 Family & Group # Common Names Trade Names (Combination Products) Benzimidazole (Group 1) benomyl Benlate, Tersan 1991 thiabendazole Arbotect 20-S, Decco Salt No. 19, LSP Flowable Fungicide, Mertect 340-F thiophanate-methyl Cavalier, Cleary's 3336, OHP 6672, Regal SysTec, Tee-Off, T-Methyl 4.5F AG, TM 85, Topsin M Dicarboximide (Group 2) iprodione Epic 30, Ipro, Meteor, Nevado, OHP Chipco 26019, Rovral, (Interface) vinclozolin Curalan, Ronilan Phenylpyrroles (Group 12) fludioxonil Cannonball, Emblem, Maxim, Medallion, Mozart, Scholar, Spirato, (Academy, Miravis Prime, Palladium, Switch) Anilinopyrimidines (Group 9) cyprodinil Vangard (Palladium, Switch, Inspire Super) pyrimethanil Penbotec, Scala, (Luna Tranquility) Hydroxyanilide (Group 17) fenhexamid Decree, Elevate, Judge fenpyrazamine Protexio Carboxamide (Group 7) boscalid Emerald, Endura, (Encartis, Honor, Pageant, Pristine) carboxin Vitavax fluopyram Luna Privilege, Velum Prime (Broadform, Luna Experience, Luna Sensation, Luna Tranquility, Propulse) flutolanil Contrast, Moncut, ProStar fluxapyroxad (Lexicon, Merivon, Orkestra) inpyrfluxam Excalia isofetamid Kenja oxycarboxin Carboject, Plantvax penthiopyrad Fontelis, Velista, Vertisan pydiflumetofen Miravis, Posterity, Miravis Ace A (Miravis Neo, Miravis Prime, Miravis Duo, Miravis Top) solatenol Aprovia (Contend A, Elatus, Mural) (benzovindiflupyr) Phenylamide (Group 4) mefenoxam Apron, Ridomil Gold, Subdue MAXX, (Quadris Ridomil Gold, Uniform) metalaxyl Acquire, Allegiance, MetaStar, Ridomil, Sebring, Subdue oxadixy1 Anchor Phosphonate (Group P7) aluminum tris Aliette, Flanker, Legion, Signature, Areca Phosphorous Acid Agri-Fos, Alude, Appear, Fiata, Fosphite, Phospho Jet, Phostrol, Rampart, Reload Cinnamic acid (Group 40) dimethomorph Forum, Stature, (Orvego, Zampro) mandipropamid Micora, Revus, (Revus Top) OSBPI (Group 49) oxathiapiprolin Segovis Triazoles carboxamide (Group 22) ethaboxam V-10208 Group 27 cymoxanil Curzate, (Tanos) Carbamate (Group 28) propamocarb Banol, Previcur, Proplant, Tattoo Benzamide (Group 43) fluopicolide Adorn, Presidio Demethylation-inhibiting (Group 3) Piperazines triforine Funginex, Triforine Pyrimidines fenarimol Focus, Rubigan, Vintage Imidazole imazalil Fungaflor, (Raxil MD Extra) triflumizole Procure, Terraguard, Trionic Triazoles cyproconizole Sentinel difenoconazole Dividend, Inspire, (Academy, Briskway, Contend A, Inspire Super, Quadris Top, Revus Top) Miravis Duo fenbuconazole Enable, Indar flutriafol Topguard, (Topguard EQ) mefentrifluconazole Maxtima (Navicon) metconazole Quash, Tourney ipconazole Rancona myclobutanil Eagle, Hoist, Immunox, Laredo, Nova, Rally, Sonoma, Systhane propiconazole Alamo, Banner, Break, Bumper, Infuse, Kestrel Mex, Miravis Ace B, PropiMax, ProPensity, Strider, Tilt, Topaz, (Aframe Plus, Concert, Contend B, Headway, Quilt Xcel, Stratego) prothioconazole Proline (Propulse) tebuconazole Bayer Advanced, Elite, Folicur, Lynx, Mirage, Orius, Raxil, Sativa, Tebucon, Tebuject, Tebusha, Tebustar, Toledo, (Absolute, Luna Experience, Unicorn), etc. tetraconazole Mettle triadimefon Bayleton, Strike, (Armada, Tartan, Trigo) triadimenol Baytan triticonazole Charter, Trinity, (Pillar) Morpholine (Group 5) piperalin Pipron spiroxamine Accrue Group U6 cyflufenamid Torino Group 50 metrafenone Vivando pyriofenone Prolivo QoI Strobilurins (Group 11) azoxystrobin Abound, Aframe, Dynasty, Heritage, Prott, Quadris, Quilt, (Aframe Plus, Briskway, Contend B, Dexter Max, Elatus, Headway, Mural, Quadris Top, Quilt Xcel, Renown, Topguard EQ, Uniform) femoxadone (Tanos) fenamidone Fenstop, Reason fluoxastrobin Aftershock, Disarm, Evito, Fame kresoxim-methyl Cygnus, Sovran mandestrobin Intuity, Pinpoint picoxystrobin Aproach pyraclostrobin Cabrio, Empress, Headline, Insignia, Stamina, (Honor, Lexicon, Merivon, Navicon, Orkestra, Pageant, Pillar, Pristine) trifloxystrobin Compass, Flint, Gem, (Absolute, Armada, Broadform, Interface, Luna Sensation, Stratego, Tartan, Trigo) Quinoline (Group 13) quinoxyfen Quintec Inorganic Compounds Coppers (Group MI) bordeaux None copper ammonium complex Copper Count-N copper hydroxide Champ, Champion, Kalmor, Kentan, Kocide, Nu-Cop copper oxide Nordox copper oxychloride COCS, Oxycop copper sulfate Cuprofix Disperss, many others Sulfur (Group M2) sulfur Cosavet, Kumulus, Microthiol Disperss, Thiosperse Lime sulfur Ca polysulfides Lime Sulfur, Sulforix Ethylenebisdithiocarbamates mancozeb Dithane, Fore, Penncozeb, Protect, Manex, Manzate, (EBDC) (Group M3) Roper, Wingman, (Dexter Max, Gavel) maneb Maneb metiram Polyram EBDC-like (Group M3) ferbam Carbamate, Ferbam thiram Difiant, Spotrete, Thiram ziram Ziram Aromatic Hydrocarbon (Group 14) dicloran (DCNA) Allisan, Botran etridizole Terrazole, Truban pentachloronitrobenzene Autilus, Defend, Engage, PCNB, Terraclor, (Premion) Chloronitrile (Group M5) chlorothalonil Bravo, Daconil, Docket, Echo, Ensign, Exotherm Termil, Funginil, Legend, Manicure, Pegasus, Terranil, (Concert, Spectro) Phthalimides (Group M4) captan Captan Guanidines (Group U12) dodine Syllit QiI fungicides (Group 21) cyazofamid Ranman, Segway Polyoxin (Group 19) polyoxin Affirm, Endorse, Oso, Ph-D, Tavano, Veranda Group 29 fluazinam Omega, Secure Thiazolidine (U13) flutianil Gatten
[0204] Fungicides are cataloged more broadly by the Fungicide Resistance Action Committee (FRAC) in the FRAC Code List 2022 and reproduced in Appendix 1 and which is incorporated herein by reference in its entirety.
[0205] In one embodiment, a presently disclosed enhancer compound, such as a compound of Formulas (I), (Ia), (Ib), (Ic) and/or (II), is used in combination with one or more compound from the Families or Groups set forth in Table 2, Appendix 1, or both. In certain embodiments, a presently disclosed enhancer is used in combination with one or more fungicides recited in column 1 of Table 2.
[0206] In particular embodiments, a disclosed enhancer is used in combination with one or more of a fungicide selected from the benzimidazoles, dicarboximides, phenylpyrroles, anilinopyrimidines, hydroxyanilides, carboxamides, phenyl amides, phosphonates, cinnamic acids, oxysterol binding protein inhibitors (OSBPI), triazole carboxamides, cymoxanil, carbamates, benzamides, demethylation inhibiting piperazines, demethylation inhibiting pyrimidines, demethylation inhibiting azoles, including imidazoles, and triazoles, such as cyproconazole, difenoconazole, fenbuconazole, flutriafol, mefentrifluconazole, metconazole, ipconazole, prothioconazole, tebuconazole, tetraconazole, triadimefon, triadimenol, triticonazole, morpholines, cyflufenamid, metrafenone, pyriofenone, strobilurins, copper ammonium complex, copper hydroxide, copper oxide, copper oxychloride, copper sulfate, sulfur, lime sulfur, ethylenebisdithiocarbamates, aromatic hydrocarbons, phthalimides, guanidines, polyoxins, fluazinam and thiazolidines.
[0207] Particular fungicides that are potentiated by use in combination with an enhancer according to the methods herein by administration of an apyrase inhibitor are coppers, such as copper octanoate, copper hydroxide and the like, myclobutanil, propiconazole, tebuconazole, epoxiconazole, difenoconazole, triticonazole, and prothioconazole.
[0208] In one embodiment, the combined treatment with a selected fungicide and an enhancer according to the present disclosure, such as a compound of Formulas (I), (Ia), (Ib), (Ic) and/or (II), provides synergistic fungicidal activity against plant pathogenic fungi.
[0209] In one embodiment, the disclosure provides compositions and methods of treating plants or plant seeds infected with or at risk of being infected with a fungal pathogen. In one embodiment compositions of the present disclosure comprise a formulation of a fungicide, an enhancer and a phytologically acceptable carrier. In another embodiment, the fungicide and enhancer are administered in separate compositions. In further embodiments, an agricultural or horticultural fungicide is used in combination with other compounds in addition to the presently disclosed apyrase inhibitors. As with the apyrase inhibitors, such other compounds can be administered in the same or separate compositions as the fungicide. Examples of the other components include known carriers to be used to conduct formulation. Additional examples thereof include conventionally-known herbicides, insecticidal/acaricidal agents, nematodes, soil pesticides, plant control agents, synergistic agents, fertilizers, soil conditioners, and animal feeds. In one embodiment, the inclusion of such other components yields synergistic effects on crop growth.
[0210] In one embodiment, the presently disclosed compounds, including compounds according to Formulas (I), (Ia), (Ib), (Ic) and (II), are used to potentiate the effect of a herbicide. Exemplary herbicides for use in combination with the present compounds are known to those of skill in the art and include, without limitation, those described in Appendix 2. By way of example, suitable herbicides for use in combination with the present compounds include inhibitors of acetyl CoA synthase, inhibitors of acetolactate synthesis, inhibitors of microtubule assembly, inhibitors of microtubule organization, auxin mimics, photosynthesis inhibitors, deoxy-D-xylulose phosphate synthase inhibitors, enolpyruvyl shikimate phosphate synthase inhibitors, phytoene desaturase inhibitors, glutamine synthetase inhibitors, dihydropteroate synthesis inhibitors, protoporphyrinogen oxidase inhibitors, cellulose synthesis inhibitors, uncouplers, hydroxyphenyl pyruvate dioxygenase inhibitors, fatty acid thioesterase inhibitors, serine-threonine protein phosphatase inhibitors, solanesyl diphosphate synthase inhibitors, inhibitors of very long-chain fatty acid synthesis, homogentisate solanesyltransferase inhibitors, lycopene cyclase inhibitors.
[0211] In one embodiment, the presently disclosed compounds, including compounds according to Formulas (I), (Ia), (Ib), (Ic) and/or (11), are used to potentiate the effect of an insecticide. Exemplary insecticides for use in combination with the present compounds are known to those of skill in the art and include, without limitation, those described in Appendix 3.
V. Formulations
[0212] The present disclosure provides specific apyrase inhibitors, such as compounds of Formulas (I), (Ia), (Ib), (Ic) and/or (II), to enhance the potency of pesticides to effectively restrict the growth of plant pathogenic species. In certain non-limiting embodiments, the apyrase inhibitors can be provided at: from about 0.01 to about 80% weight to weight in a final composition, or from about 25% to about 55%, such as from about 30% to about 50%, from about 35% to about 45%, such as about 0.01, 0.05, 0.1, 0.5, 1.0, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, 2.0, 2.5, 3.0, 4.0, 5.0, 7.5, 10, 20, 30, 40, 50, 55, 60 or 80% weight to weight in a final composition. In one embodiment the apyrase inhibitors are provided in liquid form at from about 0.01 to about 50%, such as from about 15% to about 50%, from about 20% to about 45%, from about 25% to about 40%, such as about 0.01, 0.05, 0.1, 0.5, 1.0, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, 2.0, 2.5, 3.0, 4.0, 5.0, 7.5, 10, 15, 20, 30, 40 or 50% volume to volume in a final diluted composition. The skilled artisan will recognize that the formulation of the pesticide, the apyrase inhibitor or a combination thereof can be provided in a concentrate that can be diluted prior to use, or can be provided in a diluted form ready for treatment.
[0213] The enhancer, pesticide and combinations thereof are not particularly limited by the dosage form. Examples of the dosage form include wettable powders, emulsions, emulsifiable concentrates, oil-dispersible liquids, powders, granules, water-soluble agents, suspensions, granular wettable powders, and tablets. The method for preparing formulation is not particularly limited, and conventionally-known methods may be adopted depending on the dosage form.
[0214] Several formulation examples are described below. The preparation formulations shown below are merely examples, and may be modified within a range not contrary to the essence of the present disclosure. For example, additional active and inert components may be added to the formulations below.
[0215] Part means part by mass unless otherwise specified.
Formulation Example 1: Wettable Powders
[0216] 40 parts of an enhancer disclosed herein, 53 parts of diatomaceous earth, 4 parts of ethoxylated higher alcohol sulfate ester combined with a suitable solid carrier such as magnesium sulfate, and 3 parts of alkyl naphthalene sulfonate are mixed uniformly, and then finely pulverized to obtain wettable powders containing 40 parts by mass of the enhancer.
Formulation Example 2: Emulsifiable Concentrates
[0217] 3 parts of an enhancer disclosed herein, 60 parts of mixed petroleum distillates, 27 parts of dimethyl lactamide, and 10 parts of tristyrylphenol ethoxylates are mixed and dissolved to obtain an emulsifiable concentrate containing 3% by mass of the enhancer.
Formulation Example 3: Granules
[0218] 5 parts of an enhancer disclosed herein, 10 parts of talc, 38 parts of clay, 10 parts of bentonite, 30 parts of sodium lignosulfonate and 7 parts of sodium alkyl sulfate are mixed uniformly, and then finely pulverized, followed by conducting fluidized bed granulation to make the median particle diameter thereof be 0.2 to 2.0 mm, and thus granules containing 5% by mass of an enhancer on a dry weight basis disclosed herein are obtained.
Formulation Example 4: Granules
[0219] 5 parts of an enhancer disclosed herein, 73 parts of clay, 20 parts of bentonite, 1 part of sodium dioctyl sulfosuccinate, and 1 part of potassium phosphate are mixed and then pulverized, followed by adding water thereto, and then kneading the mixture. Then, extrusion granulation is conducted, and the resultant is dried to obtain granules containing 5% by mass of the enhancer on a dry weight basis.
Formulation Example 5: Suspensions
[0220] 10 parts of an enhancer disclosed herein, 4 parts of polyoxyethylene alkyl ether, 2 parts of 3 kDa sodium polycarboxylate as dispersant, 10 parts of glycerin, 0.2 parts of xanthan gum, 0.1 parts of biocides as stabilizer, 0.1 parts of organosilicone antifoam emulsion and 73.6 parts of water are mixed, and then wet pulverized until the particle size is 3 microns or less to obtain a suspension containing 10% by mass of the enhancer.
Formulation Example 6: Oil Dispersible Concentrates
[0221] 40 parts of an enhancer disclosed herein, 5 parts of Atlox 4914, 5 parts of organo-modified bentonite and 50 parts of methylated rapeseed oil as carrier are mixed uniformly and then wet pulverized until the median particle size is 3 microns or less to obtain an oil dispersible concentrate containing 40% by mass of the enhancer.
[0222] The skilled artisan will recognize that the various compositions are used commercially at varying concentrations and formulations. For example, it is common for fungicides to be formulated as liquids commercially at 10-40% concentrations. In one embodiment, the presently disclosed enhancers allow the use of a lower amount of a given fungicide due to the enhanced efficacy of fungicide in combination with an enhancer disclosed herein.
VI. Methods for Assessing Enhancer Activity
Method 1: Apyrase Inhibition Assay
[0223] Apyrase inhibitors useful as enhancers of pesticidal activity are assessed using an in vitro assay. The method of Windsor, Bio Techniques 33:1024-1030 (November 2002) was used as follows
Screen for Apyrase Inhibitors
[0224] 96 well plates were used for the assay: (Greiner bio-one: REF-655901-96 well, PS, F-bottom, Clear, Non-binding)
Buffers:
[0225] Reaction Buffer: 60 mM Hepes, 3 mM MgCl.sub.2, 3 mM CaCl.sub.2 and 3 mM ATP (pH 6.5) [0226] Development Buffer A: 2% aqueous ammonium molybdate [0227] Development Buffer B: 11% ascorbic acid in 37.5% TCA in water [0228] Stop buffer C: 2% trisodium citrate in 2% acetic acid solution in water [0229] Add 100 l of reaction buffer to each well. [0230] Add 10 l of DMSO (control) or inhibitor/compound or compounds such as N1915 or orthovanadate to each well. (use inhibitor conc at 1 mM; orthovanadate at 2 mM and N1915 at 1 mM) [0231] Add 10 l of apyrase (concentration based on optimization Dilute 1 U/l enzyme to different concentrations such as 0.1U, 0.05U, 0.0025, 0.001U, 0.0005Uto find a good range) [0232] Incubate plate at room temperature for 1 hr [0233] Mix development buffer A and B in the ratio of 1:1.5 (just before use). [0234] Add 50 ul of A:B mix in each well (incubate for 2 mins) [0235] Add 50 ul of C in each well [0236] Measure/Read Absorbance of plate @630 nm
[0237] Inhibitory data for the apyrase assay described above are provided for selected compounds in Table 3. In Table 3, D indicates inhibition of <10%. C indicates inhibition of from 10% to 20%, B indicates inhibition of from 20% to 30%, and A indicates inhibition above 30%:
TABLE-US-00003 TABLE 3 ID % Inhibition of Apyrase I-1 A I-2 A I-3 A I-4 A I-5 A I-6 A I-7 A I-8 A I-9 A I-10 B I-11 B I-12 B I-13 B I-14 A I-15 B I-16 B I-17 B I-18 B I-19 B I-20 C I-21 C I-22 C I-23 C I-24 C I-25 C I-26 C I-27 C I-28 C I-29 C I-30 C I-31 C I-32 C I-33 C I-34 C I-35 C I-36 C I-37 D I-38 D I-39 D I-40 D I-41 D I-42 D I-43 D I-44 D I-45 D I-46 D I-47 D I-48 D I-49 D I-50 D I-51 D I-52 D I-53 D I-54 D I-55 D I-56 D I-57 D I-58 D I-59 D I-60 D I-61 D I-62 A I-63 A I-64 B I-65 D I-66 A I-67 A
[0238] With reference to Table 3, percent inhibition of apyrase is reported as the rounded average of at least two assay results.
Method 2: In Vitro Assessment of Combination Activity
[0239] Selected compounds are assessed in combination with fungicides against a range of commercially important plant pathogenic fungi.
[0240] The test is conducted as follows. A fungicide is applied to a fungal plant pathogen at a rate slightly below that at which it gave any control, in combination with a suitable dose of the test compound. The test compound is recorded as active if control of the pathogen is observed.
[0241] In more detail, the test is conducted as follows. For each combination of fungicide, pathogen and test compound, the following wells are used. Well 1 contains a fungal pathogen growing on agar, and a fungicide at a rate just below that at which it gives any control of the pathogen. Well 2 is the same as Well 1, except that the test compound is also added at Rate 1. Well 3 is the same as Well 2, except that the test compound is added at Rate 2, where Rate 2 was higher than Rate 1. Finally, as a benchmark. Well 4 is the same as Well 1, except that it contains the fungicide at a higher rate, at which it gives partial control of the pathogen. Each of the Wells 1 to 4 are run in duplicate, giving a total of 8 wells for each combination of fungicide, pathogen and test compound. For each well, after a suitable period of incubation, a visual assessment of the % control of the pathogen by the fungicide is made. Test compounds are scored as inactive, active or highly active.
[0242] The following fungicides are used in this assay: azoxystrobin, fluxapyroxad, and desthio prothioconazole. The following fungal pathogens are used in this assay: First, a strain of Zymoseptoria tritici with a reduced susceptibility to strobilurin fungicides; second a strain of Zymoseptoria tritici with a reduced susceptibility to SDHI fungicides (i.e., those that inhibit succinate dehydrogenase); and third, Microdochium nivale. In this assay, Roux Compound 13 exhibits activity in only one combination, enhancing the activity of azoxystrobin against Microdochium nivale, but failing to enhance activity of any fungicide against either of the Zymoseptoria tritici strains. In contrast, present compounds are effective in the combination assay.
Method 3: Greenhouse Crop Tests
[0243] In this method, exemplary compounds were evaluated for their ability to control Brown Rust (Puccinia recondita) on wheat, in a controlled greenhouse environment in combination with one of four fungicides, Amistar, Imtrex, Proline or Balaya. In these studies, JB Diego wheat plants were used. Seeds were sown in 9 cm diameter pots to a depth of 1 to 2 cm using Petersfield potting compost (75% medium grade peat, 12% screened sterilized loam, 3% medium grade vermiculite, 10% grit (5 mm screened, lime free), 1.5 kg PG mix per m3, lime to pH5.5-6.0 and wetting agent (Vitax Ultrawet 200 ml per m3) and germinated/grown at 23 C under a 16 h day/8 h night light regime. Plants were treated two to three weeks after sowing when they were at the BBCH 11 growth stage (first pair of true leaves (unifoliate) unfolded). Plants were inoculated with the Puccinia triticina (Brown rust on wheat plants) 24 hours after treatment. A track sprayer was used to treat the plants with the mixture of commercial fungicide and test compound using a water volume of 200 L/ha. Four replicates were used for each combination of fungicide and test compound. Each plant was evaluated at fourteen days (once the disease symptoms were fully expressed) for % control of the disease. Appropriate controls were used for all experiments, including an inoculation check wherein plants were inoculated with their specific pathogen to assess disease levels. Also, each commercial fungicide was tested on its own as a part of each treatment, this being benchmark against which the experimental compounds were evaluated. Exemplary compounds demonstrated enhanced disease control in combination with fungicides as compared to disease control observed with fungicide alone. That is, the present compounds, although not fungicidal by themselves, enhance the activity of fungicides, thus the enhancer compounds work synergistically in combination with fungicides to control disease.
[0244] In these studies the fungicide was applied at the following rates
TABLE-US-00004 Amistar Imtrex Proline Balaya Brown Rust 0.04 L/ha 0.45 L/ha 0.15 L/ha 0.25 L/ha
[0245] In this method, working examples enhanced the activity of Amistar against Brown Rust on wheat by significant amounts relative to the activity of Amistar alone. Compounds I-1, I-14, I-63 and I-67 all provided greater than 50% additional disease control benefit in combination with Amistar over Amistar alone. Compounds I-3, I-5 and I-6 provided greater than 30% additional Brown Rust control relative to Amistar alone, and compound I-66 provided greater than 20% additional Brown Rust control in combination with Amistar over Amistar alone.
[0246] Working examples also enhanced the activity of Imtrex against Brown Rust on wheat by significant amounts relative to Imtrex treatment alone. For example, compounds I-1 and I-67 provided greater than 50% additional disease control benefit in combination with Imtrex over lmtrex alone. Compounds I-13, I-63 and I-3 provided greater than 30% additional Brown Rust control relative to Imtrex alone, and compounds I-5 and I-66 provided greater than 15% additional Brown Rust control in combination with Imtrex over Imtrex alone.
[0247] Working examples I-6, I-14 and I-67 enhanced the activity of Balaya against Brown Rust on wheat by over 50% over Balaya alone. Working examples I-66 and I-63 each provided greater than 30% additional Brown Rust control benefit in combination with Balaya over Balaya alone. Compounds I-1 and I-5 provided greater than 20% additional Brown Rust control in combination with Balaya over Balaya alone. Compound I-3 provided measurable additional Brown Rust control in combination with Balaya over Balaya alone.
[0248] The Brown Rust isolate used in this method is resistant to Proline and no control was observed with Proline alone at the application rate of 0.15 L/hectare. Exemplary compounds showed some control in combination with Proline applied at 0.15 L/hectare and in these examples Brown Rust control was observed to be comparable to that achieved with 0.72 L/hectare Proline alone.
Method 4: Enhancement of Herbicide Activity
[0249] This method demonstrates the enhancement of herbicidal activity provided by the present compounds. Specifically, Amaranthus retroflexus (pigweed) was treated pre-emergence with metribuzin alone or in combination with an enhancer compound disclosed herein. Fifteen seeds of Amaranthus retroflexus were sown in soil in each pot and then sprayed with a mixture of metribuzin at the appropriate rate shown in Table 4 and the compound of this invention at 100 g/ha using a track sprayer at a water volume of 200 L/hectare. Small amounts of acetone were used to aid solubility. The pots were watered immediately after sowing and treatment and then allowed to stand in a glasshouse. Assessment of kill was made seven and fourteen days after treatment. The test included four replicates for each treatment and the control. Results are shown in Table 4. Exemplary compounds I-14 and I-63 demonstrated significant enhancement of metribuzin herbicidal activity at seven and fourteen days.
TABLE-US-00005 TABLE 4 Pre-Emergence Amaranthus Kill Percentage Assessed 7 DAT Assessed 14 DAT Enhancer Metribuzin rate (g/ha) Metribuzin rate (g/ha) Compound 0 50 100 200 0 50 100 200 None 0.0 0.0 15.2 60.9 4.8 7.7 38.3 74.0 (metribuzin only) I-14 21.3 93.9 98.0 32.7 94.0 100.0 I-63 2.0 34.0 96.3 4.1 34.0 98.2
VII. Methods for Making Enhancer Compounds
[0250] Exemplary enhancer compounds were purchased from commercial suppliers, such as Enamine, located at Industriepark Hoechst, G837, 65926 Frankfurt am Main Germany.
[0251] Compounds disclosed herein, including compounds of Formulas (I), (Ia), (Ib), (Ic) and (II), can be prepared as will be understood by those of skill upon consideration of the present disclosure. For example, compounds containing a carboxamide group can be prepared by the reaction between an amine and a carboxylic acid that has been activated in some way, in a suitable solvent and at a suitable temperature. For example, a carboxylic acid can be activated by converting it into the corresponding carboxylic acid halide, such as an acid bromide or chloride; reaction with an amine then gives the required carboxamide together with an acid, such as hydrobromic or hydrochloric acid, which is usually neutralized by a base, such as a tertiary amine base in the reaction mixture. Examples of methods that can be used to synthesize compounds of the invention are described in ACCS Sustainable Chemistry & Engineering 2022, 10, 16046-16054 and in Journal of Medicinal Chemistry 2016, 59, 6512-6530 which describes the reaction of carboxylic acid chloride groups with primary or secondary amines to yield the corresponding amide compounds.
[0252] Reaction of dicarboxylic acid compounds with a first amine followed by reaction of the second carboxylic acid moiety with a second amine to form bis-carboxamide compounds is described in, for example, International App. Pub. Nos. WO 2008/008234 and WO 99/43651 and Zhurnal Organicheskoi Khimii 1988, 24(9), 1968-72. These methods can be used as will be recognized by those of skill in the art of organic synthesis upon consideration of the present disclosure, in particular the the methods set forth below:
Synthesis of Enhancer Compounds
##STR00079##
[0253] Scheme 1 illustrates a suitable preparation for symmetrical compounds of Formula (I) disclosed herein (for example wherein compounds have R.sup.1=R.sup.2 and R.sup.3=R.sup.4). In addition to the reagents shown in the scheme, an amine of formula R.sup.2R.sup.3NH is used (for the symmetrical product compounds, this is equivalent to the amine R.sup.2R.sup.4NH). See, ACS Sustainable Chemistry & Engineering 2022, 10, 16046-16054 and in Journal of Medicinal Chemistry 2016, 59, 6512-6530 which describes the reaction of carboxylic acid chloride groups with primary or secondary amines to yield the corresponding amide compounds.
[0254] Furthermore, the chemistry shown in Scheme 1 can be used to make unsymmetrical compounds of Formula (I), by treatment first with an amine of formula R.sub.1R.sup.3NH, together with the reagents shown in Scheme 1, and then with an amine of formula R.sup.2R.sup.3NH, together with the reagents shown in Scheme 1. Various methods can be used to minimize over-reaction at the first step, e.g., slow addition of the amine R.sup.1R.sup.3NH to a stirred mixture of the other reactants. Chemistry parallel to that shown in Scheme 1 can be used to make ortho- and para-substituted compounds of Formula (I) by using the corresponding ortho- or para-substituted bis-acid chloride as starting material.
##STR00080##
[0255] Scheme 2 illustrates two sequential amide bond forming reactions using coupling agents, such as those selected from the carbodiimides, such as DCC (dicyclohexyl carbodiimide), EDCI (1-Ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride), or the like, carbonyldiimidazole, phosphonium salt reagents, such as BOP, PyBOP, PyBrOP and the like, and uronium salt reagents, such as HBTU, HATU, and the like. Additional coupling reagents are known to those of skill in the art and can be selected upon consideration of the schemes and compounds illustrated herein. The amide bond forming techniques of Scheme 2 also are applicable to the ortho and para analogs of the meta diacid, amide and diamide compounds illustrated therein. Additional reagents and techniques consistent with Scheme 2, will be readily apparent to those of skill in the art upon consideration of the present disclosure and further in view of International App. Pub. Nos. WO 2008/008234 and WO 99/43651 and Zhurnal Organicheskoi Khimii 1988, 24(9), 1968-72.
[0256] An alternative preparation of ortho diamide compounds is illustrated in Scheme 3:
##STR00081##
[0257] With continued reference to Scheme 3, the first step finds precedent in Journal of Organic Chemistry 2001, 66, 1548-1552, Bioorganic & Medicinal Chemistry Letters 2001, 11, 2671-2674, and Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry 1998, 37B, 704-706. The second step is a conventional coupling reaction that can be conducted as is well known to those of skill in the art and consistent with the techniques used in Scheme 2.
[0258] Schemes 4-6 illustrate preparation of dihydrophthalazine-1,4-dione compounds:
##STR00082##
[0259] Scheme 4 is further illustrated by Chemische Berichte 1985, 118, 4404-14.
##STR00083##
[0260] With reference to Scheme 5, R may be any suitable group, such as hydrogen, alkyl or other group as will be appreciated by those of skill in the art. See also, ChemistryA European Journal 2018, 24, 590-593.
##STR00084##
[0261] With reference to Scheme 6, the reaction can be performed in one step when R.sup.1 and R.sup.2 are the same, or optionally in two steps when R.sup.1 and R.sup.2 are different.
[0262] With reference to Schemes 1-6, the groups R.sup.1, R.sup.2, R.sup.3, R.sup.4 and Z are as described herein throughout.
TABLE-US-00006 APPENDIX 1 CHEMICALOR TARGET SITE BIOLOGICAL FRAC MOA AND CODE GROUP NAME GROUP COMMON NAME COMMENTS CODE A: nucleic A1 PA - fungicides acylalanines benalaxyl Resistance and cross resistance 4 acids RNA polymerase I (PhenylAmides) benalaxyl-M well known in various metabolism (=kiralaxyl) Oomycetes but mechanism furalaxyl unknown. metalaxyl High risk. metalaxyl-M See FRAC Phenylamide (=mefenoxam) Guidelines for resistance oxazolidinones oxadixyl management butyrolactones ofurace A2 hydroxy- hydroxy- bupirimate Medium risk. Resistance and 8 adenosin- (2-amino-) (2-amino-) dimethirimol cross resistance known in deaminase pyrimidines pyrimidines ethirimol powdery mildews. Resistance management required. A3 heteroaromatics isoxazoles hymexazole Resistance not known. 32 DNA/RNA synthesis isothiazolones octhilinone (proposed) A4 carboxylic acids carboxylic acids oxolinic acid Bactericide. Resistance known. 31 DNA topoisomerase Risk in fungi unknown. type II (gyrase) Resistance management required. A5 DHODHI- phenyl-propanol ipflufenoquin Medium to high risk. 52 inhibition of fungicides dihydroorotate dehydrogenase within de novo pyrimidine biosynthesis B: B1 MBC - benzimidazoles benomyl Resistance common in many Cytoskeleton tubulin fungicides carbendazim fungal species. Several target and motor polymerization (Methyl fuberidazole site mutations, mostly protein Benzimidazole thiabendazole E198A/G/K, F200Y in -tubulin Carbamates) thiophanates thiophanate gene. thiophanate-methy Positive cross resistance between the group members. Negative cross resistance to N-phenyl carbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management. B2 N-phenyl N-phenyl diethofencarb Resistance known. Target site 10 tubulin carbamates carbamates mutation E198K. Negative cross polymerization resistance to benzimidazoles. High risk. Resistance management required. B3 benzamides toluamides zoxamide Low to medium risk. 22 tubulin thiazole ethylamino- ethaboxam Resistance management polymerization carboxamide thiazole- required. carboxamide B4 phenylureas phenylureas pencycuron Resistance not known. 20 cell division (unknown site) B5 benzamides pyridinylmethyl- fluopicolide Resistant isolates detected in 43 delocalisation of benzamides fluopimomide grapevine downy mildew. spectrin-like Medium risk. proteins Resistance management required B6 cyanoacrylates aminocyanoac- phenamacril Resistance known in Fusarium 47 actin/myosin/fimbrin rylates graminearum. Target site function mutations in the gene coding for myosin-5 found in lab studies. Medium to high risk. Resistance management required. aryl-phenyl- benzophenone metrafenone Less sensitive isolates detected 50 ketones benzoylpyridine pyriofenone in powdery mildews (Blumeria and Sphaerotheca) Medium risk. Resistance management required. Reclassified from U8 in 2018 B7 pyridazine pyridazine pyridachlometyl High risk. 53 tubulin dynamics modulator C. C1 pyrimidinamines pyrimidinamines diflumetorim Resistance not known. 39 respiration complex I NADH pyrazole-MET1 pyrazole-5- tolfenpyrad oxido-reductase carboxamides Quinazoline quinazoline fenazaquin C2 SDHI phenyl-benzamides benodanil Resistance known for several 7 complex II: (Succinate- flutolanil fungal species in field succinate-dehydro- dehydrogenase mepronil populations and lab mutants. genase inhibitors) phenyl-oxo-ethyl isofetamid Target site mutations in sdh thiophene amide gene, e.g. H/Y (or H/L) at 257, pyridinyl-ethyl- fluopyram 267, 272 or P225L, dependent benzamides on fungal species. phenyl-cyclobutyl- cyclobutrifluram Resistance management pyridineamide required. furan-carboxamides fenfuram Medium to high risk. oxathiin- carboxin See FRAC SDHI Guidelines carboxamides oxycarboxin for resistance management. thiazole- thifluzamide carboxamides pyrazole-4- benzovindiflupyr carboxamides bixafen fluindapyr fluxapyroxad furametpyr inpyrfluxam isopyrazam penflufen penthiopyrad sedaxane N-cyclopropyl-N- isoflucypram benzyl-pyrazole- carboxamides N-methoxy- pydiflumetofen (phenyl-ethyl)- pyrazole- carboxamides pyridine- boscalid carboxamides pyrazine- pyraziflumid carboxamides C. C3 Qol-fungicides methoxy-acrylates azoxystrobin Resistance known in various 11 respiration complex III: (Quinone outside coumoxystrobin fungal species. Target site cytochrome bc1 Inhibitors) enoxastrobin mutations in cyt b gene (G143A, (ubiquinol oxidase) flufenoxystrobin F129L) and additional at Qo site (cyt b picoxystrobin mechanisms. gene) pyraoxystrobin Cross resistance shown methoxy-acetamide mandestrobin between all members of the methoxy-carbamates pyraclostrobin Code 11 fungicides. pyrametostrobin High risk. triclopyricarb See FRAC Qol Guidelines oximino-acetates kresoxim-methyl for resistance management. trifloxystrobin oximino-acetamides dimoxystrobin fenaminstrobin metominostrobin orysastrobin oxazolidine-diones famoxadone dihydro-dioxazines fluoxastrobin imidazolinones fenamidone benzyl-carbamates pyribencarb Qol-fungicides tetrazolinones metyltetraprole Resistance not known. Not .sup.11A (Quinone outside cross resistant with Code 11 Inhibitors; fungicides on G143A mutants. Subgroup A) High risk. See FRAC Qol Guidelines for resistance management. C: C4 Qil - fungicides cyano-imidazole cyazofamid Resistance risk unknown but 21 respiration complex III: (Quinone inside sulfamoyl-triazole amisulbrom assumed to be medium to high (continued) cytochrome bc1 Inhibitors) picolinamides fenpicoxamid (mutations at target site known (ubiquinone florylpicoxamid in model organisms). reductase) at Qi site Resistance management required. No spectrum overlap with the Oomycete-fungicides cyazofamid and amisulbrom C5 dinitrophenyl- binapacryl Resistance not known. 29 uncouplers of crotonates meptyldinocap Also acaricidal activity. oxidative dinocap phosphorylation 2,6-dinitro-anilines fluazinam Low risk. However, resistance claimed in Botrytis in Japan. (pyr.-hydrazones) (ferimzone) Reclassified to U 14 in 2012. C6 organo tin tri-phenyl tin fentin acetate Some resistance cases 30 inhibitors of compounds compounds fentin chloride known. Low to medium risk. oxidative fentin hydroxide phosphorylation, ATP synthase C7 thiophene- thiophene- silthiofam Resistance reported. Risk low. 38 ATP transport carboxamides carboxamides (proposed) C8 QoSI fungicides triazolo- ametoctradin Not cross resistant to QoI 45 complex III: (Quinone outside pyrimidylamine fungicides. cytochrome bc1 Inhibitor, Resistance risk assumed to (ubiquinone stigmatellin be medium to high reductase) at binding type) (single site inhibitor). Qo site, stigmatellin Resistance management binding sub-site required. D: amino D1 AP - fungicides anilino-pyrimidines cyprodinil Resistance known in Botrytis acids and methionine (Anilino- mepanipyrim and Venturia, sporadically in protein biosynthesis Pyrimidines) pyrimethanil Oculimacula. (proposed) Medium risk. (cgs gene) See FRAC Anilinopyrimidine Guidelines for resistance management. D2 enopyranuronic enopyranuronic blasticidin-S Low to medium risk. 23 protein synthesis acid antibiotic acid antibiotic Resistance management (ribosome, required. termination step) D3 hexopyranosyl hexopyranosyl kasugamycin Resistance known in fungal 24 protein synthesis antibiotic antibiotic and bacterial (P. glumae) (ribosome, initiation pathogens. Medium risk. step) Resistance management required. D4 glucopyranosyl glucopyranosyl streptomycin Bactericide. Resistance 25 protein synthesis antibiotic antibiotic known. High risk. (ribosome, initiation Resistance management step) required. D5 tetracycline tetracycline oxytetracycline Bactericide. Resistance 41 protein synthesis antibiotic antibiotic known. High risk. (ribosome, Resistance management elongation step) required. E: signal E1 aza- aryloxyquinoline quinoxyfen Resistance to quinoxyfen 13 transduction signal transduction naphthalenes quinazolinone proquinazid known. (mechanism unknown) Medium risk. Resistance management required. Cross resistance found in Erysiphe (Uncinula) necator but not in Blumeria graminis. E2 PP-fungicides phenylpyrroles fenpiclonil Resistance found sporadically, 12 MAP/Histidine- (PhenylPyrroles) fludioxonil mechanism speculative. Kinase in osmotic Low to medium risk. signal transduction Resistance management (os-2, HOG1) required. E3 dicarboximides dicarboximides chlozolinate Resistance common in Botrytis 2 MAP/Histidine- dimethachlone and some other pathogens. Kinase in osmotic iprodione Several mutations in OS-1, signal transduction procymidone mostly I365S. (os-1, Daf1) vinclozolin Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management F: lipid F1 formerly dicarboximides synthesis or F2 phosphoro- phosphoro- edifenphos Resistance known in specific 6 transport/ phospholipid thiolates thiolates iprobenfos (IBP) fungi. membrane biosynthesis, pyrazophos Low to medium risk. integrity or methyltransferase Dithiolanes dithiolanes isoprothiolane Resistance management function required if used for risky pathogens. F3 AH-fungicides aromatic biphenyl Resistance known in some 14 cell peroxidation (Aromatic hydrocarbons chloroneb fungi. (proposed) Hydrocarbons) dicloran Low to medium risk. (chlorophenyls, quintozene (PCNB) Cross resistance patterns nitroanilines) tecnazene (TCNB) complex due to different tolclofos-methyl activity spectra. heteroaromatics 1,2,4-thiadiazoles etridiazole F4 Carbamates carbamates iodocarb Low to medium risk. 28 cell membrane propamocarb Resistance management permeability, fatty prothiocarb required. acids (proposed) F5 formerly CAA-fungicides F6 formerly Bacillus amyloliquefaciens strains (FRAC Code 44); microbial disrupters reclassified to BM02 in 2020 of pathogen cell membranes F7 formerly extract from Melaleuca alternifolia (tea tree oil) cell membrane and plant oils (eugenol, geraniol, thymol) disruption FRAC Code 46, reclassified to BM01 in 2021 F8 Polyene amphoteric macrolide natamycin Resistance not known. 48 ergosterol binding antifungal antibiotic (pimaricin) Agricultural, food and topical from Streptomyces medical uses. natalensis or S. chattanoogensis F9 OSBPI piperidinyl-thiazole- oxathiapiprolin Resistance risk assumed to be 49 lipid homeostasis oxysterol binding isoxazolines fluoxapiprolin medium to high (single site and transfer/storage protein inhibitor). Resistance homologue managementrequired inhibition (Previously U15). F10 protein fragment polypeptide polypeptide Resistance not known. 51 interaction with lipid ASFBIOF01-02 fraction of the cell membrane, with multiple effects on cell membrane integrity G: sterol G1 DMI-fungicides piperazines triforine There are big differences in 3 biosynthesis C14- demethylase (DeMethylation pyridines pyrifenox the activity spectra of DMI in
in sterol Inhibitors) pyrisoxazole fungicides. biosynthesis (SBI: Class I) pyrimidines fenarimol Resistance is known in various (erg11/cyp51) nuarimol fungal species. Several imidazoles imazalil resistance mechanisms are oxpoconazole known incl. target site pefurazoate mutations in cyp51 (erg 11) prochloraz gene, e.g. V136A, Y137F, triflumizole A379G, I381V; cyp51 triazoles azaconazole promotor; ABC transporters bitertanol and others. bromuconazole Generally wise to accept that cyproconazole cross resistance is present difenoconazole between DMI fungicides active diniconazole against the same fungus. epoxiconazole DMI fungicides are Sterol etaconazole Biosynthesis Inhibitors(SBIs), fenbuconazole but show no cross resistance fluquinconazole to other SBI classes. flusilazole Medium risk. flutriafol See FRAC SBI Guidelines hexaconazole for resistance management. imibenconazole ipconazole mefentrifluconazole metconazole myclobutanil penconazole propiconazole simeconazole tebuconazole tetraconazole triadimefon triadimenol triticonazole triazolinthiones prothioconazole G2 amines morpholines aldimorph Decreased sensitivity for 5 .sup.14-reductase (morpholines) dodemorph powdery mildews. and .sup.8.fwdarw..sup.7- (SBI: Class II) fenpropimorph Cross resistance within the isomerase tridemorph group generally found but not in sterol piperidines fenpropidin to other SBI classes. biosynthesis piperalin Low to medium risk. (erg24, erg2) spiroketal-amines spiroxamine See FRAC SBI Guidelines for resistance management G3 KRI fungicides hydroxyanilides fenhexamid Low to medium risk. 17 3-keto reductase, (KetoReductase amino- fenpyrazamine Resistance management C4- de-methylation Inhibitors) pyrazolinone required. (erg27) (SBI: Class III) G4 thiocarbamates pyributicarb Resistance not known, fungicidal and herbicidal activity. squalene-epoxidase (SBI class IV) allylamines naftifine Medical fungicides only. 18 in sterol terbinafine biosynthesis (erg1) H: cell wall H3 Formerly glucopyranosyl reclassified to U18 26 biosynthesis antibiotic (validamycin) H4 polyoxins peptidyl pyrimidine polyoxin Resistance known. 19 chitin synthase nucleoside Medium risk. Resistance management required. H5 CAA-fungicides cinnamic acid dimethomorph Resistance known in 40 cellulose synthase (Carboxylic Acid amides flumorph Plasmopara viticola but not in Amides) pyrimorph Phytophthora infestans. valinamide benthiavalicarb Cross resistance between all carbamates iprovalicarb members of the CAA group. valifenalate Low to medium risk. mandelic acid mandipropamid See FRAC CAA Guidelines for amides resistance management. I: melanin I1 MBI-R isobenzo-furanone fthalide Resistance not known. 16.1 synthesis in reductase in (Melanin pyrrolo-quinolinone pyroquilon cell wall melanin Biosynthesis triazolobenzo- tricyclazole biosynthesis Inhibitors - thiazole Reductase) I2 MBI-D cyclopropane- carpropamid Resistance known. 16.2 dehydratase in (Melanin carboxamide Medium risk. melanin Biosynthesis carboxamide diclocymet Resistance management biosynthesis Inhibitors - propionamide fenoxanil required. Dehydratase) I3 MBI-P trifluoroethyl- tolprocarb Resistance not known. 16.3 polyketide synthase (Melanin carbamate Additional activity against in melanin Biosynthesis bacteria and fungi through biosynthesis Inhibitors - induction of host plant defence Polyketide synthase) P: host plant P 01 benzo-thiadiazole benzo-thiadiazole acibenzolar-S- Resistance not known. P 01 defence salicylate-related (BTH) (BTH) methyl induction P 02 benzisothiazole benzisothiazole probenazole (also Resistance not known. P 02 salicylate-related antibacterial and antifungal activity) P 03 thiadiazole- thiadiazole- tiadinil Resistance not known. P 03 salicylate-related carboxamide carboxamide isotianil P 04 natural polysaccharides laminarin Resistance not known. P 04 polysaccharide compound elicitors P 05 plant extract complex mixture, extract from Resistance not known. P 05 anthraquinone ethanol extract Reynoutria elicitors (anthraquinones, sachalinensis resveratrol) (giant knotweed) P 06 microbial bacterial Bacillus mycoides Resistance not known. P 06 microbial elicitors Bacillus spp. isolate J fungal cell walls of Saccharomyces spp. Saccharomyces cerevisiae strain LAS117 P 07 phosphonates ethyl phosphonates fosetyl-Al Few resistance cases P07 phosphonates phosphorous acid reported in few and salts pathogens. Low risk. Reclassified from U33 in 2018 P 08 isothiazole isothiazolylmethyl dichlobentiazox activates SAR both up- P 08 salicylate-related ether and downstream of SA. Resistance not known. U: Unknown unknown cyanoacetamide- cyanoacetamide- cymoxanil Resistance claims described. 27 mode of oxime oxime Low to medium risk. action (U Resistance management numbers not required. appearing formerly phosphonates (FRAC code 33), reclassified to P 07 in 2018 in the list unknown phthalamic acids phthalamic acids tecloftalam Resistance not known. 34 derive from (Bactericide) reclassified unknown benzotriazines benzotriazines triazoxide Resistance not known. 35 fungicides) unknown benzene- benzene- flusulfamide Resistance not known. 36 sulfonamides sulphonamides unknown pyridazinones pyridazinones diclomezine Resistance not known. 37 formerly methasulfocarb (FRAC code 42), reclassified to M 12 in 2018 unknown phenyl-acetamide phenyl-acetamide cyflufenamid Resistance in Sphaerotheca. U 06 Resistance management required cell membrane guanidines guanidines dodine Resistance known in U 12 disruption Venturia inaequalis. (proposed) Low to medium risk. Resistance management recommended. unknown thiazolidine cyano-methylene- flutianil Resistance in Sphaerotheca and U 13 thiazolidines Podosphaera xanthii. Resistance management required. unknown pyrimidinone- pyrimidinone- ferimzone Resistance not known U 14 hydrazones hydrazones (previously C5). complex III: 4-quinolyl-acetate 4-quinolyl-acetates tebufloquin Not cross resistant to QoI. U 16 cytochrome bc1, Resistance risk unknown but unknown binding assumed to be medium. site (proposed) Resistance management required. Unknown tetrazolyloxime tetrazolyloximes picarbutrazox Resistance not known. U 17 Not cross resistant to PA, QoI, CAA. Unknown glucopyranosyl glucopyranosyl validamycin Resistance not known. U 18 (Inhibition of antibiotic antibiotics Induction of host plant defense trehalase) by trehalose proposed (previously H3). Not Unknown diverse diverse mineral oils, Resistance not known. NC specified organic oils, inorganic salts, material of biological origin M: multi-site inorganic inorganic copper Also applies to organic copper M 01 Chemicals contact (electrophiles) (different salts) complexes with activity inorganic inorganic sulphur generally considered as a low M 02 multi-site (electrophiles) risk group without any signs of activity dithiocarbamates dithio-carbamates amobam resistance developing to the M 03 and relatives and relatives ferbam fungicides. (electrophiles) mancozeb reclassified from U42 in 2018 maneb metiram propineb thiram zino thiazole zineb ziram phthalimides phthalimides captan M 04 (electrophiles) captafol folpet chloronitriles chloronitriles chlorothalonil M 05 (phthalonitriles) (phthalonitriles) (unspecified mechanism) sulfamides sulfamides dichlofluanid M 06 (electrophiles) tolylfluanid bis-guanidines bis-guanidines guazatine M 07 (membrane iminoctadine disruptors, detergents) triazines triazines anilazine M 08 (unspecified mechanism) quinones quinones dithianon M 09 (anthraquinones) (anthraquinones) (electrophiles) quinoxalines quinoxalines chinomethionat/ M 10 (electrophiles) quinomethionate maleimide maleimide fluoroimide M 11 (electrophiles) thiocarbamate thiocarbamate methasulfocarb M 12 (electrophiles) BM: multiple effects on plant extract polypeptide (lectin) extract from the Resistance not known. BM 01 Biologicals ion membrane cotyledons of (previously M12). with transporters; lupine plantlets multiple chelating effects (BLAD) modes of affects fungal plant extract phenols, extract from Resistance not known. action: spores and germ sesquiterpenes, Swinglea Plant tubes, triterpenoids, glutinosa extracts induced plant coumarins defense cell membrane plant extract terpene hydrocarbons, extract from Resistance not known. disruption, cell wall, terpene alcohols and Melaleuca (previously F7) induced plant terpene phenols alternifolia defense (tea tree oil) mechanisms plant oils (mixtures): eugenol, geraniol, thymol BM: multiple effects microbial fungal T. atroviride nomenclature change from BM 02 Biologicals described (strains of living Trichoderma spp. strain I-1237 Gliocladium catenulatum to with (examples, not all microbes or extract, strain LU132 Clonostachys rosea multiple apply to all metabolites) strain SC1 Resistance not known. modes of biological groups): strain SKT-1 Bacillus amyloliquefaciens action: competition, strain 77B reclassified from F6, Code 44 Microbial mycoparasitism, T. asperellum in 2020 (living antibiosis, strain T34 synonyms for Bacillus microbes, membrane strain kd amyloliquefaciens are Bacillus extracts or disruption by T. harzianum subtilis and B. subtilis var. metabolites) fungicidal strain T-22 amyloliquefaciens (previous lipopeptides, T. virens taxonomic classification). lytic enzymes, strain G-41 induced plant fungal C. rosea defence Clonostachys spp. strain J1446 strain CR-7 fungal C. minitans Coniothyrium spp. strain CON/M/91-08 fungal H. uvarum Hanseniaspora spp. strain BC18Y fungal T. flavus Talaromyces spp. strain SAY-Y-94-01 fungal S. cerevisae Saccharomyces spp. strain LAS02 strain DDSF623 bacterial B. amyloliquefaciens Bacillus spp. strain QST713 strain FZB24 strain MBI600 strain D747 strain F727 strain AT-332 B. subtilis strain AFS032321 strain Y1336 strain HAI-0404 bacterial PHC25279 Erwinia spp. (peptide) bacterial G. cerinus Gluconobacter spp. strain BC18B bacterial P. chlororaphis Pseudomonas spp. strain AFS009 bacterial S. griseovirides Streptomyces spp. strain K61 S. lydicus strain WYEC108
indicates data missing or illegible when filed
TABLE-US-00007 APPENDIX 2 MODE OF ACTION CHEMICAL CLASSIFICATION ACTIVE Inhibition of Acetyl CoA Cyclohexanediones (DIMs) Alloxydim Carboxylase Inhibition of Acetyl CoA Cyclohexanediones (DIMs) Butroxydim Carboxylase Inhibition of Acetyl CoA Cyclohexanediones (DIMs) Clethodim Carboxylase Inhibition of Acetyl CoA Cyclohexanediones (DIMs) Cloproxydim Carboxylase Inhibition of Acetyl CoA Cyclohexanediones (DIMs) Cycloxydim Carboxylase Inhibition of Acetyl CoA Cyclohexanediones (DIMs) Profoxydim Carboxylase Inhibition of Acetyl CoA Cyclohexanediones (DIMs) Sethoxydim Carboxylase Inhibition of Acetyl CoA Cyclohexanediones (DIMs) Tepraloxydim Carboxylase Inhibition of Acetyl CoA Cyclohexanediones (DIMs) Tralkoxydim Carboxylase Inhibition of Acetyl CoA Aryloxyphenoxy-propionates Clodinafop-propargyl Carboxylase (FOPs) Inhibition of Acetyl CoA Aryloxyphenoxy-propionates Clofop Carboxylase (FOPs) Inhibition of Acetyl CoA Aryloxyphenoxy-propionates Cyhalofop-butyl Carboxylase (FOPs) Inhibition of Acetyl CoA Aryloxyphenoxy-propionates Diclofop-methyl Carboxylase (FOPs) Inhibition of Acetyl CoA Aryloxyphenoxy-propionates Fenoxaprop-ethyl Carboxylase (FOPs) Inhibition of Acetyl CoA Aryloxyphenoxy-propionates Fenthiaprop Carboxylase (FOPs) Inhibition of Acetyl CoA Aryloxyphenoxy-propionates Fluazifop-butyl Carboxylase (FOPs) Inhibition of Acetyl CoA Aryloxyphenoxy-propionates Haloxyfop-methyl Carboxylase (FOPs) Inhibition of Acetyl CoA Aryloxyphenoxy-propionates Isoxapyrifop Carboxylase (FOPs) Inhibition of Acetyl CoA Aryloxyphenoxy-propionates Metamifop Carboxylase (FOPs) Inhibition of Acetyl CoA Aryloxyphenoxy-propionates Quizalofop-ethyl Carboxylase (FOPs) Inhibition of Acetyl CoA Phenylpyrazoline Pinoxaden Carboxylase Inhibition of Acetolactate Pyrimidinyl benzoates Bispyribac-sodium Synthase Inhibition of Acetolactate Pyrimidinyl benzoates Pyribenzoxim (prodrug of Synthase bispyribac) Inhibition of Acetolactate Pyrimidinyl benzoates Pyriftalid Synthase Inhibition of Acetolactate Pyrimidinyl benzoates Pyriminobac-methyl Synthase Inhibition of Acetolactate Pyrimidinyl benzoates Pyrithiobac-sodium Synthase Inhibition of Acetolactate Sulfonanilides Pyrimisulfan Synthase Inhibition of Acetolactate Sulfonanilides Triafamone Synthase Inhibition of Acetolactate Triazolopyrimidine - Type 1 Cloransulam-methyl Synthase Inhibition of Acetolactate Triazolopyrimidine - Type 1 Diclosulam Synthase Inhibition of Acetolactate Triazolopyrimidine - Type 1 Florasulam Synthase Inhibition of Acetolactate Triazolopyrimidine - Type 1 Flumetsulam Synthase Inhibition of Acetolactate Triazolopyrimidine - Type 1 Metosulam Synthase Inhibition of Acetolactate Triazolopyrimidine - Type 2 Penoxsulam Synthase Inhibition of Acetolactate Triazolopyrimidine - Type 2 Pyroxsulam Synthase Inhibition of Acetolactate Sulfonylureas Amidosulfuron Synthase Inhibition of Acetolactate Sulfonylureas Azimsulfuron Synthase Inhibition of Acetolactate Sulfonylureas Bensulfuron-methyl Synthase Inhibition of Acetolactate Sulfonylureas Chlorimuron-ethyl Synthase Inhibition of Acetolactate Sulfonylureas Chlorsulfuron Synthase Inhibition of Acetolactate Sulfonylureas Cinosulfuron Synthase Inhibition of Acetolactate Sulfonylureas Cyclosulfamuron Synthase Inhibition of Acetolactate Sulfonylureas Ethametsulfuron-methyl Synthase Inhibition of Acetolactate Sulfonylureas Ethoxysulfuron Synthase Inhibition of Acetolactate Sulfonylureas Flazasulfuron Synthase Inhibition of Acetolactate Sulfonylureas Flucetosulfuron Synthase Inhibition of Acetolactate Sulfonylureas Flupyrsulfuron-methyl-Na Synthase Inhibition of Acetolactate Sulfonylureas Foramsulfuron Synthase Inhibition of Acetolactate Sulfonylureas Halosulfuron-methyl Synthase Inhibition of Acetolactate Sulfonylureas Imazosulfuron Synthase Inhibition of Acetolactate Sulfonylureas Iodosulfuron-methyl-Na Synthase Inhibition of Acetolactate Sulfonylureas Mesosulfuron-methyl Synthase Inhibition of Acetolactate Sulfonylureas Metazosulfuron Synthase Inhibition of Acetolactate Sulfonylureas Metsulfuron-methyl Synthase Inhibition of Acetolactate Sulfonylureas Nicosulfuron Synthase Inhibition of Acetolactate Sulfonylureas Orthosulfamuron Synthase Inhibition of Acetolactate Sulfonylureas Oxasulfuron Synthase Inhibition of Acetolactate Sulfonylureas Primisulfuron-methyl Synthase Inhibition of Acetolactate Sulfonylureas Propyrisulfuron Synthase Inhibition of Acetolactate Sulfonylureas Prosulfuron Synthase Inhibition of Acetolactate Sulfonylureas Pyrazosulfuron-ethyl Synthase Inhibition of Acetolactate Sulfonylureas Rimsulfuron Synthase Inhibition of Acetolactate Sulfonylureas Sulfometuron-methyl Synthase Inhibition of Acetolactate Sulfonylureas Sulfosulfuron Synthase Inhibition of Acetolactate Sulfonylureas Triasulfuron Synthase Inhibition of Acetolactate Sulfonylureas Tribenuron-methyl Synthase Inhibition of Acetolactate Sulfonylureas Thifensulfuron-methyl Synthase Inhibition of Acetolactate Sulfonylureas Trifloxysulfuron-Na Synthase Inhibition of Acetolactate Sulfonylureas Triflusulfuron-methyl Synthase Inhibition of Acetolactate Sulfonylureas Tritosulfuron Synthase Inhibition of Acetolactate Imidazolinones Imazamethabenz-methyl Synthase Inhibition of Acetolactate Imidazolinones Imazamox Synthase Inhibition of Acetolactate Imidazolinones Imazapic Synthase Inhibition of Acetolactate Imidazolinones Imazapyr Synthase Inhibition of Acetolactate Imidazolinones Imazaquin Synthase Inhibition of Acetolactate Imidazolinones Imazethapyr Synthase Inhibition of Acetolactate Triazolinones Flucarbazone-Na Synthase Inhibition of Acetolactate Triazolinones Propoxycarbazone-Na Synthase Inhibition of Acetolactate Triazolinones Thiencarbazone-methyl Synthase Inhbition of Photosynthesis at Triazines Atraton PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazines Atrazine PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazines Ametryne PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazines Aziprotryne = aziprotryn PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazines Chlorazine PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazines CP 17029 PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazines Cyanazine PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazines Cyprazine PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazines Desmetryne PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazines Dimethametryn PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazines Dipropetryn PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazines Eglinazine-ethyl PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazines Ipazine PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazines Methoprotryne = methoprotryn PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazines procyazine PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazines Proglinazine-ethyl PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazines Prometon PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazines Prometryne PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazines Propazine PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazines Sebuthylazine PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazines Secbumeton PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazines Simetryne PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazines Simazine PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazines Terbumeton PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazines Terbuthylazine PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazines Terbutryne PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazines Trietazine PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazolinone Amicarbazone PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazinones Ethiozin PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazinones Hexazinone PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazinones Isomethiozin PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazinones Metamitron PSII - Serine 264 Binders Inhbition of Photosynthesis at Triazinones Metribuzin PSII - Serine 264 Binders Inhbition of Photosynthesis at Uracils Bromacil PSII - Serine 264 Binders Inhbition of Photosynthesis at Uracils Isocil PSII - Serine 264 Binders Inhbition of Photosynthesis at Uracils Lenacil PSII - Serine 264 Binders Inhbition of Photosynthesis at Uracils Terbacil PSII - Serine 264 Binders Inhbition of Photosynthesis at Phenlcarbamates Chlorprocarb PSII - Serine 264 Binders Inhbition of Photosynthesis at Phenlcarbamates Desmedipham PSII - Serine 264 Binders Inhbition of Photosynthesis at Phenlcarbamates Phenisopham PSII - Serine 264 Binders Inhbition of Photosynthesis at Phenicarbamates Phenmedipham PSII - Serine 264 Binders Inhbition of Photosynthesis at Pyridazinone Chloridazon (=pyrazon) PSII - Serine 264 Binders Inhbition of Photosynthesis at Pyridazinone Brompyrazon PSII - Serine 264 Binders Inhbition of Photosynthesis at Ureas Benzthiazuron PSII - Serine 264 Binders Inhbition of Photosynthesis at Ureas Bromuron PSII - Serine 264 Binders Inhbition of Photosynthesis at Ureas Buturon PSII - Serine 264 Binders Inhbition of Photosynthesis at Ureas Chlorbromuron PSII - Serine 264 Binders Inhbition of Photosynthesis at Ureas Chlorotoluron PSII - Serine 264 Binders Inhbition of Photosynthesis at Ureas Chloroxuron PSII - Serine 264 Binders Inhbition of Photosynthesis at Ureas Difenoxuron PSII - Serine 264 Binders Inhbition of Photosynthesis at Ureas Dimefuron PSII - Serine 264 Binders Inhbition of Photosynthesis at Ureas Diuron PSII - Serine 264 Binders Inhbition of Photosynthesis at Ureas Ethidimuron PSII - Serine 264 Binders Inhbition of Photosynthesis at Ureas Fenuron PSII - Serine 264 Binders Inhbition of Photosynthesis at Ureas Fluometuron PSII - Serine 264 Binders Inhbition of Photosynthesis at Ureas Fluothiuron PSII - Serine 264 Binders Inhbition of Photosynthesis at Ureas Isoproturon PSII - Serine 264 Binders Inhbition of Photosynthesis at Ureas Isouron PSII - Serine 264 Binders Inhbition of Photosynthesis at Ureas Linuron PSII - Serine 264 Binders Inhbition of Photosynthesis at Ureas Metobenzuron PSII - Serine 264 Binders Inhbition of Photosynthesis at Ureas Metobromuron PSII - Serine 264 Binders Inhbition of Photosynthesis at Ureas Methabenzthiazuron PSII - Serine 264 Binders Inhbition of Photosynthesis at Ureas Metoxuron PSII - Serine 264 Binders Inhbition of Photosynthesis at Ureas Monolinuron PSII - Serine 264 Binders Inhbition of Photosynthesis at Ureas Monuron PSII - Serine 264 Binders Inhbition of Photosynthesis at Ureas Neburon PSII - Serine 264 Binders Inhbition of Photosynthesis at Ureas Parafluron PSII - Serine 264 Binders Inhbition of Photosynthesis at Ureas Siduron PSII - Serine 264 Binders Inhbition of Photosynthesis at Ureas Tebuthiuron PSII - Serine 264 Binders Inhbition of Photosynthesis at Ureas Thiazafluron PSII - Serine 264 Binders Inhbition of Photosynthesis at Amides Chloranocryl = dicryl PSII - Serine 264 Binders Inhbition of Photosynthesis at Amides Pentanochlor PSII - Serine 264 Binders Inhbition of Photosynthesis at Amides Propanil PSII - Serine 264 Binders Inhbition of Photosynthesis at Nitriles Bromofenoxim PSII - Histidine 215 Binders Inhbition of Photosynthesis at Nitriles Bromoxynil PSII - Histidine 215 Binders Inhbition of Photosynthesis at Nitriles Ioxynil PSII - Histidine 215 Binders Inhbition of Photosynthesis at Phenyl-pyridazines Pyridate PSII - Histidine 215 Binders Inhbition of Photosynthesis at Benzothiadiazinone Bentazon PSII - Histidine 215 Binders PS I Electron Diversion Pyridiniums Cyperquat PS I Electron Diversion Pyridiniums Diquat PS I Electron Diversion Pyridiniums Morfamquat PS I Electron Diversion Pyridiniums Paraquat Inhibition of Diphenyl ethers Lactofen Protoporphyrinogen Oxidase Inhibition of Diphenyl ethers Acifluorfen Protoporphyrinogen Oxidase Inhibition of Diphenyl ethers Bifenox Protoporphyrinogen Oxidase Inhibition of Diphenyl ethers Chlornitrofen Protoporphyrinogen Oxidase Inhibition of Diphenyl ethers Fomesafen Protoporphyrinogen Oxidase Inhibition of Diphenyl ethers Fluorodifen Protoporphyrinogen Oxidase Inhibition of Diphenyl ethers Fluoroglycofen-ethyl Protoporphyrinogen Oxidase Inhibition of Diphenyl ethers Fluoronitrofen Protoporphyrinogen Oxidase Inhibition of Diphenyl ethers Nitrofen Protoporphyrinogen Oxidase Inhibition of Diphenyl ethers Oxyfluorfen Protoporphyrinogen Oxidase Inhibition of Diphenyl ethers Chlomethoxyfen Protoporphyrinogen Oxidase Inhibition of Phenylpyrazoles Pyraflufen-ethyl Protoporphyrinogen Oxidase Inhibition of N-Phenyl-oxadiazolones Oxadiargyl Protoporphyrinogen Oxidase Inhibition of N-Phenyl-oxadiazolones Oxadiazon Protoporphyrinogen Oxidase Inhibition of N-Phenyl-triazolinones Azafenidin Protoporphyrinogen Oxidase Inhibition of N-Phenyl-triazolinones Carfentrazone-ethyl Protoporphyrinogen Oxidase Inhibition of N-Phenyl-triazolinones Sulfentrazone Protoporphyrinogen Oxidase Inhibition of N-Phenyl-imides (procide acitive Fluthiacet-methyl Protoporphyrinogen Oxidase form) Inhibition of N-Phenyl-imides Butafenacil Protoporphyrinogen Oxidase Inhibition of N-Phenyl-imides Saflufenacil Protoporphyrinogen Oxidase Inhibition of N-Phenyl-imides Pentoxazone Protoporphyrinogen Oxidase Inhibition of N-Phenyl-imides Chlorphthalim Protoporphyrinogen Oxidase Inhibition of N-Phenyl-imides Cinidon-ethyl Protoporphyrinogen Oxidase Inhibition of N-Phenyl-imides Flumiclorac-pentyl Protoporphyrinogen Oxidase Inhibition of N-Phenyl-imides Flumioxazin Protoporphyrinogen Oxidase Inhibition of N-Phenyl-imides Flumipropyn Protoporphyrinogen Oxidase Inhibition of N-Phenyl-imides Trifludimoxazin Protoporphyrinogen Oxidase Inhibition of N-Phenyl-imides Tiafenacil Protoporphyrinogen Oxidase Inhibition of Other Pyracionil Protoporphyrinogen Oxidase Inhibition of Phytoene Phenyl ethers Beflubutamid Desaturase Inhibition of Phytoene Phenyl ethers Diflufenican Desaturase Inhibition of Phytoene Phenyl ethers Picolinafen Desaturase Inhibition of Phytoene N-Phenyl heterocycles Flurochloridone Desaturase Inhibition of Phytoene N-Phenyl heterocycles Norflurazon Desaturase Inhibition of Phytoene Diphenyl heterocycles Fluridone Desaturase Inhibition of Phytoene Diphenyl heterocycles Flurtamone Desaturase Inhibition of Hydroxyphenyl Triketones Mesotrione Pyruvate Dioxygenase Inhibition of Hydroxyphenyl Triketones Sulcotrione Pyruvate Dioxygenase Inhibition of Hydroxyphenyl Triketones Tembotrione Pyruvate Dioxygenase Inhibition of Hydroxyphenyl Triketones Tefuryltrione Pyruvate Dioxygenase Inhibition of Hydroxyphenyl Triketones Bicyclopyrone Pyruvate Dioxygenase Inhibition of Hydroxyphenyl Triketones Fenquinotrione Pyruvate Dioxygenase Inhibition of Hydroxyphenyl Triketones (procide) Benzobicyclon Pyruvate Dioxygenase Inhibition of Hydroxyphenyl Pyrazoles (procide) Benzofenap Pyruvate Dioxygenase Inhibition of Hydroxyphenyl Pyrazoles Pyrasulfotole Pyruvate Dioxygenase Inhibition of Hydroxyphenyl Pyrazoles Topramezone Pyruvate Dioxygenase Inhibition of Hydroxyphenyl Pyrazoles (procide) Pyrazolynate Pyruvate Dioxygenase Inhibition of Hydroxyphenyl Pyrazoles (procide) Pyrazoxyfen Pyruvate Dioxygenase Inhibition of Hydroxyphenyl Pyrazoles Tolpyralate Pyruvate Dioxygenase Inhibition of Hydroxyphenyl Isoxazoles Isoxaflutole Pyruvate Dioxygenase Inhibition of Homogentisate Phenoxypyridazine Cyclopyrimorate Solanesyltransferase Inhibition of Deoxy-D-Xyulose Isoxazolidinone Clomazone Phosphate Synthase Inhibition of Deoxy-D-Xyulose Isoxazolidinone Bixlozone Phosphate Synthase Inhibition of Enolpyruvyl Glycine Glyphosate Shikimate Phosphate Synthase Inhibition of Glutamine Phosphinic acids Glufosinate-ammonium Synthetase Inhibition of Glutamine Phosphinic acids Bialaphos/bilanafos Synthetase Inhibition of Dihydropteroate Carbamate Asulam Synthase Inhibition of Microtubule Dinitroanilines Benefin = benfluralin Assembly Inhibition of Microtubule Dinitroanilines Butralin Assembly Inhibition of Microtubule Dinitroanilines Dinitramine Assembly Inhibition of Microtubule Dinitroanilines Ethalfluralin Assembly Inhibition of Microtubule Dinitroanilines Fluchloralin Assembly Inhibition of Microtubule Dinitroanilines Isopropalin Assembly Inhibition of Microtubule Dinitroanilines Nitralin Assembly Inhibition of Microtubule Dinitroanilines Prodiamine Assembly Inhibition of Microtubule Dinitroanilines Profluralin Assembly Inhibition of Microtubule Dinitroanilines Oryzalin Assembly Inhibition of Microtubule Dinitroanilines Pendimethalin Assembly Inhibition of Microtubule Dinitroanilines Trifluralin Assembly Inhibition of Microtubule Pyridines Dithiopyr Assembly Inhibition of Microtubule Pyridines Thiazopyr Assembly Inhibition of Microtubule Phosphoroamidates Butamifos Assembly Inhibition of Microtubule Phosphoroamidates DMPA Assembly Inhibition of Microtubule Benzoic acid Chlorthal-dimethyl = DCPA Assembly Inhibition of Microtubule Benzamides Propyzamide = pronamide Assembly Inhibition of Microtubule Carbamates Barban Organization Inhibition of Microtubule Carbamates Carbetamide Organization Inhibition of Microtubule Carbamates Chlorbufam Organization Inhibition of Microtubule Carbamates Chlorpropham Organization Inhibition of Microtubule Carbamates Propham Organization Inhibition of Microtubule Carbamates Swep Organization Inhibition of Cellulose Triazolocarboxamide Flupoxam Synthesis Inhibition of Cellulose Benzamides Isoxaben Synthesis Inhibition of Cellulose Alkylazines Triaziflam Synthesis Inhibition of Cellulose Alkylazines Indaziflam Synthesis Inhibition of Cellulose Nitriles Dichlobenil Synthesis Inhibition of Cellulose Nitriles Chlorthiamid Synthesis Uncouplers Dinitrophenols Dinosam Uncouplers Dinitrophenols Dinoseb Uncouplers Dinitrophenols DNOC Uncouplers Dinitrophenols Dinoterb Uncouplers Dinitrophenols Etinofen Uncouplers Dinitrophenols Medinoterb Inhibition of Very Long-Chain Azolyl-carboxamides Cafenstrole Fatty Acid Synthesis Inhibition of Very Long-Chain Azolyl-carboxamides Fentrazamide Fatty Acid Synthesis Inhibition of Very Long-Chain Azolyl-carboxamides Ipfencarbazone Fatty Acid Synthesis Inhibition of Very Long-Chain -Thioacetamides Anilofos Fatty Acid Synthesis Inhibition of Very Long-Chain -Thioacetamides Piperophos Fatty Acid Synthesis Inhibition of Very Long-Chain Isoxazolines Pyroxasulfone Fatty Acid Synthesis Inhibition of Very Long-Chain Isoxazolines Fenoxasulfone Fatty Acid Synthesis Inhibition of Very Long-Chain Oxiranes Indanofan Fatty Acid Synthesis Inhibition of Very Long-Chain Oxiranes Tridiphane Fatty Acid Synthesis Inhibition of Very Long-Chain -Chloroacetamides Acetochlor Fatty Acid Synthesis Inhibition of Very Long-Chain -Chloroacetamides Alachlor Fatty Acid Synthesis Inhibition of Very Long-Chain -Chloroacetamides Allidochlor = CDAA Fatty Acid Synthesis Inhibition of Very Long-Chain -Chloroacetamides Butachlor Fatty Acid Synthesis Inhibition of Very Long-Chain -Chloroacetamides Butenachlor Fatty Acid Synthesis Inhibition of Very Long-Chain -Chloroacetamides Delachlor Fatty Acid Synthesis Inhibition of Very Long-Chain -Chloroacetamides Diethatyl-ethyl Fatty Acid Synthesis Inhibition of Very Long-Chain -Chloroacetamides Dimethachlor Fatty Acid Synthesis Inhibition of Very Long-Chain -Chloroacetamides Dimethenamid Fatty Acid Synthesis Inhibition of Very Long-Chain -Chloroacetamides Metazachlor Fatty Acid Synthesis Inhibition of Very Long-Chain -Chloroacetamides Metolachlor Fatty Acid Synthesis Inhibition of Very Long-Chain -Chloroacetamides Pethoxamid Fatty Acid Synthesis Inhibition of Very Long-Chain -Chloroacetamides Pretilachlor Fatty Acid Synthesis Inhibition of Very Long-Chain -Chloroacetamides Propachlor Fatty Acid Synthesis Inhibition of Very Long-Chain -Chloroacetamides Propisochlor Fatty Acid Synthesis Inhibition of Very Long-Chain -Chloroacetamides Prynachlor Fatty Acid Synthesis Inhibition of Very Long-Chain -Chloroacetamides Thenylchlor Fatty Acid Synthesis Inhibition of Very Long-Chain -Oxyacetamides Mefenacet Fatty Acid Synthesis Inhibition of Very Long-Chain -Oxyacetamides Flufenacet Fatty Acid Synthesis Inhibition of Very Long-Chain Thiocarbamates Butylate Fatty Acid Synthesis Inhibition of Very Long-Chain Thiocarbamates Cycloate Fatty Acid Synthesis Inhibition of Very Long-Chain Thiocarbamates Dimepiperate Fatty Acid Synthesis Inhibition of Very Long-Chain Thiocarbamates EPTC Fatty Acid Synthesis Inhibition of Very Long-Chain Thiocarbamates Esprocarb Fatty Acid Synthesis Inhibition of Very Long-Chain Thiocarbamates Molinate Fatty Acid Synthesis Inhibition of Very Long-Chain Thiocarbamates Orbencarb Fatty Acid Synthesis Inhibition of Very Long-Chain Thiocarbamates Pebulate Fatty Acid Synthesis Inhibition of Very Long-Chain Thiocarbamates Prosulfocarb Fatty Acid Synthesis Inhibition of Very Long-Chain Thiocarbamates Thiobencarb (=Benthiocarb) Fatty Acid Synthesis Inhibition of Very Long-Chain Thiocarbamates Tiocarbazil Fatty Acid Synthesis Inhibition of Very Long-Chain Thiocarbamates Tri-allate Fatty Acid Synthesis Inhibition of Very Long-Chain Thiocarbamates Vernolate Fatty Acid Synthesis Inhibition of Very Long-Chain Benzofurans Benfuresate Fatty Acid Synthesis Inhibition of Very Long-Chain Benzofurans Ethofumesate Fatty Acid Synthesis Auxin Mimics Pyridine-carboxylates Picloram Auxin Mimics Pyridine-carboxylates Clopyralid Auxin Mimics Pyridine-carboxylates Aminopyralid Auxin Mimics Pyridine-carboxylates Halauxifen Auxin Mimics Pyridine-carboxylates Florpyrauxifen Auxin Mimics Pyridyloxy-carboxylates Triclopyr Auxin Mimics Pyridyloxy-carboxylates Fluroxypyr Auxin Mimics Phenoxy-carboxylates 2,4,5-T Auxin Mimics Phenoxy-carboxylates 2,4-D Auxin Mimics Phenoxy-carboxylates 2,4-DB Auxin Mimics Phenoxy-carboxylates Clomeprop Auxin Mimics Phenoxy-carboxylates Dichlorprop Auxin Mimics Phenoxy-carboxylates Fenoprop Auxin Mimics Phenoxy-carboxylates Mecoprop Auxin Mimics Phenoxy-carboxylates MCPA Auxin Mimics Phenoxy-carboxylates MCPB Auxin Mimics Benzoates Dicamba Auxin Mimics Benzoates Chloramben Auxin Mimics Benzoates TBA Auxin Mimics Quinoline-carboxylates Quinclorac Auxin Mimics Quinoline-carboxylates Quinmerac Auxin Mimics Pyrimidine-carboxylates Aminocyclopyrachlor Auxin Mimics Other Benazolin-ethyl Auxin Mimics Phenyl carboxylates Chlorfenac = fenac Auxin Mimics Phenyl carboxylates Chlorfenprop Auxin Transport Inhibitor Aryl-carboxylates Naptalam Auxin Transport Inhibitor Aryl-carboxylates Diflufenzopyr-sodium Inhibition of Fatty Acid Benzyl ether Cinmethylin Thioesterase Inhibition of Fatty Acid Benzyl ether Methiozolin Thioesterase Inhibition of Serine-Threonine Other Endothal Protein Phosphatase Inhibition of Solanesyl Diphenyl ether Aclonifen Diphosphate Synthase Inhibition of Lycopene Triazole Amitrole Cyclase Unknown Bromobutide Unknown Cumyluron Unknown Difenzoquat Unknown DSMA Unknown Dymron = Daimuron Unknown Etobenzanid Unknown Arylaminopropionic acid Flamprop-m Unknown Fosamine Unknown Methyldymron Unknown Monalide Unknown MSMA Unknown Oleic acid Unknown Oxaziclomefone Unknown Pelargonic acid Unknown Pyributicarb Unknown Quinoclamine Unknown Acetamides Diphenamid Unknown Acetamides Naproanilide Unknown Acetamides Napropamide Unknown Benzamide Tebutam Unknown Phosphorodithioate Bensulide Unknown Chlorocarbonic acids Dalapon Unknown Chlorocarbonic acids Flupropanate Unknown Chlorocarbonic acids TCA Unknown Trifluoromethanesulfonanilides Mefluidide Unknown Trifluoromethanesulfonanilides Perfluidone Unknown CAMA Unknown Cacodylic acid
TABLE-US-00008 APPENDIX 3 Sub-group, class or Main Group and Primary Site of exemplifying Active Action Ingredient Active Ingredients 1 Acetylcholinesterase (AChE) 1A Alanycarb, Aldicarb, Bendiocarb, Benfuracarb, Butocarboxim, inhibitors Carbamates Butoxycarboxim, Carbaryl, Carbofuran, Carbosulfan, Nerve action Ethiofencarb, Fenobucarb, Formetanate, Furathiocarb, {Strong evidence that action at this Isoprocarb, Methiocarb, Methomyl, Metolcarb, Oxamyl, protein is responsible for insecticidal Pirimicarb, Propoxur, Thiodicarb, Thiofanox, effects} Triazamate, Trimethacarb, XMC, Xylylcarb 1B Acephate, Azamethiphos, Azinphos-ethyl, Azinphos- Organophosphates methyl, Cadusafos, Chlorethoxyfos, Chlorfenvinphos, Chlormephos, Chlorpyrifos, Chlorpyrifos-methyl, Coumaphos, Cyanophos, Demeton-S-methyl, Diazinon, Dichlorvos/DDVP, Dicrotophos, Dimethoate, Dimethylvinphos, Disulfoton, EPN, Ethion, Ethoprophos, Famphur, Fenamiphos, Fenitrothion, Fenthion, Fosthiazate, Heptenophos, Imicyafos, Isofenphos, Isopropyl O-(methoxyaminothio- phosphoryl) salicylate, Isoxathion, Malathion, Mecarbam, Methamidophos, Methidathion, Mevinphos, Monocrotophos, Naled, Omethoate, Oxydemeton-methyl, Parathion, Parathion- methyl, Phenthoate, Phorate, Phosalone, Phosmet, Phosphamidon, Phoxim, Pirimiphos- methyl, Profenofos, Propetamphos, Prothiofos, Pyraclofos, Pyridaphenthion, Quinalphos, Sulfotep, Tebupirimfos, Temephos, Terbufos, Tetrachlorvinphos, Thiometon, Triazophos, Trichlorfon, Vamidothion 2 GABA-gated chloride channel blockers 2A Chiordane, Endosulfan Nerve action Cyclodiene {Strong evidence that action at this Organochlorines protein is responsible for insecticidal 2B Ethiprole, Fipronil effects} Phenylpyrazoles (Fiproles) 3 3A Acrinathrin, Allethrin, d-cis-trans Allethrin, d- trans Allethrin, Sodium channel modulators Pyrethroids Pyrethrins Bifenthrin, Bioallethrin, Bioallethrin S-cyclopentenyl isomer, Nerve action Bioresmethrin, Cycloprothrin, Cyfluthrin, beta- Cyfluthrin, {Strong evidence that action at this Cyhalothrin, lambda-Cyhalothrin, gamma-Cyhalothrin, protein is responsible for insecticidal Cypermethrin, alpha- Cypermethrin, beta-Cypermethrin, effects} theta- cypermethrin, zeta-Cypermethrin, Cyphenothrin, (1R)-trans- isomers], Deltamethrin, Empenthrin (EZ)- (1R)- isomers], Esfenvalerate, Etofenprox, Fenpropathrin, Fenvalerate, Flucythrinate, Flumethrin, tau-Fluvalinate, Halfenprox, Imiprothrin, Kadethrin, Permethrin, Phenothrin [(1R)-trans- isomer], Prallethrin, Pyrethrins (pyrethrum), Resmethrin, Silafluofen, Tefluthrin, Tetramethrin, Tetramethrin [(1R)-isomers], Tralomethrin, Transfluthrin, 3B DDT DDT Methoxychlor Methoxychlor 4 Nicotinic acetylcholine receptor 4A Acetamiprid, Clothianidin, Dinotefuran, (nAChR) competitive modulators Neonicotinoids Imidacloprid, Nitenpyram, Thiacloprid, Thiamethoxam, Nerve action 4B Nicotine {Strong evidence that action at one or Nicotine more of this class of protein is 4C Sulfoxaflor responsible for insecticidal effects} Sulfoximines 4D Flupyradifurone Butenolides 4E Triflumezopyrim Mesoionics 4F Flupyrimin Pyridylidenes 5 Spinosyns Spinetoram, Spinosad Nicotinic acetylcholine receptor (nAChR) allosteric modulators - Site I Nerve action {Strong evidence that action at one or more of this class of protein is responsible for insecticidal effects} 6 Avermectins, Abamectin, Emamectin benzoate, Lepimectin, Milbemectin Glutamate-gated chloride Milbemycins channel (GluCl) allosteric modulators Nerve and muscle action {Strong evidence that action at one or more of this class of protein is responsible for insecticidal effects} 7 Juvenile hormone mimics 7A Hydroprene, Kinoprene, Methoprene Growth regulation Juvenile hormone {Target protein responsible for biological analogues activity is unknown, or uncharacterized} 7B Fenoxycarb Fenoxycarb 7C Pyriproxyfen Pyriproxyfen 8 * Miscellaneous non-specific (multi- 8A Methyl bromide and other alkyl halides site) inhibitors Alkyl halides 8B Chloropicrin Chloropicrin 8C Cryolite (Sodium aluminum fluoride), Sulfuryl fluoride Fluorides 8D Borax, Boric acid, Disodium octaborate, Sodium borate, Borates Sodium metaborate 8E Tartar emetic Tartar emetic 8F Dazomet, Metam Methyl isothiocyanate generators 9 Chordotonal organ TRPV 9B Pymetrozine, Pyrifluquinazon channel modulators Nerve action Pyridine azomethine {Strong evidence that action at one or derivatives more of this class of proteins is 9D Afidopyropen responsible for insecticidal effects} Pyropenes 10 10A Clofentezine, Diflovidazin, Hexythiazox Mite growth inhibitors affecting Clofentezine Diflovidazin CHS1 Hexythiazox Growth regulation 10B Etoxazole {Strong evidence that action at one or Etoxazole more of this class of proteins is responsible for insecticidal effects} 11 11A Bacillus thuringiensis subsp. israelensis Bacillus Microbial disruptors of insect midgut Bacillus thuringiensis and thuringiensis subsp. aizawai Bacillus thuringiensis membranes the insecticidal proteins subsp. kurstaki Bacillus thuringiensis subsp. (Includes transgenic crops expressing they produce tenebrionis Bacillus thuringiensis toxins, however B.t. crop proteins: (* Please see footnote) Cry1Ab, Cry1Ac, specific guidance for resistance Cry1Fa, Cry1A.105, Cry2Ab, Vip3A, mCry3A, Cry3Ab, management of transgenic crops is not Cry3Bb, Cry34Ab1/Cry35Ab1 based on rotation of modes of action) 11B Bacillus sphaericus Bacillus sphaericus 12 12A Diafenthiuron Inhibitors of mitochondrial ATP Diafenthiuron synthase 12B Azocyclotin, Cyhexatin, Fenbutatin oxide Energy metabolism Organotin miticides {Compounds affect the function of this 12C Propargite protein, but it is not clear that this is what Propargite leads to biological activity} 12D Tetradifon Tetradifon 13 * Pyrroles Dinitrophenols Chlorfenapyr DNOC Uncouplers of oxidative Sulfluramid Sulfuramid phosphorylation via disruption of the proton gradient Energy metabolism 14 Nereistoxin analogues Bensultap, Cartap hydrochloride, Thiocyclam, Nicotinic acetylcholine receptor Thiosultap-sodium (nAChR) channel blockers Nerve action {Compounds affect the function of this protein, but it is not clear that this is what leads to biological activity} 15 Benzoylureas Bistrifluron, Chlorfluazuron, Diflubenzuron, Flucycloxuron, inhibitors of chitin biosynthesis Flufenoxuron, Hexaflumuron, Lufenuron, Novaluron, affecting CHS1 Noviflumuron, Teflubenzuron, Trifliumuron Growth regulation {Strong evidence that action at one or more of this class of proteins is responsible for insecticidal effects} 16 Buprofezin Buprofezin Inhibitors of chitin biosynthesis, type 1 Growth regulation {Target protein responsible for biological activity is unknown, or uncharacterized} 17 Cyromazine Cyromazine Moulting disruptors, Dipteran Growth regulation {Target protein responsible for biological activity is unknown, or uncharacterized} 18 Diacylhydrazines Chromafenozide, Halofenozide, Methoxyfenozide, Ecdysone receptor agonists Tebufenozide Growth regulation {Strong evidence that action at this protein is responsible for insecticidal effects} 19 Amitraz Amitraz Octopamine receptor agonists Nerve action {Good evidence that action at one or more of this class of protein is responsible for insecticidal effects} 20 20A Hydramethylnon Mitochondrial complex III electron Hydramethylnon transport inhibitors - Qo site 20B Acequinocyl Energy metabolism Acequinocyl {Good evidence that action at this 20C Fluacrypyrim protein complex is responsible for Fluacrypyrim insecticidal effects} 20D Bifenazate Bifenazate 21 21A Fenazaquin, Fenpyroximate, Pyridaben, Pyrimidifen, Mitochondrial complex I electron METI acaricides and Tebufenpyrad, Tolfenpyrad transport inhibitors insecticides Energy metabolism 21B Rotenone (Derris) {Good evidence that action at this Rotenone protein complex is responsible for insecticidal effects} 22 22A Indoxacarb Voltage-dependent sodium Oxadiazines channel blockers 22B Metaflumizone Nerve action Semicarbazones {Good evidence that action at this protein complex is responsible for Insecticidal effects} 23 Tetronic and Tetramic acid Spirodiclofen, Spiromesifen, Spiropidion, Spirotetramat Inhibitors of acetyl CoA carboxylase derivatives Lipid synthesis, growth regulation {Good evidence that action at this protein is responsible for insecticidal effects} 24 24A Aluminium phosphide, Calcium phosphide, Phosphine, Zinc Mitochondrial complex IV electron Phosphides phosphide transport inhibitors 248 Calcium cyanide, Potassium cyanide, Sodium cyanide Energy metabolism Cyanides {Good evidence that action at this protein complex is responsible for insecticidal effects} 25 25A Cyenopyrafen, Cyflumetofen Mitochondrial complex Il electron Beta-ketonitrile transport inhibitors derivatives Energy metabolism 25B Pyflubumide {Good evidence that action at this Carboxanilides protein complex is responsible for insecticidal effects} 28 Diamides Chlorantraniliprole, Cyantraniliprole, Cyclaniliprole Ryanodine receptor Flubendiamide, Tetraniliprole modulators Nerve and muscle action {Strong evidence that action at this protein complex is responsible for Insecticidal effects} 29 Flonicamid Flonicamid Chordotonal organ modulators - undefined target site Nerve action (Modulation of chordotonal organ function has been clearly demonstrated, but the specific target protein(s) responsible for biological activity are distinct from Group 9 and remain undefined) 30 Meta-diamides Isoxazolines Broflanilide GABA-gated chloride channel allosteric Fluxametamide, Isocyloseram modulators Nerve action {Strong evidence that action at this protein complex is responsible for insecticidal effects} 31 Granuloviruses (GVs) Cydia pomonella GV Baculoviruses Thaumatotibia leucotreta GV Host-specific occluded Nucleopolyhedroviruses Anticarsia gemmatalis MNPV pathogenic viruses (NPVs) Helicoverpa armigera NPV (Midgut epithelial columnar cell membrane target site - undefined) 32 GS-omega/kappa GS-omega/kappa HXTX-Hv1a peptide Nicotinic Acetylcholine Receptor HXTX-Hv1a peptide (nAChR) Allosteric Modulators - Site II Nerve action {Strong evidence that action at one or more of this class of protein is responsible for insecticidal effects} 33 Acynonapyr Acynonapyr Calcium-activated potassium channel (KCa2) modulators Nerve action {Strong evidence that action at this protein is responsible for insecticidal effects} 34 Flometoquin Flometoquin Mitochondrial complex III electron transport inhibitors - Qi site Energy metabolism {Modulation of this protein complex has been clearly demonstrated and the specific target site responsible for biological activity is distinct from Group 20} UN* Azadirachtin Azadirachtin Compounds of unknown or uncertain Benzoximate Benzoximate MoA Benzpyrimoxan Benzpyrimoxan {Target protein responsible for biological Bromopropylate Bromopropylate activity is unknown, or uncharacterized} Chinomethionat Chinomethionat Dicofol Dicofol Lime sulfur Lime sulfur Mancozeb Mancozeb Pyridalyl Pyridalyl Sulfur Sulfur UNB* Burkholderia spp Bacterial agents (non-Bt) of unknown or Wolbachia pipientis (Zap) uncertain MoA {Target protein responsible for biological activity is unknown or uncharacterized} UNE* Chenopodium ambrosioides near ambrosioides Botanical essence including extract synthetic, extracts and unrefined Fatty acid monoesters with glycerol or propanediol Neem oil oils with unknown or uncertain MoA {Target protein responsible for biological activity is unknown, or uncharacterized} UNF* Beauveria bassiana strains Fungal agents of unknown or uncertain Metarhizium anisopliae strain F52 MoA Paecilomyces fumosoroseus Apopka strain 97 {Target protein responsible for biological activity is unknown, or uncharacterized} UNM* Diatomaceous earth Non-specific mechanical and physical Mineral oil disruptors {Target protein responsible for biological activity is unknown, or uncharacterized}
[0263] Notwithstanding the appended claims, aspects of the present disclosure are further provided in the following clauses:
[0264] 1. A method for inhibiting apyrase, comprising contacting the apyrase with a compound of the formula
##STR00085##
wherein [0265] R.sup.1 and R.sup.2 are independently selected from C.sub.1-6 alkyl optionally substituted with one or more R.sup.5; C.sub.6-10 aryl, optionally substituted with one or more R.sup.5, aralkyl optionally substituted with one or more R.sup.5; cycloalkyl optionally substituted with one or more R.sup.5; C.sub.5-10 heteroaryl optionally substituted with one or more R.sup.5; and heterocyclylalkyl optionally substituted with one or more R.sup.5; [0266] R.sup.3 and R.sup.4 are independently selected from hydrogen, C.sub.1-6 alkyl, C.sub.6-10 aryl, C.sub.6-10 heteroaryl, each optionally substituted with one or more R.sup.a and R.sup.b; or R.sup.3 and R.sup.4, together with the atoms to which they are attached form a dihydrophthalazine-1,4-dione; or [0267] each R.sup.5 is independently selected from R.sup.a, R.sup.b, R.sup.a substituted with one or more R.sup.a, R.sup.b, or both and OR.sup.a substituted with one or more of the same or different R.sup.a or R.sup.b, or (CH.sub.2).sub.mR.sup.b, (CHR.sup.a).sub.nR.sup.b, O(CH.sub.2).sub.nR.sup.b, S(CH.sub.2).sub.mR.sup.b, OCHR.sup.aR.sup.b, OCR.sup.a(R.sup.b).sub.2, O(CHR.sup.a).sub.mR.sup.b, O(CH.sub.2).sub.mCH[(CH.sub.2).sub.mR.sup.b]R.sup.b, S(CHR.sup.a).sub.mR.sup.b, C(O)NH(CH.sub.2).sub.mR.sup.b, C(O)NH(CHR.sup.a).sub.mR.sup.b, O(CH.sub.2).sub.mC(O)NH(CH.sub.2).sub.mR.sup.b; [0268] each R.sup.a is independently selected from the group consisting of hydrogen, C.sub.1-6 alkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, C.sub.1-6 haloalkyl, C.sub.3-8 cycloalkyl, C.sub.6-10 aryl, C.sub.6-10 heteroaryl, C.sub.6-16 arylalkyl, 2-6 membered heteroalkyl and 3-8 membered heterocyclylalkyl, or R.sup.a together with the nitrogen and the R.sup.1 or R.sup.2 attached thereto forms a heterocyclylalkyl optionally substituted with one or more R.sup.d; [0269] Z is selected from halogen, C.sub.1-6 alkyl optionally substituted with one or more R.sup.b, OR.sup.a, C.sub.1-6 haloalkyl, or Z, together with R and the atoms to which Z and R are attached, forms a 5- or 6-membered ring optionally substituted with one or more of R.sup.a, R.sup.b, and R.sup.a substituted with one or more R.sup.b, R.sup.d, or both; [0270] R.sup.b is independently selected from the group consisting of O, OR.sup.d, halogen, C.sub.1-3 haloalkyloxy, OCF.sub.3, S, SR.sup.d, =NR.sup.d, =NOR.sup.d, NR.sup.cR.sup.c, SF.sub.5, halogen, CF.sub.3, CN, NO.sub.2, S(O)R.sup.d, S(O).sub.2R.sup.d, S(O).sub.2OR.sup.d, S(O)NR.sup.cR.sup.c, S(O).sub.2NR.sup.cR.sup.c, OS(O)R.sup.d, OS(O).sub.2R.sup.d, OS(O).sub.2OR.sup.d, OS(O).sub.2NR.sup.cR.sup.c, C(O)R.sup.d, C(O)OR.sup.d, C(O)NR.sup.cR.sup.c, C(NH)NR.sup.cR.sup.c, C(NR.sup.a)NR.sup.cR.sup.c, C(NOH)R.sup.a, C(NOH)NR.sup.cR.sup.c, OC(O)R.sup.d, OC(O)OR.sup.d, OC(O)NR.sup.cR.sup.c, OC(NH)NR.sup.cR.sup.c, OC(NR.sup.a)NR.sup.cR.sup.c, [NHC(O)].sub.nR.sup.d, [NR.sup.aC(O)].sub.nR.sup.d, [NHC(O)].sub.nOR.sup.d, [NR.sup.aC(O)].sub.nOR.sup.d, [NHC(O)].sub.nNR.sup.cR.sup.c, [NR.sup.aC(O)].sub.nNR.sup.cR.sup.c, [NHC(NH)].sub.nNR.sup.cR.sup.c and [NR.sup.aC(NR.sup.a)].sub.nNR.sup.cR.sup.c; [0271] each R.sup.c is independently R.sup.a, or, alternatively, two R.sup.c are taken together with the nitrogen atom to which they are bonded to form a 5 to 10-membered heterocyclylalkyl or heteroaryl which may optionally include one or more of the same or different additional heteroatoms and which may optionally be substituted with one or more of the same or different R.sup.e groups; [0272] each R.sup.d is independently hydrogen or C.sub.1-6 alkyl; [0273] each R.sup.e is independently halogen, C.sub.1-6 alkyl or C(O)R.sup.d; [0274] each m is independently an integer from 1 to 3; and [0275] each n is independently an integer from 0 to 3.
[0276] 2. The method of clause 1, wherein the compound has the formula
##STR00086##
[0277] 3. The method of clause 1, wherein the compound has the formula
##STR00087##
[0278] 4. The method of clause 1, wherein the compound has the formula
##STR00088##
[0279] 5. The method of any one of clauses 1-4, wherein at least one of R.sup.1 and R.sup.2 is C.sub.6-10 aryl, optionally substituted with one or more R.sup.3.
[0280] 6. The method of any one of clauses 1-5, wherein R.sup.1 and R.sup.2 are both C.sub.6-10 aryl, optionally substituted with one or more R.sup.5.
[0281] 7. The method of any one of clauses 1-6, wherein R.sup.1 and R.sup.2 are the same.
[0282] 8. The method of any one of clauses 1-5, wherein at least one of R.sup.1 and R.sup.2 is C.sub.1-6 alkyl.
[0283] 9. The method of any one of clauses 1-5, wherein one of R.sup.1 and R.sup.2 is aralkyl optionally substituted with one or more R.sup.5.
[0284] 10. The method of any one of clauses 1-5, wherein one of R.sup.1 and R.sup.2 is cycloalkyl optionally substituted with one or more R.sup.5.
[0285] 11. The method of any one of clauses 1-5, wherein one of R.sup.1 and R.sup.2 is heteroaryl optionally substituted with one or more R.sup.5.
[0286] 12. The method of any one of clauses 1-5, wherein one of R.sup.1 and R.sup.2 is heterocyclylalkyl optionally substituted with one or more R.sup.5.
[0287] 13. The method of any one of clauses 1-12, wherein at least one of R.sup.3 and R.sup.4 is hydrogen.
[0288] 14. The method of any one of clauses 1-13, wherein at least one of R; and R.sup.4 is C.sub.1-6 alkyl.
[0289] 15. The method of any one of clauses 1, 2 and 5-12, wherein the compound has the formula
##STR00089##
[0290] 16. The method of clause 1, wherein the compound has the formula
##STR00090##
[0291] 17. The method of clause 1, wherein the compound has the formula
##STR00091##
[0292] 18. The method of clause 1, wherein the compound has the formula
##STR00092##
[0293] 19. The method of clause 1, wherein R.sup.3 is R.sup.a that together with R.sup.1 and the nitrogen they are both attached to thereto forms a heterocyclylalkyl optionally substituted with one or more R.sup.d.
[0294] 20. The method of clause 1 or clause 19, wherein R.sup.4 is R.sup.a that together with R.sup.2 and the nitrogen they are both attached to thereto forms a heterocyclylalkyl optionally substituted with one or more R.sup.d.
[0295] 21. The method of clause 1, wherein R.sup.1 and R.sup.2 independently are selected from
##STR00093## ##STR00094## ##STR00095## ##STR00096##
[0296] 22. The method of any one of clauses 1-21, wherein contacting the apyrase comprises treating a crop with the compound.
[0297] 23. The method of clause 22, further comprising treating the crop with a pesticide.
[0298] 24. The method of clause 22, wherein the pesticide is selected from acaricides, fungicides, herbicides, insecticides, molluscicides, nematocides, or a combination thereof.
[0299] 25. The method of clause 23, wherein the pesticide comprises a fungicide.
[0300] 26. The method of clause 22, further comprising treating the crop with a fungicide selected from selected from benzimidazoles, dicarboximides, phenylpyrroles, anilinopyrimidines, hydroxyanilides, carboxamides, phenyl amides, phosphonates, cinnamic acids, oxysterol binding protein inhibitors (OSBPI), triazole carboxamides, cymoxanil, carbamates, benzamides, demethylation inhibiting piperazines, demethylation inhibiting pyrimidines, demethylation inhibiting azoles, including imidazoles and triazoles, such as cyproconazole, difenoconazole, fenbuconazole, flutriafol, mefentrifluconazole, metconazole, ipconazole, prothioconazole, tebuconazole, tetraconazole, triadimefon, triadimenol, triticonazole, morpholines, cyflufenamid, metrafenone, pyriofenone, strobilurins, copper ammonium complex, copper hydroxide, copper oxide, copper oxychloride, copper sulfate, sulfur, lime sulfur, ethylenebisdithiocarbamates, aromatic hydrocarbons, phthalimides, guanidines, polyoxins, fluazinam, thiazolidines and combinations thereof.
[0301] 27. The method of clause 23, wherein the pesticide comprises an herbicide.
[0302] 28. The method of clause 27, wherein the pesticide comprises glyphosate.
[0303] 29. A composition, comprising [0304] a fungicide; [0305] compound of the formula
##STR00097## wherein [0306] wherein R.sup.1 and R.sup.2 are independently selected from C.sub.1-6 alkyl optionally substituted with one or more R.sup.a optionally substituted with one or more R.sup.a, R.sup.b, or both; C.sub.6-10 aryl, optionally substituted with one or more R.sup.5, aralkyl optionally substituted with one or more R.sup.5, cycloalkyl optionally substituted with one or more R.sup.5, C.sub.5-10 heteroaryl optionally substituted with one or more R.sup.5 and heterocyclylalkyl optionally substituted with one or more R.sup.5; [0307] R.sup.3 and R.sup.4 are independently selected from hydrogen, C.sub.1-6 alkyl, C.sub.6-10 aryl, C.sub.5-10 heteroaryl, each optionally substituted with one or more R.sup.a and R.sup.b; or R.sup.3 and R.sup.4, together with the atoms to which they are attached form a dihydrophthalazine-1,4-dione; or [0308] each R.sup.5 is independently selected from R.sup.a, R.sup.b, R.sup.a substituted with one or more R.sup.a, R.sup.b, or both and OR.sup.a substituted with one or more of the same or different R.sup.a or R.sup.b, or (CH.sub.2).sub.mR.sup.b, (CH.sup.a).sub.mR.sup.b, O(CH.sub.2).sub.mR.sup.b, S(CH.sub.2).sub.mR.sup.b, OCHR.sup.aR.sup.b, OCR.sup.a(R).sub.2, O(CHR.sup.a).sub.mR.sup.b, O(CH.sub.2).sub.mCH[(CH.sub.2).sub.mR.sup.b]R.sup.b, S(CHR.sup.a).sub.mR.sup.b, C(O)NH(CH.sub.2).sub.mR.sup.b, C(O)NH(CHR.sup.a).sub.mR.sup.b, O(CH.sub.2).sub.mC(O)NH(CH.sub.2).sub.mR.sup.b; [0309] each R.sup.5 is independently selected from the group consisting of hydrogen, C.sub.1-6 alkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, C.sub.1-6 haloalkyl, C.sub.3-8 cycloalkyl, C.sub.6-10 aryl, C.sub.5-10 heteroaryl, C.sub.6-16 arylalkyl, 2-6 membered heteroalkyl and 3-8 membered heterocyclylalkyl, or R.sup.a together with the nitrogen and the R.sup.1 or R.sup.2 attached thereto forms a heterocyclylalkyl optionally substituted with one or more R.sup.d; [0310] Z is selected from halogen, C.sub.1-6 alkyl optionally substituted with one or more R.sup.b, OR.sup.a, C.sub.1-6 haloalkyl, or Z, together with R.sup.4 and the atoms to which Z and R are attached, forms a 5- or 6-membered ring optionally substituted with one or more of R.sup.a, R.sup.b, and R.sup.a substituted with one or more R.sup.b, R.sup.d, or both; [0311] R.sup.b is independently selected from the group consisting of =O, OR.sup.d, halogen, C.sub.1-3 haloalkyloxy, OCF.sub.3, S, SR.sup.d, =NR.sup.d, =NOR.sup.d, NR.sup.cR.sup.c, SF.sub.5, halogen, CF.sub.3, CN, NO.sub.2, S(O)R.sup.d, S(O).sub.2R.sup.d, S(O).sub.2OR.sup.d, S(O)NR.sup.cR.sup.c, S(O).sub.2NR.sup.cR.sup.c, OS(O)R.sup.d, OS(O).sub.2R.sup.d, OS(O).sub.2OR.sup.d, OS(O).sub.2NR.sup.cR.sup.c, C(O)R.sup.d, C(O)OR.sup.d, C(O)NR.sup.cR.sup.c, C(NH)NR.sup.cR.sup.c, C(NR.sup.a)NR.sup.cR.sup.c, C(NOH)R.sup.c, C(NOH)NR.sup.dR.sup.d, OC(O)R.sup.d, OC(O)OR.sup.d, OC(O)NR.sup.cR.sup.c, OC(NH)NR.sup.cR.sup.c, OC(NR.sup.a)NR.sup.cR.sup.c, [NHC(O)].sub.nR.sup.d, [NR.sup.aC(O)].sub.nR.sup.d, [NHC(O)].sub.nOR.sup.d, [NR.sup.aC(O)].sub.nOR.sup.d, [NHC(O)].sub.nNR.sup.cR.sup.c, [NR.sup.aC(O)].sub.nNR.sup.cR.sup.c, [NHC(NH)].sub.nNR.sup.cR.sup.c and [NR.sup.aC(NR.sup.a)].sub.nNR.sup.cR.sup.c; [0312] each R.sup.c is independently R.sup.a, or, alternatively, two R.sup.c are taken together with the nitrogen atom to which they are bonded to form a 5 to 10-membered heterocyclylalkyl or heteroaryl which may optionally include one or more of the same or different additional heteroatoms and which may optionally be substituted with one or more of the same or different R.sup.e groups; [0313] each R.sup.d is independently hydrogen or C.sub.1-6 alkyl; [0314] each R.sup.e is independently halogen, C.sub.1-6 alkyl or C(O)R.sup.d; [0315] each m is independently an integer from 1 to 3; and [0316] each n is independently an integer from 0 to 3; and
a phytologically acceptable carrier.
[0317] 30. The composition of clause 29, wherein the composition comprises from about 1 to about 80 weight percent of the compound.
[0318] 31. The composition of clause 30, wherein the composition is a suspension formulation.
[0319] 32. The composition of clause 31, wherein the composition comprises from about 1 to about 50 weight percent of the compound.
[0320] 33. The composition of clause 32, further comprising sodium polycarboxylate.
[0321] 34. The composition of clause 29, further comprising a biocide.
[0322] 35. The composition of clause 30, further comprising organosilicone antifoam emulsion.
[0323] 36. The composition of clause 33, wherein the composition is a wettable powder.
[0324] 37. The composition of clause 29, wherein the composition is an emulsifiable concentrate.
[0325] 38. The composition of clause 37, further comprising tristyrylphenol ethoxylates.
[0326] 39. The composition of clause 29, wherein the composition is an oil dispersible concentrate.
[0327] 40. A pesticidal composition, comprising [0328] a pesticide; [0329] compound of the formula
##STR00098##
wherein [0330] wherein R.sup.1 and R.sup.2 are independently selected from C.sub.1-6 alkyl optionally substituted with one or more R.sup.a optionally substituted with one or more R.sup.a, R.sup.b, or both; C.sub.6-10 aryl, optionally substituted with one or more R.sup.5, aralkyl optionally substituted with one or more R.sup.5, cycloalkyl optionally substituted with one or more R.sup.5, C.sub.5-10 heteroaryl optionally substituted with one or more R.sup.5 and heterocyclylalkyl optionally substituted with one or more R.sup.5; [0331] R.sup.3 and R.sup.4 are independently selected from hydrogen, C.sub.1-6 alkyl, C.sub.6-10 aryl, C.sub.5-10 heteroaryl, each optionally substituted with one or more R.sup.a and R.sup.b; or R.sup.3 and R.sup.4, together with the atoms to which they are attached form a dihydrophthalazine-1,4-dione; or [0332] each R.sup.5 is independently selected from R.sup.a, R.sup.b, R.sup.a substituted with one or more R.sup.a, R.sup.b, or both and OR.sup.a substituted with one or more of the same or different R.sup.a or R.sup.b, or (CH.sub.2).sub.mR.sup.b, (CHR).sub.mR.sup.b, O(CH.sub.2).sub.mR.sup.b, S(CH.sub.2).sub.mR.sup.b, OCHR.sup.aR.sup.b, OCR.sup.a(R.sup.b).sub.2, O(CHR.sup.a).sub.mR.sup.b, O(CH.sub.2).sub.mCH[(CH.sub.2).sub.mR.sup.b]R.sup.b, S(CHR.sup.a).sub.mR.sup.b, C(O)NH(CH.sub.2).sub.mR.sup.b, C(O)NH(CHR.sup.a).sub.mR.sup.b, O(CH.sub.2).sub.mC(O)NH(CH.sub.2)R.sup.b; [0333] each R.sup.a is independently selected from the group consisting of hydrogen, C.sub.1-6 alkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, C.sub.1-6 haloalkyl, C.sub.3-8 cycloalkyl, C.sub.6-10 aryl, C.sub.5-10 heteroaryl, C.sub.6-16 arylalkyl, 2-6 membered heteroalkyl and 3-8 membered heterocyclylalkyl, or R.sup.a together with the nitrogen and the R.sup.1 or R.sup.2 attached thereto forms a heterocyclylalkyl optionally substituted with one or more R.sup.d; [0334] Z is selected from halogen, C.sub.1-6 alkyl optionally substituted with one or more R.sup.b, OR.sup.a, C.sub.1-6 haloalkyl, or Z, together with R.sup.4 and the atoms to which Z and R are attached, forms a 5- or 6-membered ring optionally substituted with one or more of R.sup.a, R.sup.b, and R.sup.a substituted with one or more R.sup.b, R.sup.d, or both; [0335] R.sup.b is independently selected from the group consisting of O, OR.sup.d, halogen, C.sub.1-3 haloalkyloxy, OCF.sub.3, S, SR.sup.d, =NR.sup.d, =NOR.sup.d, NR.sup.cR.sup.c, SF.sub.5, halogen, CF.sub.3, CN, NO.sub.2, S(O)R.sup.d, S(O).sub.2R.sup.d, S(O).sub.2OR.sup.d, S(O)NR.sup.cR.sup.c, S(O).sub.2NR.sup.cR.sup.c, OS(O)R.sup.d, OS(O).sub.2R.sup.d, OS(O).sub.2OR.sup.d, OS(O).sub.2NR.sup.cR.sup.c, C(O)R.sup.d, C(O)OR.sup.d, C(O)NR.sup.cR.sup.c, C(NH)NR.sup.cR.sup.c, C(NR.sup.a)NR.sup.cR.sup.c, C(NOH)R.sup.d, C(NOH)NR.sup.cR.sup.c, OC(O)R.sup.d, OC(O)OR.sup.d, OC(O)NR.sup.cR.sup.c, OC(NH)NR.sup.cR.sup.c, OC(NR.sup.a)NR.sup.cR.sup.c, [NHC(O)].sub.nR.sup.d, [NR.sup.aC(O)].sub.nR.sup.d, [NHC(O)].sub.nOR.sup.d, [NR.sup.aC(O)].sub.nOR.sup.d, [NHC(O)].sub.nNR.sup.cR.sup.c, [NR.sup.aC(O)].sub.nNR.sup.cR.sup.c, [NHC(NH)].sub.nNR.sup.cR.sup.c and [NR.sup.aC(NR.sup.a)].sub.nNR.sup.cR.sup.c; [0336] each R.sup.c is independently R.sup.a, or, alternatively, two R.sup.c are taken together with the nitrogen atom to which they are bonded to form a 5 to 10-membered heterocyclylalkyl or heteroaryl which may optionally include one or more of the same or different additional heteroatoms and which may optionally be substituted with one or more of the same or different R.sup.e groups; [0337] each R.sup.d is independently hydrogen or C.sub.1-6 alkyl; [0338] each R.sup.e is independently halogen, C.sub.1-6 alkyl or C(O)R.sup.d; [0339] each m is independently an integer from 1 to 3; and [0340] each n is independently an integer from 0 to 3; and
a phytologically acceptable carrier.
[0341] 41. The pesticidal composition of clause 40, wherein the pesticide comprises an acaricide, fungicide, herbicide, insecticide, molluscicide, nematocide, or a combination thereof.
[0342] 42. A fungicidal composition, comprising [0343] a fungicide; [0344] compound of the formula
##STR00099## wherein [0345] wherein R.sup.1 and R.sup.2 are independently selected from C.sub.1-6 alkyl optionally substituted with one or more R.sub.a optionally substituted with one or more R.sup.a, R.sup.b, or both; C.sub.6-10 aryl, optionally substituted with one or more R.sup.5, aralkyl optionally substituted with one or more R.sup.5, cycloalkyl optionally substituted with one or more R.sup.5, C.sub.5-10 heteroaryl optionally substituted with one or more R.sup.5 and heterocyclylalkyl optionally substituted with one or more R.sup.5; [0346] R.sup.3 and R.sup.4 are independently selected from hydrogen, C.sub.1-6 alkyl, C.sub.6-10 aryl, C.sub.6-10 heteroaryl, each optionally substituted with one or more R.sup.a and R.sup.b; or R.sup.3 and R.sup.4, together with the atoms to which they are attached form a dihydrophthalazine-1,4-dione; or [0347] each R.sup.5 is independently selected from R.sup.a, R.sup.b, R.sup.a substituted with one or more R.sup.a, R.sup.b, or both and OR.sup.a substituted with one or more of the same or different R.sup.a or R.sup.b, or (CH.sub.2).sub.mR.sup.b, (CHR.sup.a).sub.mR.sup.b, O(CH.sub.2).sub.mR.sup.b, S(CH.sub.2).sub.mR.sup.b, OCHR.sup.aR.sup.b, OCR.sup.a(R.sup.b).sub.2, O(CHR.sup.a), R.sup.b, O(CH.sub.2).sub.mCH[(CH.sub.2).sub.mR.sup.b]R.sup.b, S(CHR.sup.a).sub.mR.sup.b, C(O)NH(CH.sub.2).sub.mR.sup.b, C(O)NH(CHR.sup.a).sub.mR.sup.b, O(CH.sub.2).sub.mC(O)NH(CH.sub.2).sub.mR.sup.b; [0348] each R.sup.a is independently selected from the group consisting of hydrogen, C.sub.1-6 alkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, C.sub.1-6 haloalkyl, C.sub.3-8 cycloalkyl, C.sub.6-10 aryl, C.sub.5-10 heteroaryl, C.sub.6-16 arylalkyl, 2-6 membered heteroalkyl and 3-8 membered heterocyclylalkyl, or R.sup.a together with the nitrogen and the R.sup.1 or R.sup.2 attached thereto forms a heterocyclylalkyl optionally substituted with one or more R.sup.d; [0349] Z is selected from halogen, C.sub.1-6 alkyl optionally substituted with one or more R.sup.b, OR.sup.a, C.sub.1-6 haloalkyl, or Z, together with R and the atoms to which Z and R are attached, forms a 5- or 6-membered Ting optionally substituted with one or more of R.sup.a, R.sup.b, and R.sup.a substituted with one or more R.sup.b, R.sup.d, or both; [0350] R.sup.b is independently selected from the group consisting of =O, OR.sup.d, halogen, C.sub.1-3 haloalkyloxy, OCF.sub.3, S, SR.sup.d, =NR.sup.d, =NOR.sup.d, NR.sup.cR.sup.c, SF.sub.5, halogen, CF.sub.3, CN, NO.sub.2, S(O)R.sup.d, S(O).sub.2R.sup.d, S(O).sub.2OR.sup.d, S(O)NR.sup.cR.sup.c, S(O).sub.2NR.sup.cR.sup.c, OS(O)R.sup.d, OS(O).sub.2R.sup.d, OS(O).sub.2OR.sup.d, OS(O).sub.2NR.sup.cR.sup.c, C(O)R.sup.d, C(O)OR.sup.d, C(O)NR.sup.cR.sup.c, C(NH)NR.sup.cR.sup.c, C(NR.sup.a)NR.sup.cR.sup.c, C(NOH)R.sup.a, C(NOH)NR.sup.cR.sup.c, OC(O)R.sup.d, OC(O)OR.sup.d, OC(O)NR.sup.cR.sup.c, OC(NH)NR.sup.cR.sup.c, OC(NR.sup.a)NR.sup.cR.sup.c, [NHC(O)].sub.nR.sup.d, [NR.sup.aC(O)].sub.nR.sup.d, [NHC(O)].sub.nOR.sup.d, [NR.sup.aC(O)].sub.nOR.sup.d, [NHC(O)].sub.nNR.sup.cR.sup.c, [NR.sup.aC(O)].sub.nNR.sup.cR.sup.c, [NHC(NH)].sub.nNR.sup.cR.sup.c and [NR.sup.aC(NR.sup.a)].sub.nNR.sup.cR.sup.c; [0351] each R.sup.c is independently R.sup.a, or, alternatively, two R.sup.c are taken together with the nitrogen atom to which they are bonded to form a 5 to 10-membered heterocyclylalkyl or heteroaryl which may optionally include one or more of the same or different additional heteroatoms and which may optionally be substituted with one or more of the same or different R.sup.e groups; [0352] each R.sup.d is independently hydrogen or C.sub.1-6 alkyl; [0353] each R.sup.e is independently halogen, C.sub.1-6 alkyl or C(O)R.sup.d; [0354] each m is independently an integer from 1 to 3; and [0355] each n is independently an integer from 0 to 3; and
a phytologically acceptable carrier.
[0356] 43. The composition of clause 42, wherein the fungicide is selected from the group consisting of benzimidazoles, dicarboximides, phenylpyrroles, anilinopyrimidines, hydroxyanilides, carboxamides, phenyl amides, phosphonates, cinnamic acids, oxysterol binding protein inhibitors, triazole carboxamides, cymoxanil, carbamates, benzamides, demethylation inhibiting piperazines, demethylation inhibiting pyrimidines, demethylation inhibiting azoles, including imidazoles and triazoles, cyproconazole, difenoconazole, fenbuconazole, flutriafol, mefentrifluconazole, metconazole, ipconazole, prothioconazole, tebuconazole, tetraconazole, triadimefon, triadimenol, triticonazole, morpholines, cyflufenamid, metrafenone, pyriofenone, strobilurins, copper ammonium complex, copper hydroxide, copper oxide, copper oxychloride, copper sulfate, sulfur, lime sulfur, ethylenebisdithiocarbamates, aromatic hydrocarbons, phthalimides, guanidines, polyoxins, fluazinam, thiazolidines and combinations thereof.
[0357] In view of the many possible embodiments to which the principles of the disclosed invention may be applied, it should be recognized that the illustrated embodiments are only preferred examples of the invention and should not be taken as limiting the scope of the invention. Rather, the scope of the invention is defined by the following claims. We therefore claim as our invention all that comes within the scope and spirit of these claims.